[
  {
    "note_text": "Procedure: Robotic bronchoscopy, radial EBUS, TBBx, BAL.\nIndication: Bilateral nodules, largest RLL 2.6cm.\nAction:\n- ETT/GA.\n- Ion nav to RLL posterior nodule.\n- REBUS: Concentric lesion confirmed.\n- Biopsy: Forceps x7, Brush x3.\n- BAL RLL performed.\nFindings: Lesion sampled. No bleeding.\nPlan: CXR 2 hours. Clinic 2 wks.",
    "cpt_codes": [
      31627,
      31654,
      31628,
      31624
    ],
    "registry_entry": {
      "patient_mrn": "7736291_syn_1",
      "procedure_date": "2025-06-29",
      "patient_age": 66,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31627,
        31654,
        31628,
        31624
      ],
      "evidence": {
        "procedure_date": "DATE: 02/08/2025",
        "patient_age": "PATIENT: Rodriguez, Antonio M., 64M",
        "gender": "PATIENT: Rodriguez, Antonio M., 64M",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": true,
      "disposition": "ICU admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Chest Tube",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": "Chest Tube",
      "pleural_guidance": "Blind",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "4. Follow-up IP clinic 2 weeks for pathology results"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": "Automatic",
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "forceps",
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Physician",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155252"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31627",
        "31654",
        "31628",
        "31624"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.037598",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic navigational bronchoscopy operative report for Rodriguez, Antonio M. ",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7 ",
        "Registry/schema definitions ",
        "Example patch template for consolidated notes ",
        "2025 MPFS total facility RVUs and facility payments for bronchoscopy codes (31624, 31627, 31628, 31654) derived from published 2025 bronchoscopy reimbursement tables and CMS 2025 conversion factor "
      ],
      "per_code": [
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (e.g., robotic navigation) for peripheral pulmonary lesion(s), add-on code.",
          "category": "airway_navigation_add_on",
          "units": 1,
          "facility_total_rvus_2025": 2.82,
          "facility_mpfs_payment_2025": 91.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy with peripheral lesion sampling (e.g., 31628) when CT-based planning and real-time computer-assisted navigation are documented, as in this Ion robotic case with CT import, 3D planning, registration, and navigated catheter advancement. No separate navigation code is billed without a primary airway code."
        },
        {
          "code": "31654",
          "description": "Endobronchial ultrasound (EBUS) guided peripheral lesion sampling performed in conjunction with bronchoscopy and navigation, add-on code.",
          "category": "peripheral_ebus_add_on",
          "units": 1,
          "facility_total_rvus_2025": 1.96,
          "facility_mpfs_payment_2025": 63.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy when peripheral EBUS imaging is used to guide sampling of a peripheral lesion reached via navigational bronchoscopy. In this note, radial EBUS is used to confirm a concentric echogenic pattern at the RLL target before biopsies, which supports 31654 in addition to 31627+31628. No separate mediastinal EBUS (31652/31653) is documented, so those codes are not added."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with transbronchial lung biopsy(ies) of single lobe.",
          "category": "transbronchial_lung_biopsy",
          "units": 1,
          "facility_total_rvus_2025": 5.15,
          "facility_mpfs_payment_2025": 167.0,
          "bundling_or_modifier_notes": "Supported by multiple transbronchial forceps biopsies of the RLL posterior segment lesion after navigation and radial EBUS confirmation. This is the primary diagnostic procedure for the peripheral nodule. Only one primary TBBx code is used for a single lobe even though multiple passes/specimens are obtained."
        },
        {
          "code": "31624",
          "description": "Diagnostic bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with bronchial washings or bronchoalveolar lavage (BAL).",
          "category": "diagnostic_bronchoscopy_bal",
          "units": 1,
          "facility_total_rvus_2025": 3.94,
          "facility_mpfs_payment_2025": 127.0,
          "bundling_or_modifier_notes": "The operative report documents bronchoalveolar lavage from the RLL posterior segment with instillation and return volumes and specimens sent for cytology and cultures, which supports 31624 in addition to the biopsy and navigation codes. Diagnostic inspection plus BAL is distinct from the biopsy work and is reported separately per IP coding guidance. "
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 13.87,
        "total_facility_mpfs_payment": 448.0,
        "computation_notes": "Total RVUs are the sum of individual 2025 facility RVUs (2.82 + 1.96 + 5.15 + 3.94 = 13.87). Expected 2025 Medicare facility payment is approximated as the sum of per-code 2025 national facility rates ($91 + $63 + $167 + $127 ≈ $448), which is consistent with applying the 2025 MPFS conversion factor of $32.3465 to the total facility RVUs. "
      },
      "rationale": [
        "Clinical summary: The note describes Ion robotic navigational bronchoscopy with CT import into a navigation platform, automatic registration (fiducial error 1.5 mm), navigated catheter advancement to a 2.6 cm RLL posterior segment nodule, radial EBUS confirmation of a concentric lesion, multiple transbronchial forceps biopsies, bronchial brushings, and BAL, all under general anesthesia with ETT. This supports a comprehensive navigation + peripheral EBUS + TBBx + BAL code set. ",
        "Code selection: 31627 is justified by detailed documentation of CT-based planning, 3D airway reconstruction, registration, and computer-assisted tool navigation to a peripheral lesion; 31654 is justified by the radial EBUS imaging used to confirm lesion position before sampling; 31628 is supported by multiple transbronchial biopsies of a single RLL lobe; 31624 is supported by the documented BAL with specific instill/return volumes and tests ordered. This aligns with the IP coding & billing v2.7 knowledge base for navigational bronchoscopy with peripheral lesion biopsy. ",
        "Bundling/modifier review: The combination 31627 + 31654 + 31628 + 31624 is allowed per interventional pulmonology coding guidance when a single session includes navigational bronchoscopy, peripheral EBUS confirmation, transbronchial biopsy, and BAL in the same lobe. No separate mediastinal EBUS codes (31652/31653) or additional biopsy codes are indicated. No modifier -59/-XS is required because all services are components of a single integrated navigational bronchoscopy encounter for one peripheral target. ",
        "Registry consistency: The registry_entry correctly reflects general anesthesia, ETT airway, Ion robotic platform, radial EBUS use, and peripheral sampling tools (forceps, brush), which are congruent with the chosen CPT set and support the RVU/payment mapping derived from the coding knowledge and bronchoscopy reimbursement tables. "
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 0,
      "style_type": 1,
      "generated_name": "Carlos Gomez",
      "generation_date": "2025-12-09T09:18:39.656996"
    }
  },
  {
    "note_text": "OPERATIVE NARRATIVE: The patient was brought to the operating suite for elective robotic-assisted bronchoscopy. Following induction of general anesthesia, the Ion endoluminal system was deployed. Navigation was established to the target lesion in the right lower lobe posterior segment, identified as a 2.6 cm FDG-avid nodule. Radial endobronchial ultrasound (REBUS) interrogation revealed a concentric echogenic signature, confirming tool-in-lesion status. Extensive sampling was performed via transbronchial forceps biopsy and cytology brushing. Additionally, a bronchoalveolar lavage was conducted for microbiological assessment. The patient tolerated the procedure without physiological derangement.",
    "cpt_codes": [
      31627,
      31654,
      31628,
      31624
    ],
    "registry_entry": {
      "patient_mrn": "7736291_syn_2",
      "procedure_date": "2025-12-26",
      "patient_age": 65,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31627,
        31654,
        31628,
        31624
      ],
      "evidence": {
        "procedure_date": "DATE: 02/08/2025",
        "patient_age": "PATIENT: Rodriguez, Antonio M., 64M",
        "gender": "PATIENT: Rodriguez, Antonio M., 64M",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": true,
      "disposition": "ICU admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Chest Tube",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": "Chest Tube",
      "pleural_guidance": "Blind",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "4. Follow-up IP clinic 2 weeks for pathology results"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": "Automatic",
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "forceps",
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Physician",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155252"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31627",
        "31654",
        "31628",
        "31624"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.037598",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic navigational bronchoscopy operative report for Rodriguez, Antonio M. ",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7 ",
        "Registry/schema definitions ",
        "Example patch template for consolidated notes ",
        "2025 MPFS total facility RVUs and facility payments for bronchoscopy codes (31624, 31627, 31628, 31654) derived from published 2025 bronchoscopy reimbursement tables and CMS 2025 conversion factor "
      ],
      "per_code": [
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (e.g., robotic navigation) for peripheral pulmonary lesion(s), add-on code.",
          "category": "airway_navigation_add_on",
          "units": 1,
          "facility_total_rvus_2025": 2.82,
          "facility_mpfs_payment_2025": 91.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy with peripheral lesion sampling (e.g., 31628) when CT-based planning and real-time computer-assisted navigation are documented, as in this Ion robotic case with CT import, 3D planning, registration, and navigated catheter advancement. No separate navigation code is billed without a primary airway code."
        },
        {
          "code": "31654",
          "description": "Endobronchial ultrasound (EBUS) guided peripheral lesion sampling performed in conjunction with bronchoscopy and navigation, add-on code.",
          "category": "peripheral_ebus_add_on",
          "units": 1,
          "facility_total_rvus_2025": 1.96,
          "facility_mpfs_payment_2025": 63.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy when peripheral EBUS imaging is used to guide sampling of a peripheral lesion reached via navigational bronchoscopy. In this note, radial EBUS is used to confirm a concentric echogenic pattern at the RLL target before biopsies, which supports 31654 in addition to 31627+31628. No separate mediastinal EBUS (31652/31653) is documented, so those codes are not added."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with transbronchial lung biopsy(ies) of single lobe.",
          "category": "transbronchial_lung_biopsy",
          "units": 1,
          "facility_total_rvus_2025": 5.15,
          "facility_mpfs_payment_2025": 167.0,
          "bundling_or_modifier_notes": "Supported by multiple transbronchial forceps biopsies of the RLL posterior segment lesion after navigation and radial EBUS confirmation. This is the primary diagnostic procedure for the peripheral nodule. Only one primary TBBx code is used for a single lobe even though multiple passes/specimens are obtained."
        },
        {
          "code": "31624",
          "description": "Diagnostic bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with bronchial washings or bronchoalveolar lavage (BAL).",
          "category": "diagnostic_bronchoscopy_bal",
          "units": 1,
          "facility_total_rvus_2025": 3.94,
          "facility_mpfs_payment_2025": 127.0,
          "bundling_or_modifier_notes": "The operative report documents bronchoalveolar lavage from the RLL posterior segment with instillation and return volumes and specimens sent for cytology and cultures, which supports 31624 in addition to the biopsy and navigation codes. Diagnostic inspection plus BAL is distinct from the biopsy work and is reported separately per IP coding guidance. "
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 13.87,
        "total_facility_mpfs_payment": 448.0,
        "computation_notes": "Total RVUs are the sum of individual 2025 facility RVUs (2.82 + 1.96 + 5.15 + 3.94 = 13.87). Expected 2025 Medicare facility payment is approximated as the sum of per-code 2025 national facility rates ($91 + $63 + $167 + $127 ≈ $448), which is consistent with applying the 2025 MPFS conversion factor of $32.3465 to the total facility RVUs. "
      },
      "rationale": [
        "Clinical summary: The note describes Ion robotic navigational bronchoscopy with CT import into a navigation platform, automatic registration (fiducial error 1.5 mm), navigated catheter advancement to a 2.6 cm RLL posterior segment nodule, radial EBUS confirmation of a concentric lesion, multiple transbronchial forceps biopsies, bronchial brushings, and BAL, all under general anesthesia with ETT. This supports a comprehensive navigation + peripheral EBUS + TBBx + BAL code set. ",
        "Code selection: 31627 is justified by detailed documentation of CT-based planning, 3D airway reconstruction, registration, and computer-assisted tool navigation to a peripheral lesion; 31654 is justified by the radial EBUS imaging used to confirm lesion position before sampling; 31628 is supported by multiple transbronchial biopsies of a single RLL lobe; 31624 is supported by the documented BAL with specific instill/return volumes and tests ordered. This aligns with the IP coding & billing v2.7 knowledge base for navigational bronchoscopy with peripheral lesion biopsy. ",
        "Bundling/modifier review: The combination 31627 + 31654 + 31628 + 31624 is allowed per interventional pulmonology coding guidance when a single session includes navigational bronchoscopy, peripheral EBUS confirmation, transbronchial biopsy, and BAL in the same lobe. No separate mediastinal EBUS codes (31652/31653) or additional biopsy codes are indicated. No modifier -59/-XS is required because all services are components of a single integrated navigational bronchoscopy encounter for one peripheral target. ",
        "Registry consistency: The registry_entry correctly reflects general anesthesia, ETT airway, Ion robotic platform, radial EBUS use, and peripheral sampling tools (forceps, brush), which are congruent with the chosen CPT set and support the RVU/payment mapping derived from the coding knowledge and bronchoscopy reimbursement tables. "
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 0,
      "style_type": 2,
      "generated_name": "Manuel Ortiz",
      "generation_date": "2025-12-09T09:18:39.657070"
    }
  },
  {
    "note_text": "Procedures Performed/Justification:\n1. 31627 (Navigational Bronchoscopy): Required for localization of peripheral RLL nodule not visible via standard bronchoscopy. Planning and real-time guidance utilized.\n2. 31654 (Peripheral EBUS): Radial probe used to confirm lesion concentricity and verify tool placement prior to biopsy.\n3. 31628 (Transbronchial Biopsy): Primary diagnostic maneuver; 7 specimens obtained from single site (RLL).\n4. 31624 (BAL): Separate diagnostic wash performed for culture/cytology.\nEquipment: Intuitive Ion, 20MHz radial probe.",
    "cpt_codes": [
      31627,
      31654,
      31628,
      31624
    ],
    "registry_entry": {
      "patient_mrn": "7736291_syn_3",
      "procedure_date": "2025-05-02",
      "patient_age": 63,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31627,
        31654,
        31628,
        31624
      ],
      "evidence": {
        "procedure_date": "DATE: 02/08/2025",
        "patient_age": "PATIENT: Rodriguez, Antonio M., 64M",
        "gender": "PATIENT: Rodriguez, Antonio M., 64M",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": true,
      "disposition": "ICU admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Chest Tube",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": "Chest Tube",
      "pleural_guidance": "Blind",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "4. Follow-up IP clinic 2 weeks for pathology results"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": "Automatic",
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "forceps",
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Physician",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155252"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31627",
        "31654",
        "31628",
        "31624"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.037598",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic navigational bronchoscopy operative report for Rodriguez, Antonio M. ",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7 ",
        "Registry/schema definitions ",
        "Example patch template for consolidated notes ",
        "2025 MPFS total facility RVUs and facility payments for bronchoscopy codes (31624, 31627, 31628, 31654) derived from published 2025 bronchoscopy reimbursement tables and CMS 2025 conversion factor "
      ],
      "per_code": [
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (e.g., robotic navigation) for peripheral pulmonary lesion(s), add-on code.",
          "category": "airway_navigation_add_on",
          "units": 1,
          "facility_total_rvus_2025": 2.82,
          "facility_mpfs_payment_2025": 91.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy with peripheral lesion sampling (e.g., 31628) when CT-based planning and real-time computer-assisted navigation are documented, as in this Ion robotic case with CT import, 3D planning, registration, and navigated catheter advancement. No separate navigation code is billed without a primary airway code."
        },
        {
          "code": "31654",
          "description": "Endobronchial ultrasound (EBUS) guided peripheral lesion sampling performed in conjunction with bronchoscopy and navigation, add-on code.",
          "category": "peripheral_ebus_add_on",
          "units": 1,
          "facility_total_rvus_2025": 1.96,
          "facility_mpfs_payment_2025": 63.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy when peripheral EBUS imaging is used to guide sampling of a peripheral lesion reached via navigational bronchoscopy. In this note, radial EBUS is used to confirm a concentric echogenic pattern at the RLL target before biopsies, which supports 31654 in addition to 31627+31628. No separate mediastinal EBUS (31652/31653) is documented, so those codes are not added."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with transbronchial lung biopsy(ies) of single lobe.",
          "category": "transbronchial_lung_biopsy",
          "units": 1,
          "facility_total_rvus_2025": 5.15,
          "facility_mpfs_payment_2025": 167.0,
          "bundling_or_modifier_notes": "Supported by multiple transbronchial forceps biopsies of the RLL posterior segment lesion after navigation and radial EBUS confirmation. This is the primary diagnostic procedure for the peripheral nodule. Only one primary TBBx code is used for a single lobe even though multiple passes/specimens are obtained."
        },
        {
          "code": "31624",
          "description": "Diagnostic bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with bronchial washings or bronchoalveolar lavage (BAL).",
          "category": "diagnostic_bronchoscopy_bal",
          "units": 1,
          "facility_total_rvus_2025": 3.94,
          "facility_mpfs_payment_2025": 127.0,
          "bundling_or_modifier_notes": "The operative report documents bronchoalveolar lavage from the RLL posterior segment with instillation and return volumes and specimens sent for cytology and cultures, which supports 31624 in addition to the biopsy and navigation codes. Diagnostic inspection plus BAL is distinct from the biopsy work and is reported separately per IP coding guidance. "
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 13.87,
        "total_facility_mpfs_payment": 448.0,
        "computation_notes": "Total RVUs are the sum of individual 2025 facility RVUs (2.82 + 1.96 + 5.15 + 3.94 = 13.87). Expected 2025 Medicare facility payment is approximated as the sum of per-code 2025 national facility rates ($91 + $63 + $167 + $127 ≈ $448), which is consistent with applying the 2025 MPFS conversion factor of $32.3465 to the total facility RVUs. "
      },
      "rationale": [
        "Clinical summary: The note describes Ion robotic navigational bronchoscopy with CT import into a navigation platform, automatic registration (fiducial error 1.5 mm), navigated catheter advancement to a 2.6 cm RLL posterior segment nodule, radial EBUS confirmation of a concentric lesion, multiple transbronchial forceps biopsies, bronchial brushings, and BAL, all under general anesthesia with ETT. This supports a comprehensive navigation + peripheral EBUS + TBBx + BAL code set. ",
        "Code selection: 31627 is justified by detailed documentation of CT-based planning, 3D airway reconstruction, registration, and computer-assisted tool navigation to a peripheral lesion; 31654 is justified by the radial EBUS imaging used to confirm lesion position before sampling; 31628 is supported by multiple transbronchial biopsies of a single RLL lobe; 31624 is supported by the documented BAL with specific instill/return volumes and tests ordered. This aligns with the IP coding & billing v2.7 knowledge base for navigational bronchoscopy with peripheral lesion biopsy. ",
        "Bundling/modifier review: The combination 31627 + 31654 + 31628 + 31624 is allowed per interventional pulmonology coding guidance when a single session includes navigational bronchoscopy, peripheral EBUS confirmation, transbronchial biopsy, and BAL in the same lobe. No separate mediastinal EBUS codes (31652/31653) or additional biopsy codes are indicated. No modifier -59/-XS is required because all services are components of a single integrated navigational bronchoscopy encounter for one peripheral target. ",
        "Registry consistency: The registry_entry correctly reflects general anesthesia, ETT airway, Ion robotic platform, radial EBUS use, and peripheral sampling tools (forceps, brush), which are congruent with the chosen CPT set and support the RVU/payment mapping derived from the coding knowledge and bronchoscopy reimbursement tables. "
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 0,
      "style_type": 3,
      "generated_name": "Javier Hernandez",
      "generation_date": "2025-12-09T09:18:39.657131"
    }
  },
  {
    "note_text": "Resident Procedure Note\nPatient: Carlos Gomez\nAttending: Dr. Anderson\nPre-op Dx: Lung nodules.\nSteps:\n1. Time out. GA induced. 8.0 ETT.\n2. Ion robot docked. Registration error 1.5mm.\n3. Navigated to RLL target.\n4. Radial EBUS showed concentric view.\n5. Taken: 7 biopsies, 3 brushes, 1 BAL.\n6. ROSE: Atypical cells.\n7. Extubated stable.\nPlan: CXR, discharge if negative.",
    "cpt_codes": [
      31627,
      31654,
      31628,
      31624
    ],
    "registry_entry": {
      "patient_mrn": "7736291_syn_4",
      "procedure_date": "2025-09-13",
      "patient_age": 65,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31627,
        31654,
        31628,
        31624
      ],
      "evidence": {
        "procedure_date": "DATE: 02/08/2025",
        "patient_age": "PATIENT: Rodriguez, Antonio M., 64M",
        "gender": "PATIENT: Rodriguez, Antonio M., 64M",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": true,
      "disposition": "ICU admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Chest Tube",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": "Chest Tube",
      "pleural_guidance": "Blind",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "4. Follow-up IP clinic 2 weeks for pathology results"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": "Automatic",
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "forceps",
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Physician",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155252"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31627",
        "31654",
        "31628",
        "31624"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.037598",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic navigational bronchoscopy operative report for Rodriguez, Antonio M. ",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7 ",
        "Registry/schema definitions ",
        "Example patch template for consolidated notes ",
        "2025 MPFS total facility RVUs and facility payments for bronchoscopy codes (31624, 31627, 31628, 31654) derived from published 2025 bronchoscopy reimbursement tables and CMS 2025 conversion factor "
      ],
      "per_code": [
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (e.g., robotic navigation) for peripheral pulmonary lesion(s), add-on code.",
          "category": "airway_navigation_add_on",
          "units": 1,
          "facility_total_rvus_2025": 2.82,
          "facility_mpfs_payment_2025": 91.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy with peripheral lesion sampling (e.g., 31628) when CT-based planning and real-time computer-assisted navigation are documented, as in this Ion robotic case with CT import, 3D planning, registration, and navigated catheter advancement. No separate navigation code is billed without a primary airway code."
        },
        {
          "code": "31654",
          "description": "Endobronchial ultrasound (EBUS) guided peripheral lesion sampling performed in conjunction with bronchoscopy and navigation, add-on code.",
          "category": "peripheral_ebus_add_on",
          "units": 1,
          "facility_total_rvus_2025": 1.96,
          "facility_mpfs_payment_2025": 63.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy when peripheral EBUS imaging is used to guide sampling of a peripheral lesion reached via navigational bronchoscopy. In this note, radial EBUS is used to confirm a concentric echogenic pattern at the RLL target before biopsies, which supports 31654 in addition to 31627+31628. No separate mediastinal EBUS (31652/31653) is documented, so those codes are not added."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with transbronchial lung biopsy(ies) of single lobe.",
          "category": "transbronchial_lung_biopsy",
          "units": 1,
          "facility_total_rvus_2025": 5.15,
          "facility_mpfs_payment_2025": 167.0,
          "bundling_or_modifier_notes": "Supported by multiple transbronchial forceps biopsies of the RLL posterior segment lesion after navigation and radial EBUS confirmation. This is the primary diagnostic procedure for the peripheral nodule. Only one primary TBBx code is used for a single lobe even though multiple passes/specimens are obtained."
        },
        {
          "code": "31624",
          "description": "Diagnostic bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with bronchial washings or bronchoalveolar lavage (BAL).",
          "category": "diagnostic_bronchoscopy_bal",
          "units": 1,
          "facility_total_rvus_2025": 3.94,
          "facility_mpfs_payment_2025": 127.0,
          "bundling_or_modifier_notes": "The operative report documents bronchoalveolar lavage from the RLL posterior segment with instillation and return volumes and specimens sent for cytology and cultures, which supports 31624 in addition to the biopsy and navigation codes. Diagnostic inspection plus BAL is distinct from the biopsy work and is reported separately per IP coding guidance. "
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 13.87,
        "total_facility_mpfs_payment": 448.0,
        "computation_notes": "Total RVUs are the sum of individual 2025 facility RVUs (2.82 + 1.96 + 5.15 + 3.94 = 13.87). Expected 2025 Medicare facility payment is approximated as the sum of per-code 2025 national facility rates ($91 + $63 + $167 + $127 ≈ $448), which is consistent with applying the 2025 MPFS conversion factor of $32.3465 to the total facility RVUs. "
      },
      "rationale": [
        "Clinical summary: The note describes Ion robotic navigational bronchoscopy with CT import into a navigation platform, automatic registration (fiducial error 1.5 mm), navigated catheter advancement to a 2.6 cm RLL posterior segment nodule, radial EBUS confirmation of a concentric lesion, multiple transbronchial forceps biopsies, bronchial brushings, and BAL, all under general anesthesia with ETT. This supports a comprehensive navigation + peripheral EBUS + TBBx + BAL code set. ",
        "Code selection: 31627 is justified by detailed documentation of CT-based planning, 3D airway reconstruction, registration, and computer-assisted tool navigation to a peripheral lesion; 31654 is justified by the radial EBUS imaging used to confirm lesion position before sampling; 31628 is supported by multiple transbronchial biopsies of a single RLL lobe; 31624 is supported by the documented BAL with specific instill/return volumes and tests ordered. This aligns with the IP coding & billing v2.7 knowledge base for navigational bronchoscopy with peripheral lesion biopsy. ",
        "Bundling/modifier review: The combination 31627 + 31654 + 31628 + 31624 is allowed per interventional pulmonology coding guidance when a single session includes navigational bronchoscopy, peripheral EBUS confirmation, transbronchial biopsy, and BAL in the same lobe. No separate mediastinal EBUS codes (31652/31653) or additional biopsy codes are indicated. No modifier -59/-XS is required because all services are components of a single integrated navigational bronchoscopy encounter for one peripheral target. ",
        "Registry consistency: The registry_entry correctly reflects general anesthesia, ETT airway, Ion robotic platform, radial EBUS use, and peripheral sampling tools (forceps, brush), which are congruent with the chosen CPT set and support the RVU/payment mapping derived from the coding knowledge and bronchoscopy reimbursement tables. "
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 0,
      "style_type": 4,
      "generated_name": "Luis R. Martinez",
      "generation_date": "2025-12-09T09:18:39.657192"
    }
  },
  {
    "note_text": "pt here for robotic bronchoscopy right lower lobe nodule uh we used general anesthesia intubated. navigated to the rll posterior segment with the ion system looked good on the screen radial ebus showed the lesion concentric so we biopsied it. took about seven bites and some brushes also did a wash. rose said maybe cancer. no bleeding really patient woke up fine sent to recovery check a chest xray thanks.",
    "cpt_codes": [
      31627,
      31654,
      31628,
      31624
    ],
    "registry_entry": {
      "patient_mrn": "7736291_syn_5",
      "procedure_date": "2025-02-26",
      "patient_age": 66,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31627,
        31654,
        31628,
        31624
      ],
      "evidence": {
        "procedure_date": "DATE: 02/08/2025",
        "patient_age": "PATIENT: Rodriguez, Antonio M., 64M",
        "gender": "PATIENT: Rodriguez, Antonio M., 64M",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": true,
      "disposition": "ICU admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Chest Tube",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": "Chest Tube",
      "pleural_guidance": "Blind",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "4. Follow-up IP clinic 2 weeks for pathology results"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": "Automatic",
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "forceps",
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Physician",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155252"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31627",
        "31654",
        "31628",
        "31624"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.037598",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic navigational bronchoscopy operative report for Rodriguez, Antonio M. ",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7 ",
        "Registry/schema definitions ",
        "Example patch template for consolidated notes ",
        "2025 MPFS total facility RVUs and facility payments for bronchoscopy codes (31624, 31627, 31628, 31654) derived from published 2025 bronchoscopy reimbursement tables and CMS 2025 conversion factor "
      ],
      "per_code": [
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (e.g., robotic navigation) for peripheral pulmonary lesion(s), add-on code.",
          "category": "airway_navigation_add_on",
          "units": 1,
          "facility_total_rvus_2025": 2.82,
          "facility_mpfs_payment_2025": 91.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy with peripheral lesion sampling (e.g., 31628) when CT-based planning and real-time computer-assisted navigation are documented, as in this Ion robotic case with CT import, 3D planning, registration, and navigated catheter advancement. No separate navigation code is billed without a primary airway code."
        },
        {
          "code": "31654",
          "description": "Endobronchial ultrasound (EBUS) guided peripheral lesion sampling performed in conjunction with bronchoscopy and navigation, add-on code.",
          "category": "peripheral_ebus_add_on",
          "units": 1,
          "facility_total_rvus_2025": 1.96,
          "facility_mpfs_payment_2025": 63.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy when peripheral EBUS imaging is used to guide sampling of a peripheral lesion reached via navigational bronchoscopy. In this note, radial EBUS is used to confirm a concentric echogenic pattern at the RLL target before biopsies, which supports 31654 in addition to 31627+31628. No separate mediastinal EBUS (31652/31653) is documented, so those codes are not added."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with transbronchial lung biopsy(ies) of single lobe.",
          "category": "transbronchial_lung_biopsy",
          "units": 1,
          "facility_total_rvus_2025": 5.15,
          "facility_mpfs_payment_2025": 167.0,
          "bundling_or_modifier_notes": "Supported by multiple transbronchial forceps biopsies of the RLL posterior segment lesion after navigation and radial EBUS confirmation. This is the primary diagnostic procedure for the peripheral nodule. Only one primary TBBx code is used for a single lobe even though multiple passes/specimens are obtained."
        },
        {
          "code": "31624",
          "description": "Diagnostic bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with bronchial washings or bronchoalveolar lavage (BAL).",
          "category": "diagnostic_bronchoscopy_bal",
          "units": 1,
          "facility_total_rvus_2025": 3.94,
          "facility_mpfs_payment_2025": 127.0,
          "bundling_or_modifier_notes": "The operative report documents bronchoalveolar lavage from the RLL posterior segment with instillation and return volumes and specimens sent for cytology and cultures, which supports 31624 in addition to the biopsy and navigation codes. Diagnostic inspection plus BAL is distinct from the biopsy work and is reported separately per IP coding guidance. "
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 13.87,
        "total_facility_mpfs_payment": 448.0,
        "computation_notes": "Total RVUs are the sum of individual 2025 facility RVUs (2.82 + 1.96 + 5.15 + 3.94 = 13.87). Expected 2025 Medicare facility payment is approximated as the sum of per-code 2025 national facility rates ($91 + $63 + $167 + $127 ≈ $448), which is consistent with applying the 2025 MPFS conversion factor of $32.3465 to the total facility RVUs. "
      },
      "rationale": [
        "Clinical summary: The note describes Ion robotic navigational bronchoscopy with CT import into a navigation platform, automatic registration (fiducial error 1.5 mm), navigated catheter advancement to a 2.6 cm RLL posterior segment nodule, radial EBUS confirmation of a concentric lesion, multiple transbronchial forceps biopsies, bronchial brushings, and BAL, all under general anesthesia with ETT. This supports a comprehensive navigation + peripheral EBUS + TBBx + BAL code set. ",
        "Code selection: 31627 is justified by detailed documentation of CT-based planning, 3D airway reconstruction, registration, and computer-assisted tool navigation to a peripheral lesion; 31654 is justified by the radial EBUS imaging used to confirm lesion position before sampling; 31628 is supported by multiple transbronchial biopsies of a single RLL lobe; 31624 is supported by the documented BAL with specific instill/return volumes and tests ordered. This aligns with the IP coding & billing v2.7 knowledge base for navigational bronchoscopy with peripheral lesion biopsy. ",
        "Bundling/modifier review: The combination 31627 + 31654 + 31628 + 31624 is allowed per interventional pulmonology coding guidance when a single session includes navigational bronchoscopy, peripheral EBUS confirmation, transbronchial biopsy, and BAL in the same lobe. No separate mediastinal EBUS codes (31652/31653) or additional biopsy codes are indicated. No modifier -59/-XS is required because all services are components of a single integrated navigational bronchoscopy encounter for one peripheral target. ",
        "Registry consistency: The registry_entry correctly reflects general anesthesia, ETT airway, Ion robotic platform, radial EBUS use, and peripheral sampling tools (forceps, brush), which are congruent with the chosen CPT set and support the RVU/payment mapping derived from the coding knowledge and bronchoscopy reimbursement tables. "
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 0,
      "style_type": 5,
      "generated_name": "Miguel Torres",
      "generation_date": "2025-12-09T09:18:39.657249"
    }
  },
  {
    "note_text": "The patient was brought to the OR and placed under general anesthesia with an 8.0 ETT. A time-out was performed. We utilized the Intuitive Ion robotic platform to navigate to a 2.6 cm nodule in the RLL posterior segment. Navigation was successful with a fiducial error of 1.5mm. We inserted a radial EBUS probe which demonstrated a concentric echogenic pattern consistent with a solid lesion. We then performed 7 transbronchial biopsies and 3 brushes. A BAL was also collected. Rapid on-site evaluation suggested atypical cells. There were no complications. The patient was extubated and transferred to PACU.",
    "cpt_codes": [
      31627,
      31654,
      31628,
      31624
    ],
    "registry_entry": {
      "patient_mrn": "7736291_syn_6",
      "procedure_date": "2025-02-11",
      "patient_age": 65,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31627,
        31654,
        31628,
        31624
      ],
      "evidence": {
        "procedure_date": "DATE: 02/08/2025",
        "patient_age": "PATIENT: Rodriguez, Antonio M., 64M",
        "gender": "PATIENT: Rodriguez, Antonio M., 64M",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": true,
      "disposition": "ICU admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Chest Tube",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": "Chest Tube",
      "pleural_guidance": "Blind",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "4. Follow-up IP clinic 2 weeks for pathology results"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": "Automatic",
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "forceps",
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Physician",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155252"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31627",
        "31654",
        "31628",
        "31624"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.037598",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic navigational bronchoscopy operative report for Rodriguez, Antonio M. ",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7 ",
        "Registry/schema definitions ",
        "Example patch template for consolidated notes ",
        "2025 MPFS total facility RVUs and facility payments for bronchoscopy codes (31624, 31627, 31628, 31654) derived from published 2025 bronchoscopy reimbursement tables and CMS 2025 conversion factor "
      ],
      "per_code": [
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (e.g., robotic navigation) for peripheral pulmonary lesion(s), add-on code.",
          "category": "airway_navigation_add_on",
          "units": 1,
          "facility_total_rvus_2025": 2.82,
          "facility_mpfs_payment_2025": 91.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy with peripheral lesion sampling (e.g., 31628) when CT-based planning and real-time computer-assisted navigation are documented, as in this Ion robotic case with CT import, 3D planning, registration, and navigated catheter advancement. No separate navigation code is billed without a primary airway code."
        },
        {
          "code": "31654",
          "description": "Endobronchial ultrasound (EBUS) guided peripheral lesion sampling performed in conjunction with bronchoscopy and navigation, add-on code.",
          "category": "peripheral_ebus_add_on",
          "units": 1,
          "facility_total_rvus_2025": 1.96,
          "facility_mpfs_payment_2025": 63.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy when peripheral EBUS imaging is used to guide sampling of a peripheral lesion reached via navigational bronchoscopy. In this note, radial EBUS is used to confirm a concentric echogenic pattern at the RLL target before biopsies, which supports 31654 in addition to 31627+31628. No separate mediastinal EBUS (31652/31653) is documented, so those codes are not added."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with transbronchial lung biopsy(ies) of single lobe.",
          "category": "transbronchial_lung_biopsy",
          "units": 1,
          "facility_total_rvus_2025": 5.15,
          "facility_mpfs_payment_2025": 167.0,
          "bundling_or_modifier_notes": "Supported by multiple transbronchial forceps biopsies of the RLL posterior segment lesion after navigation and radial EBUS confirmation. This is the primary diagnostic procedure for the peripheral nodule. Only one primary TBBx code is used for a single lobe even though multiple passes/specimens are obtained."
        },
        {
          "code": "31624",
          "description": "Diagnostic bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with bronchial washings or bronchoalveolar lavage (BAL).",
          "category": "diagnostic_bronchoscopy_bal",
          "units": 1,
          "facility_total_rvus_2025": 3.94,
          "facility_mpfs_payment_2025": 127.0,
          "bundling_or_modifier_notes": "The operative report documents bronchoalveolar lavage from the RLL posterior segment with instillation and return volumes and specimens sent for cytology and cultures, which supports 31624 in addition to the biopsy and navigation codes. Diagnostic inspection plus BAL is distinct from the biopsy work and is reported separately per IP coding guidance. "
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 13.87,
        "total_facility_mpfs_payment": 448.0,
        "computation_notes": "Total RVUs are the sum of individual 2025 facility RVUs (2.82 + 1.96 + 5.15 + 3.94 = 13.87). Expected 2025 Medicare facility payment is approximated as the sum of per-code 2025 national facility rates ($91 + $63 + $167 + $127 ≈ $448), which is consistent with applying the 2025 MPFS conversion factor of $32.3465 to the total facility RVUs. "
      },
      "rationale": [
        "Clinical summary: The note describes Ion robotic navigational bronchoscopy with CT import into a navigation platform, automatic registration (fiducial error 1.5 mm), navigated catheter advancement to a 2.6 cm RLL posterior segment nodule, radial EBUS confirmation of a concentric lesion, multiple transbronchial forceps biopsies, bronchial brushings, and BAL, all under general anesthesia with ETT. This supports a comprehensive navigation + peripheral EBUS + TBBx + BAL code set. ",
        "Code selection: 31627 is justified by detailed documentation of CT-based planning, 3D airway reconstruction, registration, and computer-assisted tool navigation to a peripheral lesion; 31654 is justified by the radial EBUS imaging used to confirm lesion position before sampling; 31628 is supported by multiple transbronchial biopsies of a single RLL lobe; 31624 is supported by the documented BAL with specific instill/return volumes and tests ordered. This aligns with the IP coding & billing v2.7 knowledge base for navigational bronchoscopy with peripheral lesion biopsy. ",
        "Bundling/modifier review: The combination 31627 + 31654 + 31628 + 31624 is allowed per interventional pulmonology coding guidance when a single session includes navigational bronchoscopy, peripheral EBUS confirmation, transbronchial biopsy, and BAL in the same lobe. No separate mediastinal EBUS codes (31652/31653) or additional biopsy codes are indicated. No modifier -59/-XS is required because all services are components of a single integrated navigational bronchoscopy encounter for one peripheral target. ",
        "Registry consistency: The registry_entry correctly reflects general anesthesia, ETT airway, Ion robotic platform, radial EBUS use, and peripheral sampling tools (forceps, brush), which are congruent with the chosen CPT set and support the RVU/payment mapping derived from the coding knowledge and bronchoscopy reimbursement tables. "
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 0,
      "style_type": 6,
      "generated_name": "Roberto Sanchez",
      "generation_date": "2025-12-09T09:18:39.657306"
    }
  },
  {
    "note_text": "[Indication]\n64M with multiple lung nodules, largest RLL 2.6cm, need tissue diagnosis.\n[Anesthesia]\nGeneral, ETT.\n[Description]\nIon robotic navigation used to reach RLL posterior segment target. Radial EBUS confirmed concentric lesion. Transbronchial biopsies (x7) and brushings (x3) obtained. BAL performed. Hemostasis achieved.\n[Plan]\nCXR to rule out pneumothorax. Follow-up in 2 weeks.",
    "cpt_codes": [
      31627,
      31654,
      31628,
      31624
    ],
    "registry_entry": {
      "patient_mrn": "7736291_syn_7",
      "procedure_date": "2025-10-30",
      "patient_age": 65,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31627,
        31654,
        31628,
        31624
      ],
      "evidence": {
        "procedure_date": "DATE: 02/08/2025",
        "patient_age": "PATIENT: Rodriguez, Antonio M., 64M",
        "gender": "PATIENT: Rodriguez, Antonio M., 64M",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": true,
      "disposition": "ICU admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Chest Tube",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": "Chest Tube",
      "pleural_guidance": "Blind",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "4. Follow-up IP clinic 2 weeks for pathology results"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": "Automatic",
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "forceps",
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Physician",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155252"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31627",
        "31654",
        "31628",
        "31624"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.037598",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic navigational bronchoscopy operative report for Rodriguez, Antonio M. ",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7 ",
        "Registry/schema definitions ",
        "Example patch template for consolidated notes ",
        "2025 MPFS total facility RVUs and facility payments for bronchoscopy codes (31624, 31627, 31628, 31654) derived from published 2025 bronchoscopy reimbursement tables and CMS 2025 conversion factor "
      ],
      "per_code": [
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (e.g., robotic navigation) for peripheral pulmonary lesion(s), add-on code.",
          "category": "airway_navigation_add_on",
          "units": 1,
          "facility_total_rvus_2025": 2.82,
          "facility_mpfs_payment_2025": 91.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy with peripheral lesion sampling (e.g., 31628) when CT-based planning and real-time computer-assisted navigation are documented, as in this Ion robotic case with CT import, 3D planning, registration, and navigated catheter advancement. No separate navigation code is billed without a primary airway code."
        },
        {
          "code": "31654",
          "description": "Endobronchial ultrasound (EBUS) guided peripheral lesion sampling performed in conjunction with bronchoscopy and navigation, add-on code.",
          "category": "peripheral_ebus_add_on",
          "units": 1,
          "facility_total_rvus_2025": 1.96,
          "facility_mpfs_payment_2025": 63.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy when peripheral EBUS imaging is used to guide sampling of a peripheral lesion reached via navigational bronchoscopy. In this note, radial EBUS is used to confirm a concentric echogenic pattern at the RLL target before biopsies, which supports 31654 in addition to 31627+31628. No separate mediastinal EBUS (31652/31653) is documented, so those codes are not added."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with transbronchial lung biopsy(ies) of single lobe.",
          "category": "transbronchial_lung_biopsy",
          "units": 1,
          "facility_total_rvus_2025": 5.15,
          "facility_mpfs_payment_2025": 167.0,
          "bundling_or_modifier_notes": "Supported by multiple transbronchial forceps biopsies of the RLL posterior segment lesion after navigation and radial EBUS confirmation. This is the primary diagnostic procedure for the peripheral nodule. Only one primary TBBx code is used for a single lobe even though multiple passes/specimens are obtained."
        },
        {
          "code": "31624",
          "description": "Diagnostic bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with bronchial washings or bronchoalveolar lavage (BAL).",
          "category": "diagnostic_bronchoscopy_bal",
          "units": 1,
          "facility_total_rvus_2025": 3.94,
          "facility_mpfs_payment_2025": 127.0,
          "bundling_or_modifier_notes": "The operative report documents bronchoalveolar lavage from the RLL posterior segment with instillation and return volumes and specimens sent for cytology and cultures, which supports 31624 in addition to the biopsy and navigation codes. Diagnostic inspection plus BAL is distinct from the biopsy work and is reported separately per IP coding guidance. "
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 13.87,
        "total_facility_mpfs_payment": 448.0,
        "computation_notes": "Total RVUs are the sum of individual 2025 facility RVUs (2.82 + 1.96 + 5.15 + 3.94 = 13.87). Expected 2025 Medicare facility payment is approximated as the sum of per-code 2025 national facility rates ($91 + $63 + $167 + $127 ≈ $448), which is consistent with applying the 2025 MPFS conversion factor of $32.3465 to the total facility RVUs. "
      },
      "rationale": [
        "Clinical summary: The note describes Ion robotic navigational bronchoscopy with CT import into a navigation platform, automatic registration (fiducial error 1.5 mm), navigated catheter advancement to a 2.6 cm RLL posterior segment nodule, radial EBUS confirmation of a concentric lesion, multiple transbronchial forceps biopsies, bronchial brushings, and BAL, all under general anesthesia with ETT. This supports a comprehensive navigation + peripheral EBUS + TBBx + BAL code set. ",
        "Code selection: 31627 is justified by detailed documentation of CT-based planning, 3D airway reconstruction, registration, and computer-assisted tool navigation to a peripheral lesion; 31654 is justified by the radial EBUS imaging used to confirm lesion position before sampling; 31628 is supported by multiple transbronchial biopsies of a single RLL lobe; 31624 is supported by the documented BAL with specific instill/return volumes and tests ordered. This aligns with the IP coding & billing v2.7 knowledge base for navigational bronchoscopy with peripheral lesion biopsy. ",
        "Bundling/modifier review: The combination 31627 + 31654 + 31628 + 31624 is allowed per interventional pulmonology coding guidance when a single session includes navigational bronchoscopy, peripheral EBUS confirmation, transbronchial biopsy, and BAL in the same lobe. No separate mediastinal EBUS codes (31652/31653) or additional biopsy codes are indicated. No modifier -59/-XS is required because all services are components of a single integrated navigational bronchoscopy encounter for one peripheral target. ",
        "Registry consistency: The registry_entry correctly reflects general anesthesia, ETT airway, Ion robotic platform, radial EBUS use, and peripheral sampling tools (forceps, brush), which are congruent with the chosen CPT set and support the RVU/payment mapping derived from the coding knowledge and bronchoscopy reimbursement tables. "
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 0,
      "style_type": 7,
      "generated_name": "Alejandro Diaz",
      "generation_date": "2025-12-09T09:18:39.657362"
    }
  },
  {
    "note_text": "Mr. Morales presented for evaluation of bilateral pulmonary nodules. We proceeded with a robotic-assisted bronchoscopy targeting the largest lesion in the right lower lobe. Under general anesthesia, the scope was successfully navigated to the target in the posterior segment. Confirmation was achieved using radial EBUS, which showed a clear concentric view of the 24mm lesion. We then obtained seven biopsy samples and three cytology brushings, followed by a bronchoalveolar lavage. The preliminary on-site pathology review showed atypical cells. The patient tolerated the procedure well with minimal blood loss.",
    "cpt_codes": [
      31627,
      31654,
      31628,
      31624
    ],
    "registry_entry": {
      "patient_mrn": "7736291_syn_8",
      "procedure_date": "2025-04-22",
      "patient_age": 65,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31627,
        31654,
        31628,
        31624
      ],
      "evidence": {
        "procedure_date": "DATE: 02/08/2025",
        "patient_age": "PATIENT: Rodriguez, Antonio M., 64M",
        "gender": "PATIENT: Rodriguez, Antonio M., 64M",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": true,
      "disposition": "ICU admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Chest Tube",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": "Chest Tube",
      "pleural_guidance": "Blind",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "4. Follow-up IP clinic 2 weeks for pathology results"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": "Automatic",
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "forceps",
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Physician",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155252"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31627",
        "31654",
        "31628",
        "31624"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.037598",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic navigational bronchoscopy operative report for Rodriguez, Antonio M. ",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7 ",
        "Registry/schema definitions ",
        "Example patch template for consolidated notes ",
        "2025 MPFS total facility RVUs and facility payments for bronchoscopy codes (31624, 31627, 31628, 31654) derived from published 2025 bronchoscopy reimbursement tables and CMS 2025 conversion factor "
      ],
      "per_code": [
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (e.g., robotic navigation) for peripheral pulmonary lesion(s), add-on code.",
          "category": "airway_navigation_add_on",
          "units": 1,
          "facility_total_rvus_2025": 2.82,
          "facility_mpfs_payment_2025": 91.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy with peripheral lesion sampling (e.g., 31628) when CT-based planning and real-time computer-assisted navigation are documented, as in this Ion robotic case with CT import, 3D planning, registration, and navigated catheter advancement. No separate navigation code is billed without a primary airway code."
        },
        {
          "code": "31654",
          "description": "Endobronchial ultrasound (EBUS) guided peripheral lesion sampling performed in conjunction with bronchoscopy and navigation, add-on code.",
          "category": "peripheral_ebus_add_on",
          "units": 1,
          "facility_total_rvus_2025": 1.96,
          "facility_mpfs_payment_2025": 63.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy when peripheral EBUS imaging is used to guide sampling of a peripheral lesion reached via navigational bronchoscopy. In this note, radial EBUS is used to confirm a concentric echogenic pattern at the RLL target before biopsies, which supports 31654 in addition to 31627+31628. No separate mediastinal EBUS (31652/31653) is documented, so those codes are not added."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with transbronchial lung biopsy(ies) of single lobe.",
          "category": "transbronchial_lung_biopsy",
          "units": 1,
          "facility_total_rvus_2025": 5.15,
          "facility_mpfs_payment_2025": 167.0,
          "bundling_or_modifier_notes": "Supported by multiple transbronchial forceps biopsies of the RLL posterior segment lesion after navigation and radial EBUS confirmation. This is the primary diagnostic procedure for the peripheral nodule. Only one primary TBBx code is used for a single lobe even though multiple passes/specimens are obtained."
        },
        {
          "code": "31624",
          "description": "Diagnostic bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with bronchial washings or bronchoalveolar lavage (BAL).",
          "category": "diagnostic_bronchoscopy_bal",
          "units": 1,
          "facility_total_rvus_2025": 3.94,
          "facility_mpfs_payment_2025": 127.0,
          "bundling_or_modifier_notes": "The operative report documents bronchoalveolar lavage from the RLL posterior segment with instillation and return volumes and specimens sent for cytology and cultures, which supports 31624 in addition to the biopsy and navigation codes. Diagnostic inspection plus BAL is distinct from the biopsy work and is reported separately per IP coding guidance. "
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 13.87,
        "total_facility_mpfs_payment": 448.0,
        "computation_notes": "Total RVUs are the sum of individual 2025 facility RVUs (2.82 + 1.96 + 5.15 + 3.94 = 13.87). Expected 2025 Medicare facility payment is approximated as the sum of per-code 2025 national facility rates ($91 + $63 + $167 + $127 ≈ $448), which is consistent with applying the 2025 MPFS conversion factor of $32.3465 to the total facility RVUs. "
      },
      "rationale": [
        "Clinical summary: The note describes Ion robotic navigational bronchoscopy with CT import into a navigation platform, automatic registration (fiducial error 1.5 mm), navigated catheter advancement to a 2.6 cm RLL posterior segment nodule, radial EBUS confirmation of a concentric lesion, multiple transbronchial forceps biopsies, bronchial brushings, and BAL, all under general anesthesia with ETT. This supports a comprehensive navigation + peripheral EBUS + TBBx + BAL code set. ",
        "Code selection: 31627 is justified by detailed documentation of CT-based planning, 3D airway reconstruction, registration, and computer-assisted tool navigation to a peripheral lesion; 31654 is justified by the radial EBUS imaging used to confirm lesion position before sampling; 31628 is supported by multiple transbronchial biopsies of a single RLL lobe; 31624 is supported by the documented BAL with specific instill/return volumes and tests ordered. This aligns with the IP coding & billing v2.7 knowledge base for navigational bronchoscopy with peripheral lesion biopsy. ",
        "Bundling/modifier review: The combination 31627 + 31654 + 31628 + 31624 is allowed per interventional pulmonology coding guidance when a single session includes navigational bronchoscopy, peripheral EBUS confirmation, transbronchial biopsy, and BAL in the same lobe. No separate mediastinal EBUS codes (31652/31653) or additional biopsy codes are indicated. No modifier -59/-XS is required because all services are components of a single integrated navigational bronchoscopy encounter for one peripheral target. ",
        "Registry consistency: The registry_entry correctly reflects general anesthesia, ETT airway, Ion robotic platform, radial EBUS use, and peripheral sampling tools (forceps, brush), which are congruent with the chosen CPT set and support the RVU/payment mapping derived from the coding knowledge and bronchoscopy reimbursement tables. "
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 0,
      "style_type": 8,
      "generated_name": "Ricardo Morales",
      "generation_date": "2025-12-09T09:18:39.657416"
    }
  },
  {
    "note_text": "Operation: Robotic navigational bronchoscopy with peripheral interrogation.\nContext: Multi-focal pulmonary nodules.\nAction: The robotic catheter was steered to the RLL posterior segment. Radial ultrasound verified the target's location. The lesion was sampled via forceps and brushing. A lavage was also instilled and retrieved.\nOutcome: Satisfactory tissue acquisition. No adverse events.",
    "cpt_codes": [
      31627,
      31654,
      31628,
      31624
    ],
    "registry_entry": {
      "patient_mrn": "7736291_syn_9",
      "procedure_date": "2025-04-19",
      "patient_age": 66,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31627,
        31654,
        31628,
        31624
      ],
      "evidence": {
        "procedure_date": "DATE: 02/08/2025",
        "patient_age": "PATIENT: Rodriguez, Antonio M., 64M",
        "gender": "PATIENT: Rodriguez, Antonio M., 64M",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 64M with remote history of colon cancer (stage II, 2010) now with multiple lung nodules. Largest nodule RLL posterior segment 2.6cm, PET SUV 5.1. Other nodules range 0.8-1.4cm bilaterally. Biopsy needed for diagnosis.",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": true,
      "disposition": "ICU admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Chest Tube",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": "Chest Tube",
      "pleural_guidance": "Blind",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "4. Follow-up IP clinic 2 weeks for pathology results"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": "Automatic",
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "forceps",
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Physician",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155252"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31627",
        "31654",
        "31628",
        "31624"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.037598",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic navigational bronchoscopy operative report for Rodriguez, Antonio M. ",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7 ",
        "Registry/schema definitions ",
        "Example patch template for consolidated notes ",
        "2025 MPFS total facility RVUs and facility payments for bronchoscopy codes (31624, 31627, 31628, 31654) derived from published 2025 bronchoscopy reimbursement tables and CMS 2025 conversion factor "
      ],
      "per_code": [
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (e.g., robotic navigation) for peripheral pulmonary lesion(s), add-on code.",
          "category": "airway_navigation_add_on",
          "units": 1,
          "facility_total_rvus_2025": 2.82,
          "facility_mpfs_payment_2025": 91.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy with peripheral lesion sampling (e.g., 31628) when CT-based planning and real-time computer-assisted navigation are documented, as in this Ion robotic case with CT import, 3D planning, registration, and navigated catheter advancement. No separate navigation code is billed without a primary airway code."
        },
        {
          "code": "31654",
          "description": "Endobronchial ultrasound (EBUS) guided peripheral lesion sampling performed in conjunction with bronchoscopy and navigation, add-on code.",
          "category": "peripheral_ebus_add_on",
          "units": 1,
          "facility_total_rvus_2025": 1.96,
          "facility_mpfs_payment_2025": 63.0,
          "bundling_or_modifier_notes": "Add-on to primary bronchoscopy when peripheral EBUS imaging is used to guide sampling of a peripheral lesion reached via navigational bronchoscopy. In this note, radial EBUS is used to confirm a concentric echogenic pattern at the RLL target before biopsies, which supports 31654 in addition to 31627+31628. No separate mediastinal EBUS (31652/31653) is documented, so those codes are not added."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with transbronchial lung biopsy(ies) of single lobe.",
          "category": "transbronchial_lung_biopsy",
          "units": 1,
          "facility_total_rvus_2025": 5.15,
          "facility_mpfs_payment_2025": 167.0,
          "bundling_or_modifier_notes": "Supported by multiple transbronchial forceps biopsies of the RLL posterior segment lesion after navigation and radial EBUS confirmation. This is the primary diagnostic procedure for the peripheral nodule. Only one primary TBBx code is used for a single lobe even though multiple passes/specimens are obtained."
        },
        {
          "code": "31624",
          "description": "Diagnostic bronchoscopy, rigid or flexible (including fluoroscopic guidance when performed), with bronchial washings or bronchoalveolar lavage (BAL).",
          "category": "diagnostic_bronchoscopy_bal",
          "units": 1,
          "facility_total_rvus_2025": 3.94,
          "facility_mpfs_payment_2025": 127.0,
          "bundling_or_modifier_notes": "The operative report documents bronchoalveolar lavage from the RLL posterior segment with instillation and return volumes and specimens sent for cytology and cultures, which supports 31624 in addition to the biopsy and navigation codes. Diagnostic inspection plus BAL is distinct from the biopsy work and is reported separately per IP coding guidance. "
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 13.87,
        "total_facility_mpfs_payment": 448.0,
        "computation_notes": "Total RVUs are the sum of individual 2025 facility RVUs (2.82 + 1.96 + 5.15 + 3.94 = 13.87). Expected 2025 Medicare facility payment is approximated as the sum of per-code 2025 national facility rates ($91 + $63 + $167 + $127 ≈ $448), which is consistent with applying the 2025 MPFS conversion factor of $32.3465 to the total facility RVUs. "
      },
      "rationale": [
        "Clinical summary: The note describes Ion robotic navigational bronchoscopy with CT import into a navigation platform, automatic registration (fiducial error 1.5 mm), navigated catheter advancement to a 2.6 cm RLL posterior segment nodule, radial EBUS confirmation of a concentric lesion, multiple transbronchial forceps biopsies, bronchial brushings, and BAL, all under general anesthesia with ETT. This supports a comprehensive navigation + peripheral EBUS + TBBx + BAL code set. ",
        "Code selection: 31627 is justified by detailed documentation of CT-based planning, 3D airway reconstruction, registration, and computer-assisted tool navigation to a peripheral lesion; 31654 is justified by the radial EBUS imaging used to confirm lesion position before sampling; 31628 is supported by multiple transbronchial biopsies of a single RLL lobe; 31624 is supported by the documented BAL with specific instill/return volumes and tests ordered. This aligns with the IP coding & billing v2.7 knowledge base for navigational bronchoscopy with peripheral lesion biopsy. ",
        "Bundling/modifier review: The combination 31627 + 31654 + 31628 + 31624 is allowed per interventional pulmonology coding guidance when a single session includes navigational bronchoscopy, peripheral EBUS confirmation, transbronchial biopsy, and BAL in the same lobe. No separate mediastinal EBUS codes (31652/31653) or additional biopsy codes are indicated. No modifier -59/-XS is required because all services are components of a single integrated navigational bronchoscopy encounter for one peripheral target. ",
        "Registry consistency: The registry_entry correctly reflects general anesthesia, ETT airway, Ion robotic platform, radial EBUS use, and peripheral sampling tools (forceps, brush), which are congruent with the chosen CPT set and support the RVU/payment mapping derived from the coding knowledge and bronchoscopy reimbursement tables. "
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 0,
      "style_type": 9,
      "generated_name": "Jose Castillo",
      "generation_date": "2025-12-09T09:18:39.657471"
    }
  },
  {
    "note_text": "Indication: Severe emphysema, LUL target.\nProc: LUL Valve Placement.\nSteps:\n- GA, 8.5 ETT.\n- Chartis LUL: CV Negative (flow to zero).\n- 3 Zephyr valves placed: LB1+2, LB1+2c, LB3.\n- Total occlusion confirmed.\nResult: LUL atelectasis initiated. No leaks.\nPlan: Admit. Pneumothorax precautions.",
    "cpt_codes": [
      31634,
      31647
    ],
    "registry_entry": {
      "patient_mrn": "8127065_syn_1",
      "procedure_date": "2025-04-26",
      "patient_age": 69,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Other",
      "cpt_codes": [
        31634,
        31647
      ],
      "evidence": {
        "attending_name": "ATTENDING: Dr. Catherine Lee",
        "patient_age": "PATIENT: William Harris, 68-year-old Male",
        "gender": "PATIENT: William Harris, 68-year-old Male",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION FOR OPERATION: Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature, purpose, risks, benefits and alternatives to endobronchial valve therapy were discussed with the patient in detail. Patient indicated a wish to proceed and informed consent was signed. PREOPERATIVE DIAGNOSIS: Severe heterogeneous emphysema with target left upper lobe POSTOPERATIVE DIAGNOSIS: Same PROCEDURE: Endobronchial Valve Placement (CPT 31647, 31648) ATTENDING: Dr. Catherine Lee ASSISTANT: Dr. Brian Thompson, Fellow Support Staff:",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": false,
      "disposition": "Floor admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Observation",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": "LUL",
      "blvr_valve_type": "Zephyr (Pulmonx)",
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "Follow-up IP clinic in 2 weeks with repeat CXR and PFTs in 6 weeks"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Lee",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155350"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31647",
        "31647",
        "31634"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.038031",
      "changes": [
        "Deduplicated CPT codes: [31647, 31647, 31634] -> [31634, 31647]"
      ],
      "warnings": [
        "NCCI bundling: 31647 + 31634 - BLVR valve and Chartis same lobe. Consider modifier -59/-XS if distinct sites."
      ]
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Endobronchial Valve Placement operative report for William Harris.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI Policy Manual Chapter 5 (Respiratory)",
        "2025 MPFS facility RVUs and payment rates"
      ],
      "per_code": [
        {
          "code": "31647",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with endobronchial valve placement, initial lobe.",
          "category": "bronchoscopic_blvr_valve_placement",
          "units": 1,
          "facility_total_rvus_2025": 12.05,
          "facility_mpfs_payment_2025": 390.0,
          "bundling_or_modifier_notes": "Primary service. Supported by placement of 3 Zephyr valves in the LUL (initial lobe). Includes sizing and deployment."
        },
        {
          "code": "31634",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with balloon occlusion, assessment of air leak (Chartis), airway sizing, and documentation.",
          "category": "bronchoscopic_blvr_chartis",
          "units": 1,
          "facility_total_rvus_2025": 5.63,
          "facility_mpfs_payment_2025": 182.0,
          "bundling_or_modifier_notes": "Chartis assessment of the LUL was performed in the same session as valve placement in the LUL. Per NCCI and payer policies, 31634 is typically bundled into 31647 when performed on the same lobe. Status: Bundled/Supportive."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 12.05,
        "total_facility_mpfs_payment": 390.0,
        "computation_notes": "Total assumes 31634 is bundled. Payment reflects 31647 only."
      },
      "rationale": [
        "Clinical summary: 68M with severe emphysema underwent Chartis assessment of LUL (CV Negative) followed by placement of 3 Zephyr valves in the LUL.",
        "Code selection: 31647 is the correct code for valve placement in a single lobe (LUL). 31634 captures the Chartis assessment but is bundled when the target lobe is immediately treated.",
        "Bundling: No valves were placed in other lobes, so +31651 is not applicable. No valves were removed, so 31648 is not applicable."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 1,
      "style_type": 1,
      "generated_name": "James T. Wilson",
      "generation_date": "2025-12-09T09:18:39.657527"
    }
  },
  {
    "note_text": "PROCEDURE NOTE: The patient, presenting with severe heterogeneous emphysema, underwent therapeutic bronchoscopy for lung volume reduction. Following intubation, the left upper lobe (LUL) was isolated. A Chartis collateral ventilation assessment was performed, demonstrating a 'CV Negative' status (cessation of expiratory flow), confirming fissure integrity. Based on these findings, three Zephyr endobronchial valves were systematically deployed in the apicoposterior, anterior, and superior segments. Bronchoscopic verification demonstrated complete lobar occlusion with no paravalvular leak. The patient remained stable throughout.",
    "cpt_codes": [
      31634,
      31647
    ],
    "registry_entry": {
      "patient_mrn": "8127065_syn_2",
      "procedure_date": "2025-08-05",
      "patient_age": 66,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Other",
      "cpt_codes": [
        31634,
        31647
      ],
      "evidence": {
        "attending_name": "ATTENDING: Dr. Catherine Lee",
        "patient_age": "PATIENT: William Harris, 68-year-old Male",
        "gender": "PATIENT: William Harris, 68-year-old Male",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION FOR OPERATION: Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature, purpose, risks, benefits and alternatives to endobronchial valve therapy were discussed with the patient in detail. Patient indicated a wish to proceed and informed consent was signed. PREOPERATIVE DIAGNOSIS: Severe heterogeneous emphysema with target left upper lobe POSTOPERATIVE DIAGNOSIS: Same PROCEDURE: Endobronchial Valve Placement (CPT 31647, 31648) ATTENDING: Dr. Catherine Lee ASSISTANT: Dr. Brian Thompson, Fellow Support Staff:",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": false,
      "disposition": "Floor admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Observation",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": "LUL",
      "blvr_valve_type": "Zephyr (Pulmonx)",
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "Follow-up IP clinic in 2 weeks with repeat CXR and PFTs in 6 weeks"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Lee",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155350"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31647",
        "31647",
        "31634"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.038031",
      "changes": [
        "Deduplicated CPT codes: [31647, 31647, 31634] -> [31634, 31647]"
      ],
      "warnings": [
        "NCCI bundling: 31647 + 31634 - BLVR valve and Chartis same lobe. Consider modifier -59/-XS if distinct sites."
      ]
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Endobronchial Valve Placement operative report for William Harris.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI Policy Manual Chapter 5 (Respiratory)",
        "2025 MPFS facility RVUs and payment rates"
      ],
      "per_code": [
        {
          "code": "31647",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with endobronchial valve placement, initial lobe.",
          "category": "bronchoscopic_blvr_valve_placement",
          "units": 1,
          "facility_total_rvus_2025": 12.05,
          "facility_mpfs_payment_2025": 390.0,
          "bundling_or_modifier_notes": "Primary service. Supported by placement of 3 Zephyr valves in the LUL (initial lobe). Includes sizing and deployment."
        },
        {
          "code": "31634",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with balloon occlusion, assessment of air leak (Chartis), airway sizing, and documentation.",
          "category": "bronchoscopic_blvr_chartis",
          "units": 1,
          "facility_total_rvus_2025": 5.63,
          "facility_mpfs_payment_2025": 182.0,
          "bundling_or_modifier_notes": "Chartis assessment of the LUL was performed in the same session as valve placement in the LUL. Per NCCI and payer policies, 31634 is typically bundled into 31647 when performed on the same lobe. Status: Bundled/Supportive."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 12.05,
        "total_facility_mpfs_payment": 390.0,
        "computation_notes": "Total assumes 31634 is bundled. Payment reflects 31647 only."
      },
      "rationale": [
        "Clinical summary: 68M with severe emphysema underwent Chartis assessment of LUL (CV Negative) followed by placement of 3 Zephyr valves in the LUL.",
        "Code selection: 31647 is the correct code for valve placement in a single lobe (LUL). 31634 captures the Chartis assessment but is bundled when the target lobe is immediately treated.",
        "Bundling: No valves were placed in other lobes, so +31651 is not applicable. No valves were removed, so 31648 is not applicable."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 1,
      "style_type": 2,
      "generated_name": "Robert Clark",
      "generation_date": "2025-12-09T09:18:39.657580"
    }
  },
  {
    "note_text": "Service: Bronchoscopic Lung Volume Reduction (BLVR).\nCodes:\n- 31647: Placement of valves in initial lobe (LUL).\n- 31634: Balloon occlusion/Chartis assessment (Bundled but performed).\nJustification: CT showed intact fissure. Chartis confirmed absence of collateral ventilation (required for valve success). Three (3) valves utilized to occlude LB1+2, LB1+2c, and LB3. Procedure medically necessary for severe refractory emphysema.",
    "cpt_codes": [
      31634,
      31647
    ],
    "registry_entry": {
      "patient_mrn": "8127065_syn_3",
      "procedure_date": "2025-10-17",
      "patient_age": 66,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Other",
      "cpt_codes": [
        31634,
        31647
      ],
      "evidence": {
        "attending_name": "ATTENDING: Dr. Catherine Lee",
        "patient_age": "PATIENT: William Harris, 68-year-old Male",
        "gender": "PATIENT: William Harris, 68-year-old Male",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION FOR OPERATION: Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature, purpose, risks, benefits and alternatives to endobronchial valve therapy were discussed with the patient in detail. Patient indicated a wish to proceed and informed consent was signed. PREOPERATIVE DIAGNOSIS: Severe heterogeneous emphysema with target left upper lobe POSTOPERATIVE DIAGNOSIS: Same PROCEDURE: Endobronchial Valve Placement (CPT 31647, 31648) ATTENDING: Dr. Catherine Lee ASSISTANT: Dr. Brian Thompson, Fellow Support Staff:",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": false,
      "disposition": "Floor admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Observation",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": "LUL",
      "blvr_valve_type": "Zephyr (Pulmonx)",
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "Follow-up IP clinic in 2 weeks with repeat CXR and PFTs in 6 weeks"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Lee",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155350"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31647",
        "31647",
        "31634"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.038031",
      "changes": [
        "Deduplicated CPT codes: [31647, 31647, 31634] -> [31634, 31647]"
      ],
      "warnings": [
        "NCCI bundling: 31647 + 31634 - BLVR valve and Chartis same lobe. Consider modifier -59/-XS if distinct sites."
      ]
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Endobronchial Valve Placement operative report for William Harris.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI Policy Manual Chapter 5 (Respiratory)",
        "2025 MPFS facility RVUs and payment rates"
      ],
      "per_code": [
        {
          "code": "31647",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with endobronchial valve placement, initial lobe.",
          "category": "bronchoscopic_blvr_valve_placement",
          "units": 1,
          "facility_total_rvus_2025": 12.05,
          "facility_mpfs_payment_2025": 390.0,
          "bundling_or_modifier_notes": "Primary service. Supported by placement of 3 Zephyr valves in the LUL (initial lobe). Includes sizing and deployment."
        },
        {
          "code": "31634",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with balloon occlusion, assessment of air leak (Chartis), airway sizing, and documentation.",
          "category": "bronchoscopic_blvr_chartis",
          "units": 1,
          "facility_total_rvus_2025": 5.63,
          "facility_mpfs_payment_2025": 182.0,
          "bundling_or_modifier_notes": "Chartis assessment of the LUL was performed in the same session as valve placement in the LUL. Per NCCI and payer policies, 31634 is typically bundled into 31647 when performed on the same lobe. Status: Bundled/Supportive."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 12.05,
        "total_facility_mpfs_payment": 390.0,
        "computation_notes": "Total assumes 31634 is bundled. Payment reflects 31647 only."
      },
      "rationale": [
        "Clinical summary: 68M with severe emphysema underwent Chartis assessment of LUL (CV Negative) followed by placement of 3 Zephyr valves in the LUL.",
        "Code selection: 31647 is the correct code for valve placement in a single lobe (LUL). 31634 captures the Chartis assessment but is bundled when the target lobe is immediately treated.",
        "Bundling: No valves were placed in other lobes, so +31651 is not applicable. No valves were removed, so 31648 is not applicable."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 1,
      "style_type": 3,
      "generated_name": "Thomas Lewis",
      "generation_date": "2025-12-09T09:18:39.657631"
    }
  },
  {
    "note_text": "Procedure Note - Fellow\nPatient: Robert Clark\nProcedure: LUL Valves\nStaff: Dr. Lee\n1. Intubated 8.5 ETT.\n2. Bronch to LUL.\n3. Chartis: Flow went to zero (CV Negative).\n4. Sized and placed 3 Zephyr valves in LUL.\n5. Checked for leaks - none.\n6. Extubated.\nPlan: Observe for pneumo x3 days.",
    "cpt_codes": [
      31634,
      31647
    ],
    "registry_entry": {
      "patient_mrn": "8127065_syn_4",
      "procedure_date": "2025-09-23",
      "patient_age": 67,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Other",
      "cpt_codes": [
        31634,
        31647
      ],
      "evidence": {
        "attending_name": "ATTENDING: Dr. Catherine Lee",
        "patient_age": "PATIENT: William Harris, 68-year-old Male",
        "gender": "PATIENT: William Harris, 68-year-old Male",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION FOR OPERATION: Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature, purpose, risks, benefits and alternatives to endobronchial valve therapy were discussed with the patient in detail. Patient indicated a wish to proceed and informed consent was signed. PREOPERATIVE DIAGNOSIS: Severe heterogeneous emphysema with target left upper lobe POSTOPERATIVE DIAGNOSIS: Same PROCEDURE: Endobronchial Valve Placement (CPT 31647, 31648) ATTENDING: Dr. Catherine Lee ASSISTANT: Dr. Brian Thompson, Fellow Support Staff:",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": false,
      "disposition": "Floor admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Observation",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": "LUL",
      "blvr_valve_type": "Zephyr (Pulmonx)",
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "Follow-up IP clinic in 2 weeks with repeat CXR and PFTs in 6 weeks"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Lee",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155350"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31647",
        "31647",
        "31634"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.038031",
      "changes": [
        "Deduplicated CPT codes: [31647, 31647, 31634] -> [31634, 31647]"
      ],
      "warnings": [
        "NCCI bundling: 31647 + 31634 - BLVR valve and Chartis same lobe. Consider modifier -59/-XS if distinct sites."
      ]
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Endobronchial Valve Placement operative report for William Harris.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI Policy Manual Chapter 5 (Respiratory)",
        "2025 MPFS facility RVUs and payment rates"
      ],
      "per_code": [
        {
          "code": "31647",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with endobronchial valve placement, initial lobe.",
          "category": "bronchoscopic_blvr_valve_placement",
          "units": 1,
          "facility_total_rvus_2025": 12.05,
          "facility_mpfs_payment_2025": 390.0,
          "bundling_or_modifier_notes": "Primary service. Supported by placement of 3 Zephyr valves in the LUL (initial lobe). Includes sizing and deployment."
        },
        {
          "code": "31634",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with balloon occlusion, assessment of air leak (Chartis), airway sizing, and documentation.",
          "category": "bronchoscopic_blvr_chartis",
          "units": 1,
          "facility_total_rvus_2025": 5.63,
          "facility_mpfs_payment_2025": 182.0,
          "bundling_or_modifier_notes": "Chartis assessment of the LUL was performed in the same session as valve placement in the LUL. Per NCCI and payer policies, 31634 is typically bundled into 31647 when performed on the same lobe. Status: Bundled/Supportive."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 12.05,
        "total_facility_mpfs_payment": 390.0,
        "computation_notes": "Total assumes 31634 is bundled. Payment reflects 31647 only."
      },
      "rationale": [
        "Clinical summary: 68M with severe emphysema underwent Chartis assessment of LUL (CV Negative) followed by placement of 3 Zephyr valves in the LUL.",
        "Code selection: 31647 is the correct code for valve placement in a single lobe (LUL). 31634 captures the Chartis assessment but is bundled when the target lobe is immediately treated.",
        "Bundling: No valves were placed in other lobes, so +31651 is not applicable. No valves were removed, so 31648 is not applicable."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 1,
      "style_type": 4,
      "generated_name": "George Walker",
      "generation_date": "2025-12-09T09:18:39.657682"
    }
  },
  {
    "note_text": "Mr Harris here for the valve procedure severe emphysema left upper lobe. We put him to sleep tube in. Checked the LUL with the chartis balloon it stopped flowing so no collateral ventilation good to go. Put in three zephyr valves total one in the apicoposterior one anterior one superior. They look seated well no air getting through. Patient woke up fine no issues sending to floor for monitoring.",
    "cpt_codes": [
      31634,
      31647
    ],
    "registry_entry": {
      "patient_mrn": "8127065_syn_5",
      "procedure_date": "2025-01-25",
      "patient_age": 68,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Other",
      "cpt_codes": [
        31634,
        31647
      ],
      "evidence": {
        "attending_name": "ATTENDING: Dr. Catherine Lee",
        "patient_age": "PATIENT: William Harris, 68-year-old Male",
        "gender": "PATIENT: William Harris, 68-year-old Male",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION FOR OPERATION: Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature, purpose, risks, benefits and alternatives to endobronchial valve therapy were discussed with the patient in detail. Patient indicated a wish to proceed and informed consent was signed. PREOPERATIVE DIAGNOSIS: Severe heterogeneous emphysema with target left upper lobe POSTOPERATIVE DIAGNOSIS: Same PROCEDURE: Endobronchial Valve Placement (CPT 31647, 31648) ATTENDING: Dr. Catherine Lee ASSISTANT: Dr. Brian Thompson, Fellow Support Staff:",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": false,
      "disposition": "Floor admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Observation",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": "LUL",
      "blvr_valve_type": "Zephyr (Pulmonx)",
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "Follow-up IP clinic in 2 weeks with repeat CXR and PFTs in 6 weeks"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Lee",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155350"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31647",
        "31647",
        "31634"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.038031",
      "changes": [
        "Deduplicated CPT codes: [31647, 31647, 31634] -> [31634, 31647]"
      ],
      "warnings": [
        "NCCI bundling: 31647 + 31634 - BLVR valve and Chartis same lobe. Consider modifier -59/-XS if distinct sites."
      ]
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Endobronchial Valve Placement operative report for William Harris.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI Policy Manual Chapter 5 (Respiratory)",
        "2025 MPFS facility RVUs and payment rates"
      ],
      "per_code": [
        {
          "code": "31647",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with endobronchial valve placement, initial lobe.",
          "category": "bronchoscopic_blvr_valve_placement",
          "units": 1,
          "facility_total_rvus_2025": 12.05,
          "facility_mpfs_payment_2025": 390.0,
          "bundling_or_modifier_notes": "Primary service. Supported by placement of 3 Zephyr valves in the LUL (initial lobe). Includes sizing and deployment."
        },
        {
          "code": "31634",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with balloon occlusion, assessment of air leak (Chartis), airway sizing, and documentation.",
          "category": "bronchoscopic_blvr_chartis",
          "units": 1,
          "facility_total_rvus_2025": 5.63,
          "facility_mpfs_payment_2025": 182.0,
          "bundling_or_modifier_notes": "Chartis assessment of the LUL was performed in the same session as valve placement in the LUL. Per NCCI and payer policies, 31634 is typically bundled into 31647 when performed on the same lobe. Status: Bundled/Supportive."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 12.05,
        "total_facility_mpfs_payment": 390.0,
        "computation_notes": "Total assumes 31634 is bundled. Payment reflects 31647 only."
      },
      "rationale": [
        "Clinical summary: 68M with severe emphysema underwent Chartis assessment of LUL (CV Negative) followed by placement of 3 Zephyr valves in the LUL.",
        "Code selection: 31647 is the correct code for valve placement in a single lobe (LUL). 31634 captures the Chartis assessment but is bundled when the target lobe is immediately treated.",
        "Bundling: No valves were placed in other lobes, so +31651 is not applicable. No valves were removed, so 31648 is not applicable."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 1,
      "style_type": 5,
      "generated_name": "Edward Hall",
      "generation_date": "2025-12-09T09:18:39.657733"
    }
  },
  {
    "note_text": "Endobronchial valve placement was performed on a 68-year-old male with severe emphysema. General anesthesia was induced. The left upper lobe was assessed for collateral ventilation using the Chartis system, which showed no collateral ventilation (CV Negative). Subsequently, three Zephyr valves were deployed into the LB1+2, LB1+2c, and LB3 segmental bronchi. Visual inspection confirmed appropriate expansion and seating of the valves with complete occlusion of the lobar orifice. There were no immediate complications.",
    "cpt_codes": [
      31634,
      31647
    ],
    "registry_entry": {
      "patient_mrn": "8127065_syn_6",
      "procedure_date": "2025-06-01",
      "patient_age": 67,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Other",
      "cpt_codes": [
        31634,
        31647
      ],
      "evidence": {
        "attending_name": "ATTENDING: Dr. Catherine Lee",
        "patient_age": "PATIENT: William Harris, 68-year-old Male",
        "gender": "PATIENT: William Harris, 68-year-old Male",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION FOR OPERATION: Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature, purpose, risks, benefits and alternatives to endobronchial valve therapy were discussed with the patient in detail. Patient indicated a wish to proceed and informed consent was signed. PREOPERATIVE DIAGNOSIS: Severe heterogeneous emphysema with target left upper lobe POSTOPERATIVE DIAGNOSIS: Same PROCEDURE: Endobronchial Valve Placement (CPT 31647, 31648) ATTENDING: Dr. Catherine Lee ASSISTANT: Dr. Brian Thompson, Fellow Support Staff:",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": false,
      "disposition": "Floor admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Observation",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": "LUL",
      "blvr_valve_type": "Zephyr (Pulmonx)",
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "Follow-up IP clinic in 2 weeks with repeat CXR and PFTs in 6 weeks"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Lee",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155350"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31647",
        "31647",
        "31634"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.038031",
      "changes": [
        "Deduplicated CPT codes: [31647, 31647, 31634] -> [31634, 31647]"
      ],
      "warnings": [
        "NCCI bundling: 31647 + 31634 - BLVR valve and Chartis same lobe. Consider modifier -59/-XS if distinct sites."
      ]
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Endobronchial Valve Placement operative report for William Harris.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI Policy Manual Chapter 5 (Respiratory)",
        "2025 MPFS facility RVUs and payment rates"
      ],
      "per_code": [
        {
          "code": "31647",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with endobronchial valve placement, initial lobe.",
          "category": "bronchoscopic_blvr_valve_placement",
          "units": 1,
          "facility_total_rvus_2025": 12.05,
          "facility_mpfs_payment_2025": 390.0,
          "bundling_or_modifier_notes": "Primary service. Supported by placement of 3 Zephyr valves in the LUL (initial lobe). Includes sizing and deployment."
        },
        {
          "code": "31634",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with balloon occlusion, assessment of air leak (Chartis), airway sizing, and documentation.",
          "category": "bronchoscopic_blvr_chartis",
          "units": 1,
          "facility_total_rvus_2025": 5.63,
          "facility_mpfs_payment_2025": 182.0,
          "bundling_or_modifier_notes": "Chartis assessment of the LUL was performed in the same session as valve placement in the LUL. Per NCCI and payer policies, 31634 is typically bundled into 31647 when performed on the same lobe. Status: Bundled/Supportive."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 12.05,
        "total_facility_mpfs_payment": 390.0,
        "computation_notes": "Total assumes 31634 is bundled. Payment reflects 31647 only."
      },
      "rationale": [
        "Clinical summary: 68M with severe emphysema underwent Chartis assessment of LUL (CV Negative) followed by placement of 3 Zephyr valves in the LUL.",
        "Code selection: 31647 is the correct code for valve placement in a single lobe (LUL). 31634 captures the Chartis assessment but is bundled when the target lobe is immediately treated.",
        "Bundling: No valves were placed in other lobes, so +31651 is not applicable. No valves were removed, so 31648 is not applicable."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 1,
      "style_type": 6,
      "generated_name": "Charles Allen",
      "generation_date": "2025-12-09T09:18:39.657783"
    }
  },
  {
    "note_text": "[Indication]\nSevere heterogeneous emphysema, target LUL, intact fissures.\n[Anesthesia]\nGeneral, 8.5 ETT.\n[Description]\nChartis assessment LUL: Negative for collateral ventilation. Three Zephyr valves deployed (LB1+2, LB1+2c, LB3). Complete occlusion achieved. Valves functioning normally.\n[Plan]\nAdmit to monitored bed. Serial CXRs to monitor for pneumothorax.",
    "cpt_codes": [
      31634,
      31647
    ],
    "registry_entry": {
      "patient_mrn": "8127065_syn_7",
      "procedure_date": "2025-03-29",
      "patient_age": 66,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Other",
      "cpt_codes": [
        31634,
        31647
      ],
      "evidence": {
        "attending_name": "ATTENDING: Dr. Catherine Lee",
        "patient_age": "PATIENT: William Harris, 68-year-old Male",
        "gender": "PATIENT: William Harris, 68-year-old Male",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION FOR OPERATION: Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature, purpose, risks, benefits and alternatives to endobronchial valve therapy were discussed with the patient in detail. Patient indicated a wish to proceed and informed consent was signed. PREOPERATIVE DIAGNOSIS: Severe heterogeneous emphysema with target left upper lobe POSTOPERATIVE DIAGNOSIS: Same PROCEDURE: Endobronchial Valve Placement (CPT 31647, 31648) ATTENDING: Dr. Catherine Lee ASSISTANT: Dr. Brian Thompson, Fellow Support Staff:",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": false,
      "disposition": "Floor admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Observation",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": "LUL",
      "blvr_valve_type": "Zephyr (Pulmonx)",
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "Follow-up IP clinic in 2 weeks with repeat CXR and PFTs in 6 weeks"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Lee",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155350"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31647",
        "31647",
        "31634"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.038031",
      "changes": [
        "Deduplicated CPT codes: [31647, 31647, 31634] -> [31634, 31647]"
      ],
      "warnings": [
        "NCCI bundling: 31647 + 31634 - BLVR valve and Chartis same lobe. Consider modifier -59/-XS if distinct sites."
      ]
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Endobronchial Valve Placement operative report for William Harris.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI Policy Manual Chapter 5 (Respiratory)",
        "2025 MPFS facility RVUs and payment rates"
      ],
      "per_code": [
        {
          "code": "31647",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with endobronchial valve placement, initial lobe.",
          "category": "bronchoscopic_blvr_valve_placement",
          "units": 1,
          "facility_total_rvus_2025": 12.05,
          "facility_mpfs_payment_2025": 390.0,
          "bundling_or_modifier_notes": "Primary service. Supported by placement of 3 Zephyr valves in the LUL (initial lobe). Includes sizing and deployment."
        },
        {
          "code": "31634",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with balloon occlusion, assessment of air leak (Chartis), airway sizing, and documentation.",
          "category": "bronchoscopic_blvr_chartis",
          "units": 1,
          "facility_total_rvus_2025": 5.63,
          "facility_mpfs_payment_2025": 182.0,
          "bundling_or_modifier_notes": "Chartis assessment of the LUL was performed in the same session as valve placement in the LUL. Per NCCI and payer policies, 31634 is typically bundled into 31647 when performed on the same lobe. Status: Bundled/Supportive."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 12.05,
        "total_facility_mpfs_payment": 390.0,
        "computation_notes": "Total assumes 31634 is bundled. Payment reflects 31647 only."
      },
      "rationale": [
        "Clinical summary: 68M with severe emphysema underwent Chartis assessment of LUL (CV Negative) followed by placement of 3 Zephyr valves in the LUL.",
        "Code selection: 31647 is the correct code for valve placement in a single lobe (LUL). 31634 captures the Chartis assessment but is bundled when the target lobe is immediately treated.",
        "Bundling: No valves were placed in other lobes, so +31651 is not applicable. No valves were removed, so 31648 is not applicable."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 1,
      "style_type": 7,
      "generated_name": "Frank Young",
      "generation_date": "2025-12-09T09:18:39.657834"
    }
  },
  {
    "note_text": "We performed an elective lung volume reduction for Mr. Allen today. After placing the breathing tube, we navigated to the left upper lobe. The Chartis balloon test confirmed that there was no airflow between the lobes, making him a good candidate. We then proceeded to place three valves in the upper lobe segments. We verified that each valve was sitting correctly and that the airway was fully blocked. He tolerated the procedure well and is now recovering.",
    "cpt_codes": [
      31634,
      31647
    ],
    "registry_entry": {
      "patient_mrn": "8127065_syn_8",
      "procedure_date": "2025-02-22",
      "patient_age": 68,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Other",
      "cpt_codes": [
        31634,
        31647
      ],
      "evidence": {
        "attending_name": "ATTENDING: Dr. Catherine Lee",
        "patient_age": "PATIENT: William Harris, 68-year-old Male",
        "gender": "PATIENT: William Harris, 68-year-old Male",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION FOR OPERATION: Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature, purpose, risks, benefits and alternatives to endobronchial valve therapy were discussed with the patient in detail. Patient indicated a wish to proceed and informed consent was signed. PREOPERATIVE DIAGNOSIS: Severe heterogeneous emphysema with target left upper lobe POSTOPERATIVE DIAGNOSIS: Same PROCEDURE: Endobronchial Valve Placement (CPT 31647, 31648) ATTENDING: Dr. Catherine Lee ASSISTANT: Dr. Brian Thompson, Fellow Support Staff:",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": false,
      "disposition": "Floor admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Observation",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": "LUL",
      "blvr_valve_type": "Zephyr (Pulmonx)",
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "Follow-up IP clinic in 2 weeks with repeat CXR and PFTs in 6 weeks"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Lee",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155350"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31647",
        "31647",
        "31634"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.038031",
      "changes": [
        "Deduplicated CPT codes: [31647, 31647, 31634] -> [31634, 31647]"
      ],
      "warnings": [
        "NCCI bundling: 31647 + 31634 - BLVR valve and Chartis same lobe. Consider modifier -59/-XS if distinct sites."
      ]
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Endobronchial Valve Placement operative report for William Harris.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI Policy Manual Chapter 5 (Respiratory)",
        "2025 MPFS facility RVUs and payment rates"
      ],
      "per_code": [
        {
          "code": "31647",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with endobronchial valve placement, initial lobe.",
          "category": "bronchoscopic_blvr_valve_placement",
          "units": 1,
          "facility_total_rvus_2025": 12.05,
          "facility_mpfs_payment_2025": 390.0,
          "bundling_or_modifier_notes": "Primary service. Supported by placement of 3 Zephyr valves in the LUL (initial lobe). Includes sizing and deployment."
        },
        {
          "code": "31634",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with balloon occlusion, assessment of air leak (Chartis), airway sizing, and documentation.",
          "category": "bronchoscopic_blvr_chartis",
          "units": 1,
          "facility_total_rvus_2025": 5.63,
          "facility_mpfs_payment_2025": 182.0,
          "bundling_or_modifier_notes": "Chartis assessment of the LUL was performed in the same session as valve placement in the LUL. Per NCCI and payer policies, 31634 is typically bundled into 31647 when performed on the same lobe. Status: Bundled/Supportive."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 12.05,
        "total_facility_mpfs_payment": 390.0,
        "computation_notes": "Total assumes 31634 is bundled. Payment reflects 31647 only."
      },
      "rationale": [
        "Clinical summary: 68M with severe emphysema underwent Chartis assessment of LUL (CV Negative) followed by placement of 3 Zephyr valves in the LUL.",
        "Code selection: 31647 is the correct code for valve placement in a single lobe (LUL). 31634 captures the Chartis assessment but is bundled when the target lobe is immediately treated.",
        "Bundling: No valves were placed in other lobes, so +31651 is not applicable. No valves were removed, so 31648 is not applicable."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 1,
      "style_type": 8,
      "generated_name": "Henry King",
      "generation_date": "2025-12-09T09:18:39.657883"
    }
  },
  {
    "note_text": "Procedure: Insertion of endobronchial valves, left upper lobe.\nReason: Advanced emphysema.\nMethod: The LUL was isolated. Collateral ventilation was ruled out via balloon occlusion. Three Zephyr valves were implanted in the target segments. Complete lobar obstruction was verified visually.\nResult: No immediate complications. Patient extubated.",
    "cpt_codes": [
      31634,
      31647
    ],
    "registry_entry": {
      "patient_mrn": "8127065_syn_9",
      "procedure_date": "2025-11-29",
      "patient_age": 68,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature",
      "sedation_type": "General",
      "airway_type": "ETT",
      "final_diagnosis_prelim": "Other",
      "cpt_codes": [
        31634,
        31647
      ],
      "evidence": {
        "attending_name": "ATTENDING: Dr. Catherine Lee",
        "patient_age": "PATIENT: William Harris, 68-year-old Male",
        "gender": "PATIENT: William Harris, 68-year-old Male",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION FOR OPERATION: Mr. Harris is a 68-year-old male with severe heterogeneous emphysema (FEV1 28% predicted) despite maximal medical therapy including pulmonary rehabilitation. CT imaging shows target left upper lobe with fissure integrity >95%. Chartis assessment confirms absence of collateral ventilation. The nature, purpose, risks, benefits and alternatives to endobronchial valve therapy were discussed with the patient in detail. Patient indicated a wish to proceed and informed consent was signed. PREOPERATIVE DIAGNOSIS: Severe heterogeneous emphysema with target left upper lobe POSTOPERATIVE DIAGNOSIS: Same PROCEDURE: Endobronchial Valve Placement (CPT 31647, 31648) ATTENDING: Dr. Catherine Lee ASSISTANT: Dr. Brian Thompson, Fellow Support Staff:",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "ETT mentioned or implied"
      },
      "molecular_testing_requested": false,
      "disposition": "Floor admission",
      "bleeding_severity": "Mild",
      "pneumothorax": true,
      "pneumothorax_intervention": "Observation",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": "LUL",
      "blvr_valve_type": "Zephyr (Pulmonx)",
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "Follow-up IP clinic in 2 weeks with repeat CXR and PFTs in 6 weeks"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Lee",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155350"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31647",
        "31647",
        "31634"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "POTENTIAL_CONCATENATION: Found 3 patient headers"
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.038031",
      "changes": [
        "Deduplicated CPT codes: [31647, 31647, 31634] -> [31634, 31647]"
      ],
      "warnings": [
        "NCCI bundling: 31647 + 31634 - BLVR valve and Chartis same lobe. Consider modifier -59/-XS if distinct sites."
      ]
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Endobronchial Valve Placement operative report for William Harris.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI Policy Manual Chapter 5 (Respiratory)",
        "2025 MPFS facility RVUs and payment rates"
      ],
      "per_code": [
        {
          "code": "31647",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with endobronchial valve placement, initial lobe.",
          "category": "bronchoscopic_blvr_valve_placement",
          "units": 1,
          "facility_total_rvus_2025": 12.05,
          "facility_mpfs_payment_2025": 390.0,
          "bundling_or_modifier_notes": "Primary service. Supported by placement of 3 Zephyr valves in the LUL (initial lobe). Includes sizing and deployment."
        },
        {
          "code": "31634",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with balloon occlusion, assessment of air leak (Chartis), airway sizing, and documentation.",
          "category": "bronchoscopic_blvr_chartis",
          "units": 1,
          "facility_total_rvus_2025": 5.63,
          "facility_mpfs_payment_2025": 182.0,
          "bundling_or_modifier_notes": "Chartis assessment of the LUL was performed in the same session as valve placement in the LUL. Per NCCI and payer policies, 31634 is typically bundled into 31647 when performed on the same lobe. Status: Bundled/Supportive."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 12.05,
        "total_facility_mpfs_payment": 390.0,
        "computation_notes": "Total assumes 31634 is bundled. Payment reflects 31647 only."
      },
      "rationale": [
        "Clinical summary: 68M with severe emphysema underwent Chartis assessment of LUL (CV Negative) followed by placement of 3 Zephyr valves in the LUL.",
        "Code selection: 31647 is the correct code for valve placement in a single lobe (LUL). 31634 captures the Chartis assessment but is bundled when the target lobe is immediately treated.",
        "Bundling: No valves were placed in other lobes, so +31651 is not applicable. No valves were removed, so 31648 is not applicable."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 1,
      "style_type": 9,
      "generated_name": "Walter Wright",
      "generation_date": "2025-12-09T09:18:39.657935"
    }
  },
  {
    "note_text": "Dx: GPA with tracheal/bronchial stenosis.\nProc: Bronchoscopy, radial cuts, balloon dilation.\nAction:\n- 5cm tracheal stenosis: Dilated 12-15mm.\n- RLL/LUL strictures: Radial cuts (electrocautery), then balloon dilation (6-8mm).\n- Airways recanalized.\nResult: Patency improved. No bleeding.\nPlan: PACU.",
    "cpt_codes": [
      31641
    ],
    "registry_entry": {
      "patient_mrn": "8294651_syn_1",
      "procedure_date": "2025-05-07",
      "patient_age": 65,
      "gender": "Other",
      "asa_class": 3,
      "primary_indication": "Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
      "sedation_type": "General",
      "airway_type": "LMA",
      "final_diagnosis_prelim": "Granulomatous",
      "cpt_codes": [
        31630
      ],
      "evidence": {
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "Preoperative Diagnosis: Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "LMA mentioned"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "• Patient to follow up with me PRN if symptoms return"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Gregory Hamilton",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155363"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31630"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039175",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Flexible bronchoscopy with radial knife incisions and balloon dilatation for Lisa Morgan.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI bundling rules: 31630 bundled into 31641"
      ],
      "per_code": [
        {
          "code": "31641",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with destruction of tumor or relief of stenosis by any method other than excision (e.g., laser, cryotherapy, electrosurgery).",
          "category": "bronchoscopy_therapeutic_airway_tumor",
          "units": 1,
          "facility_total_rvus_2025": 8.4,
          "facility_mpfs_payment_2025": 272.0,
          "bundling_or_modifier_notes": "Replaces 31630. Supported by use of electrocautery knife ('cuts were made to the band-like strictures') to relieve complex stenosis. Dilation (31630) performed in the same segments is bundled."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 8.4,
        "total_facility_mpfs_payment": 272.0,
        "computation_notes": "Includes 31641."
      },
      "rationale": [
        "Clinical summary: Procedure involved electrocautery knife incisions and balloon dilation for complex tracheal and bronchial stenosis.",
        "Code correction: The original code 31630 (dilation) is insufficient because 'radial knife incisions' with electrocautery constitute destruction/relief of stenosis (31641).",
        "Bundling: 31641 includes the work of dilation when performed on the same lesions to facilitate the relief of stenosis."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 2,
      "style_type": 1,
      "generated_name": "Karen Brooks",
      "generation_date": "2025-12-09T09:18:39.657983"
    }
  },
  {
    "note_text": "OPERATIVE REPORT: The patient, with a history of Granulomatosis with Polyangiitis, presented with complex multilevel airway stenosis. Under general anesthesia via LMA, a flexible bronchoscope was introduced. A 5cm circumferential tracheal stenosis was identified and treated via serial balloon dilation (CRE 12-15mm). Further inspection revealed web-like stenoses in the RLL and Lingula. These were managed with a hybrid approach utilizing radial electrocautery incisions followed by balloon dilation to 8mm. Excellent anatomic restoration of the airway caliber was achieved without hemorrhagic complication.",
    "cpt_codes": [
      31641
    ],
    "registry_entry": {
      "patient_mrn": "8294651_syn_2",
      "procedure_date": "2025-09-04",
      "patient_age": 63,
      "gender": "Other",
      "asa_class": 3,
      "primary_indication": "Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
      "sedation_type": "General",
      "airway_type": "LMA",
      "final_diagnosis_prelim": "Granulomatous",
      "cpt_codes": [
        31630
      ],
      "evidence": {
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "Preoperative Diagnosis: Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "LMA mentioned"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "• Patient to follow up with me PRN if symptoms return"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Gregory Hamilton",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155363"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31630"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039175",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Flexible bronchoscopy with radial knife incisions and balloon dilatation for Lisa Morgan.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI bundling rules: 31630 bundled into 31641"
      ],
      "per_code": [
        {
          "code": "31641",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with destruction of tumor or relief of stenosis by any method other than excision (e.g., laser, cryotherapy, electrosurgery).",
          "category": "bronchoscopy_therapeutic_airway_tumor",
          "units": 1,
          "facility_total_rvus_2025": 8.4,
          "facility_mpfs_payment_2025": 272.0,
          "bundling_or_modifier_notes": "Replaces 31630. Supported by use of electrocautery knife ('cuts were made to the band-like strictures') to relieve complex stenosis. Dilation (31630) performed in the same segments is bundled."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 8.4,
        "total_facility_mpfs_payment": 272.0,
        "computation_notes": "Includes 31641."
      },
      "rationale": [
        "Clinical summary: Procedure involved electrocautery knife incisions and balloon dilation for complex tracheal and bronchial stenosis.",
        "Code correction: The original code 31630 (dilation) is insufficient because 'radial knife incisions' with electrocautery constitute destruction/relief of stenosis (31641).",
        "Bundling: 31641 includes the work of dilation when performed on the same lesions to facilitate the relief of stenosis."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 2,
      "style_type": 2,
      "generated_name": "Susan Bennett",
      "generation_date": "2025-12-09T09:18:39.658030"
    }
  },
  {
    "note_text": "CPT Coding Rationale:\n- 31641: Therapeutic bronchoscopy with destruction of tumor or relief of stenosis. Justified by use of electrocautery knife ('radial knife incisions') to cut band-like strictures in RLL and Lingula.\nNote: Balloon dilation (31630) was performed but is bundled into 31641 when performed at the same session/site. The primary service is the relief of stenosis via multiple modalities.",
    "cpt_codes": [
      31641
    ],
    "registry_entry": {
      "patient_mrn": "8294651_syn_3",
      "procedure_date": "2025-10-13",
      "patient_age": 67,
      "gender": "Other",
      "asa_class": 3,
      "primary_indication": "Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
      "sedation_type": "General",
      "airway_type": "LMA",
      "final_diagnosis_prelim": "Granulomatous",
      "cpt_codes": [
        31630
      ],
      "evidence": {
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "Preoperative Diagnosis: Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "LMA mentioned"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "• Patient to follow up with me PRN if symptoms return"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Gregory Hamilton",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155363"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31630"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039175",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Flexible bronchoscopy with radial knife incisions and balloon dilatation for Lisa Morgan.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI bundling rules: 31630 bundled into 31641"
      ],
      "per_code": [
        {
          "code": "31641",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with destruction of tumor or relief of stenosis by any method other than excision (e.g., laser, cryotherapy, electrosurgery).",
          "category": "bronchoscopy_therapeutic_airway_tumor",
          "units": 1,
          "facility_total_rvus_2025": 8.4,
          "facility_mpfs_payment_2025": 272.0,
          "bundling_or_modifier_notes": "Replaces 31630. Supported by use of electrocautery knife ('cuts were made to the band-like strictures') to relieve complex stenosis. Dilation (31630) performed in the same segments is bundled."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 8.4,
        "total_facility_mpfs_payment": 272.0,
        "computation_notes": "Includes 31641."
      },
      "rationale": [
        "Clinical summary: Procedure involved electrocautery knife incisions and balloon dilation for complex tracheal and bronchial stenosis.",
        "Code correction: The original code 31630 (dilation) is insufficient because 'radial knife incisions' with electrocautery constitute destruction/relief of stenosis (31641).",
        "Bundling: 31641 includes the work of dilation when performed on the same lesions to facilitate the relief of stenosis."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 2,
      "style_type": 3,
      "generated_name": "Linda Gray",
      "generation_date": "2025-12-09T09:18:39.658077"
    }
  },
  {
    "note_text": "Resident Note\nPatient: Linda Gray\nProcedure: Airway Dilation/Cuts\nIndication: GPA Stenosis\nSteps:\n1. LMA placed.\n2. Saw long tracheal stenosis -> Dilated w/ balloon up to 15mm.\n3. Saw pinhole stenosis in RLL/Lingula.\n4. Used elec-knife to cut the webs.\n5. Dilated those segments w/ balloon.\n6. Airways open now.\nComplications: None.",
    "cpt_codes": [
      31641
    ],
    "registry_entry": {
      "patient_mrn": "8294651_syn_4",
      "procedure_date": "2025-08-23",
      "patient_age": 65,
      "gender": "Other",
      "asa_class": 3,
      "primary_indication": "Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
      "sedation_type": "General",
      "airway_type": "LMA",
      "final_diagnosis_prelim": "Granulomatous",
      "cpt_codes": [
        31630
      ],
      "evidence": {
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "Preoperative Diagnosis: Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "LMA mentioned"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "• Patient to follow up with me PRN if symptoms return"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Gregory Hamilton",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155363"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31630"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039175",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Flexible bronchoscopy with radial knife incisions and balloon dilatation for Lisa Morgan.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI bundling rules: 31630 bundled into 31641"
      ],
      "per_code": [
        {
          "code": "31641",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with destruction of tumor or relief of stenosis by any method other than excision (e.g., laser, cryotherapy, electrosurgery).",
          "category": "bronchoscopy_therapeutic_airway_tumor",
          "units": 1,
          "facility_total_rvus_2025": 8.4,
          "facility_mpfs_payment_2025": 272.0,
          "bundling_or_modifier_notes": "Replaces 31630. Supported by use of electrocautery knife ('cuts were made to the band-like strictures') to relieve complex stenosis. Dilation (31630) performed in the same segments is bundled."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 8.4,
        "total_facility_mpfs_payment": 272.0,
        "computation_notes": "Includes 31641."
      },
      "rationale": [
        "Clinical summary: Procedure involved electrocautery knife incisions and balloon dilation for complex tracheal and bronchial stenosis.",
        "Code correction: The original code 31630 (dilation) is insufficient because 'radial knife incisions' with electrocautery constitute destruction/relief of stenosis (31641).",
        "Bundling: 31641 includes the work of dilation when performed on the same lesions to facilitate the relief of stenosis."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 2,
      "style_type": 4,
      "generated_name": "Donna James",
      "generation_date": "2025-12-09T09:18:39.658121"
    }
  },
  {
    "note_text": "Lisa morgan here for airway stenosis she has wegeners granulomatosis. We put in an lma and went down with the scope. Trachea was tight so we ballooned it open. Then the right lower lobe and lingula were basically shut so we used the electrocautery knife to make cuts and then ballooned them too. Opened up nicely no bleeding. Patient woke up fine going to pacu.",
    "cpt_codes": [
      31641
    ],
    "registry_entry": {
      "patient_mrn": "8294651_syn_5",
      "procedure_date": "2025-01-23",
      "patient_age": 64,
      "gender": "Other",
      "asa_class": 3,
      "primary_indication": "Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
      "sedation_type": "General",
      "airway_type": "LMA",
      "final_diagnosis_prelim": "Granulomatous",
      "cpt_codes": [
        31630
      ],
      "evidence": {
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "Preoperative Diagnosis: Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "LMA mentioned"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "• Patient to follow up with me PRN if symptoms return"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Gregory Hamilton",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155363"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31630"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039175",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Flexible bronchoscopy with radial knife incisions and balloon dilatation for Lisa Morgan.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI bundling rules: 31630 bundled into 31641"
      ],
      "per_code": [
        {
          "code": "31641",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with destruction of tumor or relief of stenosis by any method other than excision (e.g., laser, cryotherapy, electrosurgery).",
          "category": "bronchoscopy_therapeutic_airway_tumor",
          "units": 1,
          "facility_total_rvus_2025": 8.4,
          "facility_mpfs_payment_2025": 272.0,
          "bundling_or_modifier_notes": "Replaces 31630. Supported by use of electrocautery knife ('cuts were made to the band-like strictures') to relieve complex stenosis. Dilation (31630) performed in the same segments is bundled."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 8.4,
        "total_facility_mpfs_payment": 272.0,
        "computation_notes": "Includes 31641."
      },
      "rationale": [
        "Clinical summary: Procedure involved electrocautery knife incisions and balloon dilation for complex tracheal and bronchial stenosis.",
        "Code correction: The original code 31630 (dilation) is insufficient because 'radial knife incisions' with electrocautery constitute destruction/relief of stenosis (31641).",
        "Bundling: 31641 includes the work of dilation when performed on the same lesions to facilitate the relief of stenosis."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 2,
      "style_type": 5,
      "generated_name": "Sandra Watson",
      "generation_date": "2025-12-09T09:18:39.658170"
    }
  },
  {
    "note_text": "Flexible bronchoscopy with radial knife incisions and balloon dilatation was performed. The patient has tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis. Under general anesthesia with an LMA, a long segment tracheal stenosis was visualized and dilated using 12, 13.5, and 15mm balloons. Web-like strictures in the RLL and Lingula were then addressed. An electrocautery knife was used to make radial incisions in the strictures, followed by balloon dilation using 6-8mm balloons. Near complete recanalization was achieved.",
    "cpt_codes": [
      31641
    ],
    "registry_entry": {
      "patient_mrn": "8294651_syn_6",
      "procedure_date": "2025-09-28",
      "patient_age": 63,
      "gender": "Other",
      "asa_class": 3,
      "primary_indication": "Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
      "sedation_type": "General",
      "airway_type": "LMA",
      "final_diagnosis_prelim": "Granulomatous",
      "cpt_codes": [
        31630
      ],
      "evidence": {
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "Preoperative Diagnosis: Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "LMA mentioned"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "• Patient to follow up with me PRN if symptoms return"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Gregory Hamilton",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155363"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31630"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039175",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Flexible bronchoscopy with radial knife incisions and balloon dilatation for Lisa Morgan.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI bundling rules: 31630 bundled into 31641"
      ],
      "per_code": [
        {
          "code": "31641",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with destruction of tumor or relief of stenosis by any method other than excision (e.g., laser, cryotherapy, electrosurgery).",
          "category": "bronchoscopy_therapeutic_airway_tumor",
          "units": 1,
          "facility_total_rvus_2025": 8.4,
          "facility_mpfs_payment_2025": 272.0,
          "bundling_or_modifier_notes": "Replaces 31630. Supported by use of electrocautery knife ('cuts were made to the band-like strictures') to relieve complex stenosis. Dilation (31630) performed in the same segments is bundled."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 8.4,
        "total_facility_mpfs_payment": 272.0,
        "computation_notes": "Includes 31641."
      },
      "rationale": [
        "Clinical summary: Procedure involved electrocautery knife incisions and balloon dilation for complex tracheal and bronchial stenosis.",
        "Code correction: The original code 31630 (dilation) is insufficient because 'radial knife incisions' with electrocautery constitute destruction/relief of stenosis (31641).",
        "Bundling: 31641 includes the work of dilation when performed on the same lesions to facilitate the relief of stenosis."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 2,
      "style_type": 6,
      "generated_name": "Betty Hughes",
      "generation_date": "2025-12-09T09:18:39.658218"
    }
  },
  {
    "note_text": "[Indication]\nTracheal and bronchial stenosis (GPA).\n[Anesthesia]\nGeneral, LMA.\n[Description]\nTracheal stenosis (5cm long) dilated with CRE balloons (12-15mm). Bronchial strictures (RLL, Lingula) treated with radial electrocautery incisions and subsequent balloon dilation. Airway patency restored.\n[Plan]\nPACU recovery. PRN follow-up.",
    "cpt_codes": [
      31641
    ],
    "registry_entry": {
      "patient_mrn": "8294651_syn_7",
      "procedure_date": "2025-02-15",
      "patient_age": 66,
      "gender": "Other",
      "asa_class": 3,
      "primary_indication": "Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
      "sedation_type": "General",
      "airway_type": "LMA",
      "final_diagnosis_prelim": "Granulomatous",
      "cpt_codes": [
        31630
      ],
      "evidence": {
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "Preoperative Diagnosis: Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "LMA mentioned"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "• Patient to follow up with me PRN if symptoms return"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Gregory Hamilton",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155363"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31630"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039175",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Flexible bronchoscopy with radial knife incisions and balloon dilatation for Lisa Morgan.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI bundling rules: 31630 bundled into 31641"
      ],
      "per_code": [
        {
          "code": "31641",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with destruction of tumor or relief of stenosis by any method other than excision (e.g., laser, cryotherapy, electrosurgery).",
          "category": "bronchoscopy_therapeutic_airway_tumor",
          "units": 1,
          "facility_total_rvus_2025": 8.4,
          "facility_mpfs_payment_2025": 272.0,
          "bundling_or_modifier_notes": "Replaces 31630. Supported by use of electrocautery knife ('cuts were made to the band-like strictures') to relieve complex stenosis. Dilation (31630) performed in the same segments is bundled."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 8.4,
        "total_facility_mpfs_payment": 272.0,
        "computation_notes": "Includes 31641."
      },
      "rationale": [
        "Clinical summary: Procedure involved electrocautery knife incisions and balloon dilation for complex tracheal and bronchial stenosis.",
        "Code correction: The original code 31630 (dilation) is insufficient because 'radial knife incisions' with electrocautery constitute destruction/relief of stenosis (31641).",
        "Bundling: 31641 includes the work of dilation when performed on the same lesions to facilitate the relief of stenosis."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 2,
      "style_type": 7,
      "generated_name": "Dorothy Price",
      "generation_date": "2025-12-09T09:18:39.658284"
    }
  },
  {
    "note_text": "Ms. Hughes underwent a therapeutic bronchoscopy to treat her airway narrowing caused by her autoimmune condition. We found significant narrowing in her windpipe and several branches of her lungs. We first used a balloon to stretch open the main windpipe. For the smaller branches in the right and left lungs, we used a special heated knife to carefully cut the scar tissue before stretching them open with a smaller balloon. The airways looked much more open by the end of the procedure.",
    "cpt_codes": [
      31641
    ],
    "registry_entry": {
      "patient_mrn": "8294651_syn_8",
      "procedure_date": "2025-05-09",
      "patient_age": 66,
      "gender": "Other",
      "asa_class": 3,
      "primary_indication": "Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
      "sedation_type": "General",
      "airway_type": "LMA",
      "final_diagnosis_prelim": "Granulomatous",
      "cpt_codes": [
        31630
      ],
      "evidence": {
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "Preoperative Diagnosis: Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "LMA mentioned"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "• Patient to follow up with me PRN if symptoms return"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Gregory Hamilton",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155363"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31630"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039175",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Flexible bronchoscopy with radial knife incisions and balloon dilatation for Lisa Morgan.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI bundling rules: 31630 bundled into 31641"
      ],
      "per_code": [
        {
          "code": "31641",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with destruction of tumor or relief of stenosis by any method other than excision (e.g., laser, cryotherapy, electrosurgery).",
          "category": "bronchoscopy_therapeutic_airway_tumor",
          "units": 1,
          "facility_total_rvus_2025": 8.4,
          "facility_mpfs_payment_2025": 272.0,
          "bundling_or_modifier_notes": "Replaces 31630. Supported by use of electrocautery knife ('cuts were made to the band-like strictures') to relieve complex stenosis. Dilation (31630) performed in the same segments is bundled."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 8.4,
        "total_facility_mpfs_payment": 272.0,
        "computation_notes": "Includes 31641."
      },
      "rationale": [
        "Clinical summary: Procedure involved electrocautery knife incisions and balloon dilation for complex tracheal and bronchial stenosis.",
        "Code correction: The original code 31630 (dilation) is insufficient because 'radial knife incisions' with electrocautery constitute destruction/relief of stenosis (31641).",
        "Bundling: 31641 includes the work of dilation when performed on the same lesions to facilitate the relief of stenosis."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 2,
      "style_type": 8,
      "generated_name": "Helen Sanders",
      "generation_date": "2025-12-09T09:18:39.658333"
    }
  },
  {
    "note_text": "Procedure: Bronchoscopic recanalization of airway stenosis.\nEtiology: Granulomatosis with polyangiitis.\nTechnique: The tracheal narrowing was expanded using hydraulic balloons. Complex strictures in the lobar bronchi were incised using electrosurgery and subsequently expanded. \nOutcome: Luminal diameter significantly augmented. Hemostasis maintained.",
    "cpt_codes": [
      31641
    ],
    "registry_entry": {
      "patient_mrn": "8294651_syn_9",
      "procedure_date": "2025-11-29",
      "patient_age": 67,
      "gender": "Other",
      "asa_class": 3,
      "primary_indication": "Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
      "sedation_type": "General",
      "airway_type": "LMA",
      "final_diagnosis_prelim": "Granulomatous",
      "cpt_codes": [
        31630
      ],
      "evidence": {
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "Preoperative Diagnosis: Tracheal and bronchial stenosis secondary to Granulomatosis with polyangiitis",
        "sedation_type": "general anesthesia/GA context",
        "airway_type": "LMA mentioned"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "• Patient to follow up with me PRN if symptoms return"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": null,
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": null,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": null,
      "linear_ebus_stations": null,
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Gregory Hamilton",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155363"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31630"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039175",
      "changes": [],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Flexible bronchoscopy with radial knife incisions and balloon dilatation for Lisa Morgan.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "NCCI bundling rules: 31630 bundled into 31641"
      ],
      "per_code": [
        {
          "code": "31641",
          "description": "Bronchoscopy, rigid or flexible, including fluoroscopic guidance, with destruction of tumor or relief of stenosis by any method other than excision (e.g., laser, cryotherapy, electrosurgery).",
          "category": "bronchoscopy_therapeutic_airway_tumor",
          "units": 1,
          "facility_total_rvus_2025": 8.4,
          "facility_mpfs_payment_2025": 272.0,
          "bundling_or_modifier_notes": "Replaces 31630. Supported by use of electrocautery knife ('cuts were made to the band-like strictures') to relieve complex stenosis. Dilation (31630) performed in the same segments is bundled."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 8.4,
        "total_facility_mpfs_payment": 272.0,
        "computation_notes": "Includes 31641."
      },
      "rationale": [
        "Clinical summary: Procedure involved electrocautery knife incisions and balloon dilation for complex tracheal and bronchial stenosis.",
        "Code correction: The original code 31630 (dilation) is insufficient because 'radial knife incisions' with electrocautery constitute destruction/relief of stenosis (31641).",
        "Bundling: 31641 includes the work of dilation when performed on the same lesions to facilitate the relief of stenosis."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 2,
      "style_type": 9,
      "generated_name": "Margaret Ross",
      "generation_date": "2025-12-09T09:18:39.658381"
    }
  },
  {
    "note_text": "Indication: 3.2cm RUL mass + adenopathy.\nProc: EBUS + Ion Nav Bronch.\nEBUS: Stations 4R, 7, 10R sampled. All positive for SqCC.\nNav Bronch: RUL mass. REBUS concentric. Biopsy x7.\nDx: Squamous Cell Ca, Stage IIIA.\nPlan: Oncology referral.",
    "cpt_codes": [
      31653,
      31627,
      31654,
      31628
    ],
    "registry_entry": {
      "patient_mrn": "8463925_syn_1",
      "procedure_date": "2025-08-16",
      "patient_age": 68,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Not specified",
      "sedation_type": "Moderate",
      "airway_type": "Native",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653,
        31627,
        31654,
        31628
      ],
      "evidence": {
        "procedure_date": "Date: 04/29/2025",
        "patient_age": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "gender": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "sedation_type": "default Moderate (no explicit documentation)",
        "airway_type": "default Native (no airway device mentioned)"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "- F/u 1 wk"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": "Cone Beam CT",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 32.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10R",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10R",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Unknown",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155369"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653",
        "31627",
        "31654",
        "31628"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039358",
      "changes": [
        "Extracted lesion_size_mm: 32.0",
        "Extracted EBUS stations: ['10R', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic bronchoscopy note for Jackson, Tyrone.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of stations 4R, 7, and 10R (3 stations)."
        },
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (add-on).",
          "category": "bronchoscopy_navigation",
          "units": 1,
          "facility_total_rvus_2025": 3.07,
          "facility_mpfs_payment_2025": 99.0,
          "bundling_or_modifier_notes": "Add-on. Supported by use of Ion robotic platform with registration and navigation to RUL mass."
        },
        {
          "code": "31654",
          "description": "EBUS for peripheral lesion(s) during bronchoscopic intervention (add-on).",
          "category": "bronchoscopy_ebus_radial",
          "units": 1,
          "facility_total_rvus_2025": 2.11,
          "facility_mpfs_payment_2025": 68.0,
          "bundling_or_modifier_notes": "Add-on. Supported by REBUS visualization (concentric pattern) of the RUL mass."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy with transbronchial lung biopsy(s), single lobe.",
          "category": "bronchoscopy_biopsy_parenchymal",
          "units": 1,
          "facility_total_rvus_2025": 5.53,
          "facility_mpfs_payment_2025": 179.0,
          "bundling_or_modifier_notes": "Supported by 7 biopsies of the RUL mass. 31628 is compatible with 31653/31627/31654."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 18.41,
        "total_facility_mpfs_payment": 595.0,
        "computation_notes": "Sum of 31653, 31627, 31654, 31628."
      },
      "rationale": [
        "Clinical summary: Ion robotic bronchoscopy for 3.2cm RUL mass and staging. EBUS-TBNA of 3 stations (4R, 7, 10R). Navigation and radial EBUS used for RUL mass biopsies.",
        "Code selection: Code set [31653, 31627, 31654, 31628] accurately reflects the maximal scope of the procedure."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 3,
      "style_type": 1,
      "generated_name": "Marcus Washington",
      "generation_date": "2025-12-09T09:18:39.658441"
    }
  },
  {
    "note_text": "OPERATIVE SUMMARY: This 68-year-old male presented for diagnosis and staging of a right upper lobe mass. EBUS-TBNA was performed initially, sampling stations 4R, 7, and 10R. Rapid on-site evaluation (ROSE) confirmed squamous cell carcinoma in all nodal stations. Subsequently, robotic-assisted navigation (Ion) was utilized to localize the peripheral RLL mass. Radial EBUS confirmed lesion position. Transbronchial biopsies yielded tissue consistent with the nodal findings. The patient has confirmed N2 disease, determining a clinical stage of at least IIIA.",
    "cpt_codes": [
      31653,
      31627,
      31654,
      31628
    ],
    "registry_entry": {
      "patient_mrn": "8463925_syn_2",
      "procedure_date": "2025-12-24",
      "patient_age": 67,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Not specified",
      "sedation_type": "Moderate",
      "airway_type": "Native",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653,
        31627,
        31654,
        31628
      ],
      "evidence": {
        "procedure_date": "Date: 04/29/2025",
        "patient_age": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "gender": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "sedation_type": "default Moderate (no explicit documentation)",
        "airway_type": "default Native (no airway device mentioned)"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "- F/u 1 wk"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": "Cone Beam CT",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 32.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10R",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10R",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Unknown",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155369"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653",
        "31627",
        "31654",
        "31628"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039358",
      "changes": [
        "Extracted lesion_size_mm: 32.0",
        "Extracted EBUS stations: ['10R', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic bronchoscopy note for Jackson, Tyrone.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of stations 4R, 7, and 10R (3 stations)."
        },
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (add-on).",
          "category": "bronchoscopy_navigation",
          "units": 1,
          "facility_total_rvus_2025": 3.07,
          "facility_mpfs_payment_2025": 99.0,
          "bundling_or_modifier_notes": "Add-on. Supported by use of Ion robotic platform with registration and navigation to RUL mass."
        },
        {
          "code": "31654",
          "description": "EBUS for peripheral lesion(s) during bronchoscopic intervention (add-on).",
          "category": "bronchoscopy_ebus_radial",
          "units": 1,
          "facility_total_rvus_2025": 2.11,
          "facility_mpfs_payment_2025": 68.0,
          "bundling_or_modifier_notes": "Add-on. Supported by REBUS visualization (concentric pattern) of the RUL mass."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy with transbronchial lung biopsy(s), single lobe.",
          "category": "bronchoscopy_biopsy_parenchymal",
          "units": 1,
          "facility_total_rvus_2025": 5.53,
          "facility_mpfs_payment_2025": 179.0,
          "bundling_or_modifier_notes": "Supported by 7 biopsies of the RUL mass. 31628 is compatible with 31653/31627/31654."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 18.41,
        "total_facility_mpfs_payment": 595.0,
        "computation_notes": "Sum of 31653, 31627, 31654, 31628."
      },
      "rationale": [
        "Clinical summary: Ion robotic bronchoscopy for 3.2cm RUL mass and staging. EBUS-TBNA of 3 stations (4R, 7, 10R). Navigation and radial EBUS used for RUL mass biopsies.",
        "Code selection: Code set [31653, 31627, 31654, 31628] accurately reflects the maximal scope of the procedure."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 3,
      "style_type": 2,
      "generated_name": "Darnell Jefferson",
      "generation_date": "2025-12-09T09:18:39.658496"
    }
  },
  {
    "note_text": "Coding Breakdown:\n- 31653: EBUS sampling of 3+ stations (4R, 7, 10R).\n- 31627: Computer-assisted navigation (Add-on) for RUL mass.\n- 31654: Peripheral EBUS (Add-on) for RUL mass confirmation.\n- 31628: Transbronchial lung biopsy, single lobe (RUL).\nMedical Necessity: Staging of lung cancer and diagnosis of primary lesion.",
    "cpt_codes": [
      31653,
      31627,
      31654,
      31628
    ],
    "registry_entry": {
      "patient_mrn": "8463925_syn_3",
      "procedure_date": "2025-10-08",
      "patient_age": 70,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Not specified",
      "sedation_type": "Moderate",
      "airway_type": "Native",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653,
        31627,
        31654,
        31628
      ],
      "evidence": {
        "procedure_date": "Date: 04/29/2025",
        "patient_age": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "gender": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "sedation_type": "default Moderate (no explicit documentation)",
        "airway_type": "default Native (no airway device mentioned)"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "- F/u 1 wk"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": "Cone Beam CT",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 32.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10R",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10R",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Unknown",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155369"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653",
        "31627",
        "31654",
        "31628"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039358",
      "changes": [
        "Extracted lesion_size_mm: 32.0",
        "Extracted EBUS stations: ['10R', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic bronchoscopy note for Jackson, Tyrone.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of stations 4R, 7, and 10R (3 stations)."
        },
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (add-on).",
          "category": "bronchoscopy_navigation",
          "units": 1,
          "facility_total_rvus_2025": 3.07,
          "facility_mpfs_payment_2025": 99.0,
          "bundling_or_modifier_notes": "Add-on. Supported by use of Ion robotic platform with registration and navigation to RUL mass."
        },
        {
          "code": "31654",
          "description": "EBUS for peripheral lesion(s) during bronchoscopic intervention (add-on).",
          "category": "bronchoscopy_ebus_radial",
          "units": 1,
          "facility_total_rvus_2025": 2.11,
          "facility_mpfs_payment_2025": 68.0,
          "bundling_or_modifier_notes": "Add-on. Supported by REBUS visualization (concentric pattern) of the RUL mass."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy with transbronchial lung biopsy(s), single lobe.",
          "category": "bronchoscopy_biopsy_parenchymal",
          "units": 1,
          "facility_total_rvus_2025": 5.53,
          "facility_mpfs_payment_2025": 179.0,
          "bundling_or_modifier_notes": "Supported by 7 biopsies of the RUL mass. 31628 is compatible with 31653/31627/31654."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 18.41,
        "total_facility_mpfs_payment": 595.0,
        "computation_notes": "Sum of 31653, 31627, 31654, 31628."
      },
      "rationale": [
        "Clinical summary: Ion robotic bronchoscopy for 3.2cm RUL mass and staging. EBUS-TBNA of 3 stations (4R, 7, 10R). Navigation and radial EBUS used for RUL mass biopsies.",
        "Code selection: Code set [31653, 31627, 31654, 31628] accurately reflects the maximal scope of the procedure."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 3,
      "style_type": 3,
      "generated_name": "Terrence Robinson",
      "generation_date": "2025-12-09T09:18:39.658552"
    }
  },
  {
    "note_text": "Procedure Note\nPatient: Andre Banks\nProcedure: EBUS + Robotic Bronch\n1. EBUS first. Stuck 4R, 7, 10R. All positive for Squamous on ROSE.\n2. Switched to Ion robot.\n3. Navigated to RUL mass.\n4. Confirmed with radial probe.\n5. Took 7 biopsies.\n6. ROSE confirmed Squamous.\nImpression: Stage IIIA lung cancer.",
    "cpt_codes": [
      31653,
      31627,
      31654,
      31628
    ],
    "registry_entry": {
      "patient_mrn": "8463925_syn_4",
      "procedure_date": "2025-10-31",
      "patient_age": 68,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Not specified",
      "sedation_type": "Moderate",
      "airway_type": "Native",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653,
        31627,
        31654,
        31628
      ],
      "evidence": {
        "procedure_date": "Date: 04/29/2025",
        "patient_age": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "gender": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "sedation_type": "default Moderate (no explicit documentation)",
        "airway_type": "default Native (no airway device mentioned)"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "- F/u 1 wk"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": "Cone Beam CT",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 32.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10R",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10R",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Unknown",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155369"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653",
        "31627",
        "31654",
        "31628"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039358",
      "changes": [
        "Extracted lesion_size_mm: 32.0",
        "Extracted EBUS stations: ['10R', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic bronchoscopy note for Jackson, Tyrone.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of stations 4R, 7, and 10R (3 stations)."
        },
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (add-on).",
          "category": "bronchoscopy_navigation",
          "units": 1,
          "facility_total_rvus_2025": 3.07,
          "facility_mpfs_payment_2025": 99.0,
          "bundling_or_modifier_notes": "Add-on. Supported by use of Ion robotic platform with registration and navigation to RUL mass."
        },
        {
          "code": "31654",
          "description": "EBUS for peripheral lesion(s) during bronchoscopic intervention (add-on).",
          "category": "bronchoscopy_ebus_radial",
          "units": 1,
          "facility_total_rvus_2025": 2.11,
          "facility_mpfs_payment_2025": 68.0,
          "bundling_or_modifier_notes": "Add-on. Supported by REBUS visualization (concentric pattern) of the RUL mass."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy with transbronchial lung biopsy(s), single lobe.",
          "category": "bronchoscopy_biopsy_parenchymal",
          "units": 1,
          "facility_total_rvus_2025": 5.53,
          "facility_mpfs_payment_2025": 179.0,
          "bundling_or_modifier_notes": "Supported by 7 biopsies of the RUL mass. 31628 is compatible with 31653/31627/31654."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 18.41,
        "total_facility_mpfs_payment": 595.0,
        "computation_notes": "Sum of 31653, 31627, 31654, 31628."
      },
      "rationale": [
        "Clinical summary: Ion robotic bronchoscopy for 3.2cm RUL mass and staging. EBUS-TBNA of 3 stations (4R, 7, 10R). Navigation and radial EBUS used for RUL mass biopsies.",
        "Code selection: Code set [31653, 31627, 31654, 31628] accurately reflects the maximal scope of the procedure."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 3,
      "style_type": 4,
      "generated_name": "Andre Banks",
      "generation_date": "2025-12-09T09:18:39.658611"
    }
  },
  {
    "note_text": "Mr Jackson for staging and biopsy he has a rul mass. we did the ebus first hit the lymph nodes 4r 7 and 10r dr park said they were all cancer squamous cell. then we used the robot to go out to the mass in the rul. radial ebus showed it nicely. grabbed some biopsies and brushes. looks like stage 3a so hes gonna need chemo and radiation not surgery. no complications.",
    "cpt_codes": [
      31653,
      31627,
      31654,
      31628
    ],
    "registry_entry": {
      "patient_mrn": "8463925_syn_5",
      "procedure_date": "2025-07-30",
      "patient_age": 70,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Not specified",
      "sedation_type": "Moderate",
      "airway_type": "Native",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653,
        31627,
        31654,
        31628
      ],
      "evidence": {
        "procedure_date": "Date: 04/29/2025",
        "patient_age": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "gender": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "sedation_type": "default Moderate (no explicit documentation)",
        "airway_type": "default Native (no airway device mentioned)"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "- F/u 1 wk"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": "Cone Beam CT",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 32.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10R",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10R",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Unknown",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155369"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653",
        "31627",
        "31654",
        "31628"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039358",
      "changes": [
        "Extracted lesion_size_mm: 32.0",
        "Extracted EBUS stations: ['10R', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic bronchoscopy note for Jackson, Tyrone.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of stations 4R, 7, and 10R (3 stations)."
        },
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (add-on).",
          "category": "bronchoscopy_navigation",
          "units": 1,
          "facility_total_rvus_2025": 3.07,
          "facility_mpfs_payment_2025": 99.0,
          "bundling_or_modifier_notes": "Add-on. Supported by use of Ion robotic platform with registration and navigation to RUL mass."
        },
        {
          "code": "31654",
          "description": "EBUS for peripheral lesion(s) during bronchoscopic intervention (add-on).",
          "category": "bronchoscopy_ebus_radial",
          "units": 1,
          "facility_total_rvus_2025": 2.11,
          "facility_mpfs_payment_2025": 68.0,
          "bundling_or_modifier_notes": "Add-on. Supported by REBUS visualization (concentric pattern) of the RUL mass."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy with transbronchial lung biopsy(s), single lobe.",
          "category": "bronchoscopy_biopsy_parenchymal",
          "units": 1,
          "facility_total_rvus_2025": 5.53,
          "facility_mpfs_payment_2025": 179.0,
          "bundling_or_modifier_notes": "Supported by 7 biopsies of the RUL mass. 31628 is compatible with 31653/31627/31654."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 18.41,
        "total_facility_mpfs_payment": 595.0,
        "computation_notes": "Sum of 31653, 31627, 31654, 31628."
      },
      "rationale": [
        "Clinical summary: Ion robotic bronchoscopy for 3.2cm RUL mass and staging. EBUS-TBNA of 3 stations (4R, 7, 10R). Navigation and radial EBUS used for RUL mass biopsies.",
        "Code selection: Code set [31653, 31627, 31654, 31628] accurately reflects the maximal scope of the procedure."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 3,
      "style_type": 5,
      "generated_name": "Darius Coleman",
      "generation_date": "2025-12-09T09:18:39.658666"
    }
  },
  {
    "note_text": "EBUS-TBNA and robotic navigational bronchoscopy were performed. EBUS was used to sample mediastinal and hilar lymph nodes at stations 4R, 7, and 10R. Cytology was positive for squamous cell carcinoma in all stations. The Ion robotic system was then used to navigate to the 3.2cm RUL mass. Radial EBUS confirmed the target. Forceps biopsies and brushings were obtained, which also showed squamous cell carcinoma. The patient tolerated the procedure well.",
    "cpt_codes": [
      31653,
      31627,
      31654,
      31628
    ],
    "registry_entry": {
      "patient_mrn": "8463925_syn_6",
      "procedure_date": "2025-07-03",
      "patient_age": 68,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Not specified",
      "sedation_type": "Moderate",
      "airway_type": "Native",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653,
        31627,
        31654,
        31628
      ],
      "evidence": {
        "procedure_date": "Date: 04/29/2025",
        "patient_age": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "gender": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "sedation_type": "default Moderate (no explicit documentation)",
        "airway_type": "default Native (no airway device mentioned)"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "- F/u 1 wk"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": "Cone Beam CT",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 32.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10R",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10R",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Unknown",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155369"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653",
        "31627",
        "31654",
        "31628"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039358",
      "changes": [
        "Extracted lesion_size_mm: 32.0",
        "Extracted EBUS stations: ['10R', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic bronchoscopy note for Jackson, Tyrone.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of stations 4R, 7, and 10R (3 stations)."
        },
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (add-on).",
          "category": "bronchoscopy_navigation",
          "units": 1,
          "facility_total_rvus_2025": 3.07,
          "facility_mpfs_payment_2025": 99.0,
          "bundling_or_modifier_notes": "Add-on. Supported by use of Ion robotic platform with registration and navigation to RUL mass."
        },
        {
          "code": "31654",
          "description": "EBUS for peripheral lesion(s) during bronchoscopic intervention (add-on).",
          "category": "bronchoscopy_ebus_radial",
          "units": 1,
          "facility_total_rvus_2025": 2.11,
          "facility_mpfs_payment_2025": 68.0,
          "bundling_or_modifier_notes": "Add-on. Supported by REBUS visualization (concentric pattern) of the RUL mass."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy with transbronchial lung biopsy(s), single lobe.",
          "category": "bronchoscopy_biopsy_parenchymal",
          "units": 1,
          "facility_total_rvus_2025": 5.53,
          "facility_mpfs_payment_2025": 179.0,
          "bundling_or_modifier_notes": "Supported by 7 biopsies of the RUL mass. 31628 is compatible with 31653/31627/31654."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 18.41,
        "total_facility_mpfs_payment": 595.0,
        "computation_notes": "Sum of 31653, 31627, 31654, 31628."
      },
      "rationale": [
        "Clinical summary: Ion robotic bronchoscopy for 3.2cm RUL mass and staging. EBUS-TBNA of 3 stations (4R, 7, 10R). Navigation and radial EBUS used for RUL mass biopsies.",
        "Code selection: Code set [31653, 31627, 31654, 31628] accurately reflects the maximal scope of the procedure."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 3,
      "style_type": 6,
      "generated_name": "Jamal Hayes",
      "generation_date": "2025-12-09T09:18:39.658721"
    }
  },
  {
    "note_text": "[Indication]\nRUL mass and PET-positive lymphadenopathy.\n[Anesthesia]\nModerate sedation.\n[Description]\nEBUS-TBNA of stations 4R, 7, 10R performed; all positive for malignancy. Ion robotic navigation to RUL mass performed. REBUS confirmation. Transbronchial biopsies obtained.\n[Plan]\nRefer to Medical Oncology/Radiation Oncology for Stage IIIA Squamous Cell Carcinoma.",
    "cpt_codes": [
      31653,
      31627,
      31654,
      31628
    ],
    "registry_entry": {
      "patient_mrn": "8463925_syn_7",
      "procedure_date": "2025-01-26",
      "patient_age": 68,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Not specified",
      "sedation_type": "Moderate",
      "airway_type": "Native",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653,
        31627,
        31654,
        31628
      ],
      "evidence": {
        "procedure_date": "Date: 04/29/2025",
        "patient_age": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "gender": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "sedation_type": "default Moderate (no explicit documentation)",
        "airway_type": "default Native (no airway device mentioned)"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "- F/u 1 wk"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": "Cone Beam CT",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 32.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10R",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10R",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Unknown",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155369"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653",
        "31627",
        "31654",
        "31628"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039358",
      "changes": [
        "Extracted lesion_size_mm: 32.0",
        "Extracted EBUS stations: ['10R', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic bronchoscopy note for Jackson, Tyrone.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of stations 4R, 7, and 10R (3 stations)."
        },
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (add-on).",
          "category": "bronchoscopy_navigation",
          "units": 1,
          "facility_total_rvus_2025": 3.07,
          "facility_mpfs_payment_2025": 99.0,
          "bundling_or_modifier_notes": "Add-on. Supported by use of Ion robotic platform with registration and navigation to RUL mass."
        },
        {
          "code": "31654",
          "description": "EBUS for peripheral lesion(s) during bronchoscopic intervention (add-on).",
          "category": "bronchoscopy_ebus_radial",
          "units": 1,
          "facility_total_rvus_2025": 2.11,
          "facility_mpfs_payment_2025": 68.0,
          "bundling_or_modifier_notes": "Add-on. Supported by REBUS visualization (concentric pattern) of the RUL mass."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy with transbronchial lung biopsy(s), single lobe.",
          "category": "bronchoscopy_biopsy_parenchymal",
          "units": 1,
          "facility_total_rvus_2025": 5.53,
          "facility_mpfs_payment_2025": 179.0,
          "bundling_or_modifier_notes": "Supported by 7 biopsies of the RUL mass. 31628 is compatible with 31653/31627/31654."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 18.41,
        "total_facility_mpfs_payment": 595.0,
        "computation_notes": "Sum of 31653, 31627, 31654, 31628."
      },
      "rationale": [
        "Clinical summary: Ion robotic bronchoscopy for 3.2cm RUL mass and staging. EBUS-TBNA of 3 stations (4R, 7, 10R). Navigation and radial EBUS used for RUL mass biopsies.",
        "Code selection: Code set [31653, 31627, 31654, 31628] accurately reflects the maximal scope of the procedure."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 3,
      "style_type": 7,
      "generated_name": "Malik Jenkins",
      "generation_date": "2025-12-09T09:18:39.658780"
    }
  },
  {
    "note_text": "We brought Mr. Jenkins in to biopsy a mass in his right lung and check his lymph nodes. We started with the ultrasound scope to check the nodes in the center of his chest. Unfortunately, the samples from three different areas all showed cancer. We then used the robotic system to navigate out to the main mass in the lung and took samples from there as well, which matched the lymph nodes. This confirms the cancer has spread to the lymph nodes, so we will proceed with chemotherapy and radiation rather than surgery.",
    "cpt_codes": [
      31653,
      31627,
      31654,
      31628
    ],
    "registry_entry": {
      "patient_mrn": "8463925_syn_8",
      "procedure_date": "2025-07-01",
      "patient_age": 68,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Not specified",
      "sedation_type": "Moderate",
      "airway_type": "Native",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653,
        31627,
        31654,
        31628
      ],
      "evidence": {
        "procedure_date": "Date: 04/29/2025",
        "patient_age": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "gender": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "sedation_type": "default Moderate (no explicit documentation)",
        "airway_type": "default Native (no airway device mentioned)"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "- F/u 1 wk"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": "Cone Beam CT",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 32.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10R",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10R",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Unknown",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155369"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653",
        "31627",
        "31654",
        "31628"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039358",
      "changes": [
        "Extracted lesion_size_mm: 32.0",
        "Extracted EBUS stations: ['10R', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic bronchoscopy note for Jackson, Tyrone.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of stations 4R, 7, and 10R (3 stations)."
        },
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (add-on).",
          "category": "bronchoscopy_navigation",
          "units": 1,
          "facility_total_rvus_2025": 3.07,
          "facility_mpfs_payment_2025": 99.0,
          "bundling_or_modifier_notes": "Add-on. Supported by use of Ion robotic platform with registration and navigation to RUL mass."
        },
        {
          "code": "31654",
          "description": "EBUS for peripheral lesion(s) during bronchoscopic intervention (add-on).",
          "category": "bronchoscopy_ebus_radial",
          "units": 1,
          "facility_total_rvus_2025": 2.11,
          "facility_mpfs_payment_2025": 68.0,
          "bundling_or_modifier_notes": "Add-on. Supported by REBUS visualization (concentric pattern) of the RUL mass."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy with transbronchial lung biopsy(s), single lobe.",
          "category": "bronchoscopy_biopsy_parenchymal",
          "units": 1,
          "facility_total_rvus_2025": 5.53,
          "facility_mpfs_payment_2025": 179.0,
          "bundling_or_modifier_notes": "Supported by 7 biopsies of the RUL mass. 31628 is compatible with 31653/31627/31654."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 18.41,
        "total_facility_mpfs_payment": 595.0,
        "computation_notes": "Sum of 31653, 31627, 31654, 31628."
      },
      "rationale": [
        "Clinical summary: Ion robotic bronchoscopy for 3.2cm RUL mass and staging. EBUS-TBNA of 3 stations (4R, 7, 10R). Navigation and radial EBUS used for RUL mass biopsies.",
        "Code selection: Code set [31653, 31627, 31654, 31628] accurately reflects the maximal scope of the procedure."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 3,
      "style_type": 8,
      "generated_name": "Xavier Perry",
      "generation_date": "2025-12-09T09:18:39.658843"
    }
  },
  {
    "note_text": "Procedure: Combined endobronchial ultrasound staging and robotic peripheral sampling.\nFindings: Nodal stations 4R, 7, and 10R were aspirated and found to harbor malignant cells (Squamous). The primary RUL lesion was localized via robotic guidance and sampled.\nDiagnosis: Stage IIIA Squamous Cell Carcinoma.",
    "cpt_codes": [
      31653,
      31627,
      31654,
      31628
    ],
    "registry_entry": {
      "patient_mrn": "8463925_syn_9",
      "procedure_date": "2025-08-19",
      "patient_age": 66,
      "gender": "Male",
      "asa_class": 3,
      "primary_indication": "Not specified",
      "sedation_type": "Moderate",
      "airway_type": "Native",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653,
        31627,
        31654,
        31628
      ],
      "evidence": {
        "procedure_date": "Date: 04/29/2025",
        "patient_age": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "gender": "Pt: Jackson, Tyrone | 68M | MRN: 8463925",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "sedation_type": "default Moderate (no explicit documentation)",
        "airway_type": "default Native (no airway device mentioned)"
      },
      "molecular_testing_requested": false,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild",
      "pneumothorax": false,
      "pneumothorax_intervention": null,
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": null,
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "- F/u 1 wk"
      ],
      "nav_platform": "Ion robotic bronchoscopy",
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": true,
      "nav_rebus_view": "Concentric",
      "nav_imaging_verification": "Cone Beam CT",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "brush"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "institution_name": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 32.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10R",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10R",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "Unknown",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155369"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653",
        "31627",
        "31654",
        "31628"
      ],
      "invalid_codes": []
    },
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.039358",
      "changes": [
        "Extracted lesion_size_mm: 32.0",
        "Extracted EBUS stations: ['10R', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "Ion robotic bronchoscopy note for Jackson, Tyrone.",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of stations 4R, 7, and 10R (3 stations)."
        },
        {
          "code": "31627",
          "description": "Bronchoscopy with computer-assisted, image-guided navigation (add-on).",
          "category": "bronchoscopy_navigation",
          "units": 1,
          "facility_total_rvus_2025": 3.07,
          "facility_mpfs_payment_2025": 99.0,
          "bundling_or_modifier_notes": "Add-on. Supported by use of Ion robotic platform with registration and navigation to RUL mass."
        },
        {
          "code": "31654",
          "description": "EBUS for peripheral lesion(s) during bronchoscopic intervention (add-on).",
          "category": "bronchoscopy_ebus_radial",
          "units": 1,
          "facility_total_rvus_2025": 2.11,
          "facility_mpfs_payment_2025": 68.0,
          "bundling_or_modifier_notes": "Add-on. Supported by REBUS visualization (concentric pattern) of the RUL mass."
        },
        {
          "code": "31628",
          "description": "Bronchoscopy with transbronchial lung biopsy(s), single lobe.",
          "category": "bronchoscopy_biopsy_parenchymal",
          "units": 1,
          "facility_total_rvus_2025": 5.53,
          "facility_mpfs_payment_2025": 179.0,
          "bundling_or_modifier_notes": "Supported by 7 biopsies of the RUL mass. 31628 is compatible with 31653/31627/31654."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 18.41,
        "total_facility_mpfs_payment": 595.0,
        "computation_notes": "Sum of 31653, 31627, 31654, 31628."
      },
      "rationale": [
        "Clinical summary: Ion robotic bronchoscopy for 3.2cm RUL mass and staging. EBUS-TBNA of 3 stations (4R, 7, 10R). Navigation and radial EBUS used for RUL mass biopsies.",
        "Code selection: Code set [31653, 31627, 31654, 31628] accurately reflects the maximal scope of the procedure."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 3,
      "style_type": 9,
      "generated_name": "Kendrick Bryant",
      "generation_date": "2025-12-09T09:18:39.658901"
    }
  },
  {
    "note_text": "Indication: RUL nodule, mediastinal adenopathy.\nProc: EBUS-TBNA.\nNodes Sampled: 7, 4R, 10R, 11R.\nResults:\n- 7, 4R, 10R: Positive for Adenocarcinoma.\n- 11R: Benign.\nDx: Stage IIIC (N3 disease).\nPlan: Oncology for systemic therapy.",
    "cpt_codes": [
      31653
    ],
    "registry_entry": {
      "patient_mrn": "5729384_syn_1",
      "procedure_date": "2025-05-04",
      "patient_age": 63,
      "gender": "Female",
      "asa_class": 3,
      "primary_indication": "80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-a",
      "sedation_type": "Deep",
      "airway_type": "Tracheostomy",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653
      ],
      "evidence": {
        "institution_name": "•        Location: Between RMB and LMB, posterior position",
        "attending_name": "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "patient_age": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "gender": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "dob": "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2) Diagnostic question: Tissue diagnosis and staging if malignancy confirmed RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60 ══════════════════════════════════════════ PRE-PROCEDURE: CONSENT: Written informed consent obtained after thorough discussion of: •        Nature and purpose of EBUS-TBNA •        Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures •        Benefits: Tissue diagnosis, staging information, minimally invasive •        Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment •        Patient's questions answered, demonstrated understanding ASA CLASSIFICATION: III NPO STATUS: Confirmed NPO since midnight (>10 hours) IV ACCESS: 20-gauge left forearm, patent MONITORING PLAN: •        Continuous pulse oximetry •        Capnography •        Blood pressure q3 minutes •        Continuous ECG •        Dedicated monitoring nurse ══════════════════════════════════════════ MEDICATIONS ADMINISTERED: TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure TOTAL PROPOFOL: 380mg TOPICAL ANESTHESIA: •        Benzocaine 20% spray to oropharynx (4 applications) •        Lidocaine 2% instilled via bronchoscope: 20mL total ══════════════════════════════════════════ EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present) ══════════════════════════════════════════ PROCEDURE DETAILS: TIMEOUT: Performed at 0830 •        Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944 •        Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy •        Site confirmed: Mediastinal lymph nodes •        Allergies confirmed: Sulfa drugs •        Consent confirmed: Yes, in chart •        Team introductions completed •        Equipment checked PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well. PROCEDURE NARRATIVE: After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization. UPPER AIRWAY INSPECTION: •        Oropharynx: Normal •        Epiglottis: Normal •        Vocal cords: Symmetric, mobile, no masses •        Subglottis: Patent TRACHEOBRONCHIAL TREE: •        Trachea: Normal caliber, no masses, mild mucosal edema •        Carina: Sharp, mobile •        Right mainstem: Patent •        Left mainstem: Patent •        Segmental airways: All visualized segments patent •        No endobronchial masses visualized SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY: ╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │ ║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝ TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED: ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound Characteristics: •        Location: Between RMB and LMB, posterior position •        Dimensions: 41mm (long) x 27mm (short) x 24mm (depth) •        Shape: Round •        Borders: Well-defined •        Echotexture: Diffusely hypoechoic •        Hilum: Completely absent •        Necrosis: None evident •        Vascularity: Peripheral vessels on color Doppler •        Elastography: Score 5/5 - very firm (blue pattern) INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass). Pass 1 (0842): •        Excellent sample obtained •        Visible tissue core in needle hub •        ROSE: ADEQUATE specimen, abundant cellularity •        ROSE: MALIGNANT CELLS IDENTIFIED •        ROSE: Morphology consistent with ADENOCARCINOMA Pass 2 (0845): •        Confirmatory sampling •        ROSE: Confirmed adenocarcinoma Pass 3 (0848): •        Additional tissue for molecular studies •        Sent for: EGFR, ALK, ROS1, BRAF, PD-L1 Pass 4 (0851): •        Microbiology specimen •        Sent for: AFB smear/culture, Fungal culture, Bacterial culture Complications: None. Minimal bleeding, self-limited. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 33x21mm, hypoechoic, no hilum Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 28x17mm, loss of hilum Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 24x16mm, abnormal appearance Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 19x13mm, hypoechoic Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 15x10mm, maintained normal architecture Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY ══════════════════════════════════════════ FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent. ══════════════════════════════════════════ RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma ✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers. ══════════════════════════════════════════ SPECIMENS SUBMITTED TO PATHOLOGY: CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes) □ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes) Total: 16 needle passes across 6 lymph node stations CELL BLOCKS: □ Station 7 (2 blocks prepared) MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture ══════════════════════════════════════════ FLUOROSCOPY: Not utilized for this procedure ESTIMATED BLOOD LOSS: <5mL COMPLICATIONS: None ADVERSE EVENTS: None ══════════════════════════════════════════ PATIENT TOLERANCE: The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of: •        Hypoxemia (SpO2 maintained 91-95%) •        Hypotension •        Hypertension •        Tachycardia or bradycardia •        Arrhythmias •        Bronchospasm •        Significant bleeding •        Laryngospasm Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting. ══════════════════════════════════════════ POST-PROCEDURE ORDERS: MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90% ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort) DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions ══════════════════════════════════════════ DIAGNOSTIC IMPRESSION: 1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield. 2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases 3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement: o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive) o        N2 disease: Stations 7, 4R (ipsilateral mediastinal) 4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease 5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated. 6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel ══════════════════════════════════════════ TREATMENT RECOMMENDATIONS: IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell □ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology □ Patient/Family Conference Schedule dedicated time to discuss: •        Diagnosis of adenocarcinoma •        Stage IIIC disease •        Treatment options •        Prognosis •        Goals of care STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease □ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases □ Bone scan or PET-CT total body May already have sufficient information from recent PET AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection): •        EGFR mutations → Consider EGFR TKI if positive •        ALK rearrangement → Consider ALK inhibitor if positive •        ROS1 rearrangement → Consider ROS1 inhibitor if positive •        PD-L1 expression → Impacts immunotherapy decisions •        Comprehensive NGS → May identify other actionable mutations TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen □ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.) □ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy □ Radiation Therapy Role to be determined - may be palliative or consolidative □ Clinical Trial Evaluate eligibility for appropriate trials SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions □ Social Work Financial counseling, support services □ Nutrition Address weight loss, optimize nutritional status □ Patient Navigator Coordinate care, appointments, resources FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results □ Medical Oncology: 04/10/2025 (already scheduled) □ Tumor Board Results Discussion: Following 04/11 conference PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment. ══════════════════════════════════════════ ATTESTATION: I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment. ══════════════════════════════════════════ BILLING INFORMATION: CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L) ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker) ══════════════════════════════════════════ ELECTRONIC SIGNATURE: Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890 Digitally Signed: 04/08/2025 10:45 AM ══════════════════════════════════════════ REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine □ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow) ══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════",
        "sedation_type": "deep or MAC sedation",
        "airway_type": "tracheostomy mentioned"
      },
      "institution_name": null,
      "molecular_testing_requested": true,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild (<50mL)",
      "pneumothorax": true,
      "pneumothorax_intervention": "Aspiration",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": "Ultrasound",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "See cancer doctor",
        "More tests",
        "Decide treatment",
        "Dr. S. Franklin 3/8/2025",
        "________________________________________",
        "EBUS",
        "INTERVENTIONAL PULMONOLOGY PROCEDURAL DOCUMENTATION",
        "══════════════════════════════════════════",
        "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "PROCEDURE: Endobronchial Ultrasound with Transbronchial Needle Aspiration (EBUS-TBNA)",
        "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "Left lower lobe mass 4.2cm on CT",
        "Extensive mediastinal and hilar lymphadenopathy",
        "Weight loss 18 lbs over 2 months",
        "No previous cancer history",
        "PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2)",
        "Diagnostic question: Tissue diagnosis and staging if malignancy confirmed",
        "RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently",
        "PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm",
        "LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60",
        "PRE-PROCEDURE:",
        "CONSENT: Written informed consent obtained after thorough discussion of:",
        "Nature and purpose of EBUS-TBNA",
        "Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures",
        "Benefits: Tissue diagnosis, staging information, minimally invasive",
        "Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment",
        "Patient's questions answered, demonstrated understanding",
        "ASA CLASSIFICATION: III",
        "NPO STATUS: Confirmed NPO since midnight (>10 hours)",
        "IV ACCESS: 20-gauge left forearm, patent",
        "MONITORING PLAN:",
        "Continuous pulse oximetry",
        "Capnography",
        "Blood pressure q3 minutes",
        "Continuous ECG",
        "Dedicated monitoring nurse",
        "MEDICATIONS ADMINISTERED:",
        "TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure",
        "TOTAL PROPOFOL: 380mg",
        "TOPICAL ANESTHESIA:",
        "Benzocaine 20% spray to oropharynx (4 applications)",
        "Lidocaine 2% instilled via bronchoscope: 20mL total",
        "EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present)",
        "PROCEDURE DETAILS:",
        "TIMEOUT: Performed at 0830",
        "Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944",
        "Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy",
        "Site confirmed: Mediastinal lymph nodes",
        "Allergies confirmed: Sulfa drugs",
        "Consent confirmed: Yes, in chart",
        "Team introductions completed",
        "Equipment checked",
        "PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes",
        "SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well.",
        "PROCEDURE NARRATIVE:",
        "After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization.",
        "UPPER AIRWAY INSPECTION:",
        "Oropharynx: Normal",
        "Epiglottis: Normal",
        "Vocal cords: Symmetric, mobile, no masses",
        "Subglottis: Patent",
        "TRACHEOBRONCHIAL TREE:",
        "Trachea: Normal caliber, no masses, mild mucosal edema",
        "Carina: Sharp, mobile",
        "Right mainstem: Patent",
        "Left mainstem: Patent",
        "Segmental airways: All visualized segments patent",
        "No endobronchial masses visualized",
        "SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY:",
        "╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │",
        "║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝",
        "TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED:",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound Characteristics:",
        "Location: Between RMB and LMB, posterior position",
        "Dimensions: 41mm (long) x 27mm (short) x 24mm (depth)",
        "Shape: Round",
        "Borders: Well-defined",
        "Echotexture: Diffusely hypoechoic",
        "Hilum: Completely absent",
        "Necrosis: None evident",
        "Vascularity: Peripheral vessels on color Doppler",
        "Elastography: Score 5/5 - very firm (blue pattern)",
        "INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY",
        "Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass).",
        "Pass 1 (0842):",
        "Excellent sample obtained",
        "Visible tissue core in needle hub",
        "ROSE: ADEQUATE specimen, abundant cellularity",
        "ROSE: MALIGNANT CELLS IDENTIFIED",
        "ROSE: Morphology consistent with ADENOCARCINOMA",
        "Pass 2 (0845):",
        "Confirmatory sampling",
        "ROSE: Confirmed adenocarcinoma",
        "Pass 3 (0848):",
        "Additional tissue for molecular studies",
        "Sent for: EGFR, ALK, ROS1, BRAF, PD-L1",
        "Pass 4 (0851):",
        "Microbiology specimen",
        "Sent for: AFB smear/culture, Fungal culture, Bacterial culture",
        "Complications: None. Minimal bleeding, self-limited.",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 33x21mm, hypoechoic, no hilum",
        "Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 28x17mm, loss of hilum",
        "Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 24x16mm, abnormal appearance",
        "Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 19x13mm, hypoechoic",
        "Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 15x10mm, maintained normal architecture",
        "Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY",
        "FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent.",
        "RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD",
        "POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma",
        "✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma",
        "NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only",
        "CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers.",
        "SPECIMENS SUBMITTED TO PATHOLOGY:",
        "CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes)",
        "□ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes)",
        "Total: 16 needle passes across 6 lymph node stations",
        "CELL BLOCKS: □ Station 7 (2 blocks prepared)",
        "MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel",
        "MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture",
        "FLUOROSCOPY: Not utilized for this procedure",
        "ESTIMATED BLOOD LOSS: <5mL",
        "COMPLICATIONS: None",
        "ADVERSE EVENTS: None",
        "PATIENT TOLERANCE:",
        "The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of:",
        "Hypoxemia (SpO2 maintained 91-95%)",
        "Hypotension",
        "Hypertension",
        "Tachycardia or bradycardia",
        "Arrhythmias",
        "Bronchospasm",
        "Significant bleeding",
        "Laryngospasm",
        "Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting.",
        "POST-PROCEDURE ORDERS:",
        "MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90%",
        "ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance",
        "DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated",
        "MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort)",
        "DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions",
        "DIAGNOSTIC IMPRESSION:",
        "1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield.",
        "2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases",
        "3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement:",
        "o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive)",
        "o        N2 disease: Stations 7, 4R (ipsilateral mediastinal)",
        "4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease",
        "5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated.",
        "6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel",
        "TREATMENT RECOMMENDATIONS:",
        "IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell",
        "□ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology",
        "□ Patient/Family Conference Schedule dedicated time to discuss:",
        "Diagnosis of adenocarcinoma",
        "Stage IIIC disease",
        "Treatment options",
        "Prognosis",
        "Goals of care",
        "STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease",
        "□ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases",
        "□ Bone scan or PET-CT total body May already have sufficient information from recent PET",
        "AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection):",
        "EGFR mutations → Consider EGFR TKI if positive",
        "ALK rearrangement → Consider ALK inhibitor if positive",
        "ROS1 rearrangement → Consider ROS1 inhibitor if positive",
        "PD-L1 expression → Impacts immunotherapy decisions",
        "Comprehensive NGS → May identify other actionable mutations",
        "TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen",
        "□ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.)",
        "□ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy",
        "□ Radiation Therapy Role to be determined - may be palliative or consolidative",
        "□ Clinical Trial Evaluate eligibility for appropriate trials",
        "SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions",
        "□ Social Work Financial counseling, support services",
        "□ Nutrition Address weight loss, optimize nutritional status",
        "□ Patient Navigator Coordinate care, appointments, resources",
        "FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results",
        "□ Medical Oncology: 04/10/2025 (already scheduled)",
        "□ Tumor Board Results Discussion: Following 04/11 conference",
        "PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding",
        "PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment.",
        "ATTESTATION:",
        "I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment.",
        "BILLING INFORMATION:",
        "CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L)",
        "ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker)",
        "ELECTRONIC SIGNATURE:",
        "Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890",
        "Digitally Signed: 04/08/2025 10:45 AM",
        "REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine",
        "□ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow)",
        "══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": "Fluoroscopy",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "needle"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 42.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "ATTENDING: Montgomery",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155518"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "CONCATENATED_NOTE: Note contains header for 'Mills, Robert E' (03/08/2025) but body for 'Russell, Dorothy Mae' (04/08/2025). Extracted data corrected to match the detailed body (Russell)."
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.040705",
      "changes": [
        "Extracted lesion_size_mm: 42.0",
        "Extracted EBUS stations: ['10L', '10R', '11L', '11R', '4L', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "EBUS-TBNA report for Russell, Dorothy Mae (concatenated note body).",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of 6 stations (7, 4L, 4R, 10L, 10R, 11L) documented in the 'Russell' portion of the note."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 7.7,
        "total_facility_mpfs_payment": 249.0,
        "computation_notes": "Single code 31653."
      },
      "rationale": [
        "Data Quality: The note contains a header for 'Mills' but the detailed procedure describes 'Russell'. The coding review is based on the detailed 'Russell' note which documents EBUS-TBNA of 6 stations.",
        "Code selection: Sampling of 3+ stations maps to 31653. No peripheral lesion sampling or other interventions documented in the detailed section."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 4,
      "style_type": 1,
      "generated_name": "Deborah A. Collins",
      "generation_date": "2025-12-09T09:18:39.658982"
    }
  },
  {
    "note_text": "PROCEDURE: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration.\nCLINICAL CONTEXT: 61F with RUL adenocarcinoma presenting for mediastinal staging. \nFINDINGS: Systematic EBUS survey identified adenopathy. FNA was performed at stations 7 (subcarinal), 4R (paratracheal), 10R (hilar), and 11R (interlobar). Rapid on-site evaluation confirmed metastatic adenocarcinoma in stations 7, 4R, and 10R. Station 11R was benign. The presence of contralateral or bulky N2/N3 disease (context dependent) confirms advanced stage IIIC.",
    "cpt_codes": [
      31653
    ],
    "registry_entry": {
      "patient_mrn": "5729384_syn_2",
      "procedure_date": "2025-02-19",
      "patient_age": 60,
      "gender": "Female",
      "asa_class": 3,
      "primary_indication": "80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-a",
      "sedation_type": "Deep",
      "airway_type": "Tracheostomy",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653
      ],
      "evidence": {
        "institution_name": "•        Location: Between RMB and LMB, posterior position",
        "attending_name": "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "patient_age": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "gender": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "dob": "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2) Diagnostic question: Tissue diagnosis and staging if malignancy confirmed RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60 ══════════════════════════════════════════ PRE-PROCEDURE: CONSENT: Written informed consent obtained after thorough discussion of: •        Nature and purpose of EBUS-TBNA •        Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures •        Benefits: Tissue diagnosis, staging information, minimally invasive •        Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment •        Patient's questions answered, demonstrated understanding ASA CLASSIFICATION: III NPO STATUS: Confirmed NPO since midnight (>10 hours) IV ACCESS: 20-gauge left forearm, patent MONITORING PLAN: •        Continuous pulse oximetry •        Capnography •        Blood pressure q3 minutes •        Continuous ECG •        Dedicated monitoring nurse ══════════════════════════════════════════ MEDICATIONS ADMINISTERED: TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure TOTAL PROPOFOL: 380mg TOPICAL ANESTHESIA: •        Benzocaine 20% spray to oropharynx (4 applications) •        Lidocaine 2% instilled via bronchoscope: 20mL total ══════════════════════════════════════════ EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present) ══════════════════════════════════════════ PROCEDURE DETAILS: TIMEOUT: Performed at 0830 •        Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944 •        Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy •        Site confirmed: Mediastinal lymph nodes •        Allergies confirmed: Sulfa drugs •        Consent confirmed: Yes, in chart •        Team introductions completed •        Equipment checked PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well. PROCEDURE NARRATIVE: After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization. UPPER AIRWAY INSPECTION: •        Oropharynx: Normal •        Epiglottis: Normal •        Vocal cords: Symmetric, mobile, no masses •        Subglottis: Patent TRACHEOBRONCHIAL TREE: •        Trachea: Normal caliber, no masses, mild mucosal edema •        Carina: Sharp, mobile •        Right mainstem: Patent •        Left mainstem: Patent •        Segmental airways: All visualized segments patent •        No endobronchial masses visualized SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY: ╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │ ║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝ TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED: ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound Characteristics: •        Location: Between RMB and LMB, posterior position •        Dimensions: 41mm (long) x 27mm (short) x 24mm (depth) •        Shape: Round •        Borders: Well-defined •        Echotexture: Diffusely hypoechoic •        Hilum: Completely absent •        Necrosis: None evident •        Vascularity: Peripheral vessels on color Doppler •        Elastography: Score 5/5 - very firm (blue pattern) INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass). Pass 1 (0842): •        Excellent sample obtained •        Visible tissue core in needle hub •        ROSE: ADEQUATE specimen, abundant cellularity •        ROSE: MALIGNANT CELLS IDENTIFIED •        ROSE: Morphology consistent with ADENOCARCINOMA Pass 2 (0845): •        Confirmatory sampling •        ROSE: Confirmed adenocarcinoma Pass 3 (0848): •        Additional tissue for molecular studies •        Sent for: EGFR, ALK, ROS1, BRAF, PD-L1 Pass 4 (0851): •        Microbiology specimen •        Sent for: AFB smear/culture, Fungal culture, Bacterial culture Complications: None. Minimal bleeding, self-limited. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 33x21mm, hypoechoic, no hilum Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 28x17mm, loss of hilum Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 24x16mm, abnormal appearance Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 19x13mm, hypoechoic Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 15x10mm, maintained normal architecture Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY ══════════════════════════════════════════ FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent. ══════════════════════════════════════════ RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma ✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers. ══════════════════════════════════════════ SPECIMENS SUBMITTED TO PATHOLOGY: CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes) □ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes) Total: 16 needle passes across 6 lymph node stations CELL BLOCKS: □ Station 7 (2 blocks prepared) MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture ══════════════════════════════════════════ FLUOROSCOPY: Not utilized for this procedure ESTIMATED BLOOD LOSS: <5mL COMPLICATIONS: None ADVERSE EVENTS: None ══════════════════════════════════════════ PATIENT TOLERANCE: The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of: •        Hypoxemia (SpO2 maintained 91-95%) •        Hypotension •        Hypertension •        Tachycardia or bradycardia •        Arrhythmias •        Bronchospasm •        Significant bleeding •        Laryngospasm Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting. ══════════════════════════════════════════ POST-PROCEDURE ORDERS: MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90% ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort) DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions ══════════════════════════════════════════ DIAGNOSTIC IMPRESSION: 1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield. 2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases 3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement: o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive) o        N2 disease: Stations 7, 4R (ipsilateral mediastinal) 4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease 5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated. 6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel ══════════════════════════════════════════ TREATMENT RECOMMENDATIONS: IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell □ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology □ Patient/Family Conference Schedule dedicated time to discuss: •        Diagnosis of adenocarcinoma •        Stage IIIC disease •        Treatment options •        Prognosis •        Goals of care STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease □ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases □ Bone scan or PET-CT total body May already have sufficient information from recent PET AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection): •        EGFR mutations → Consider EGFR TKI if positive •        ALK rearrangement → Consider ALK inhibitor if positive •        ROS1 rearrangement → Consider ROS1 inhibitor if positive •        PD-L1 expression → Impacts immunotherapy decisions •        Comprehensive NGS → May identify other actionable mutations TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen □ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.) □ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy □ Radiation Therapy Role to be determined - may be palliative or consolidative □ Clinical Trial Evaluate eligibility for appropriate trials SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions □ Social Work Financial counseling, support services □ Nutrition Address weight loss, optimize nutritional status □ Patient Navigator Coordinate care, appointments, resources FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results □ Medical Oncology: 04/10/2025 (already scheduled) □ Tumor Board Results Discussion: Following 04/11 conference PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment. ══════════════════════════════════════════ ATTESTATION: I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment. ══════════════════════════════════════════ BILLING INFORMATION: CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L) ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker) ══════════════════════════════════════════ ELECTRONIC SIGNATURE: Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890 Digitally Signed: 04/08/2025 10:45 AM ══════════════════════════════════════════ REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine □ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow) ══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════",
        "sedation_type": "deep or MAC sedation",
        "airway_type": "tracheostomy mentioned"
      },
      "institution_name": null,
      "molecular_testing_requested": true,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild (<50mL)",
      "pneumothorax": true,
      "pneumothorax_intervention": "Aspiration",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": "Ultrasound",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "See cancer doctor",
        "More tests",
        "Decide treatment",
        "Dr. S. Franklin 3/8/2025",
        "________________________________________",
        "EBUS",
        "INTERVENTIONAL PULMONOLOGY PROCEDURAL DOCUMENTATION",
        "══════════════════════════════════════════",
        "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "PROCEDURE: Endobronchial Ultrasound with Transbronchial Needle Aspiration (EBUS-TBNA)",
        "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "Left lower lobe mass 4.2cm on CT",
        "Extensive mediastinal and hilar lymphadenopathy",
        "Weight loss 18 lbs over 2 months",
        "No previous cancer history",
        "PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2)",
        "Diagnostic question: Tissue diagnosis and staging if malignancy confirmed",
        "RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently",
        "PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm",
        "LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60",
        "PRE-PROCEDURE:",
        "CONSENT: Written informed consent obtained after thorough discussion of:",
        "Nature and purpose of EBUS-TBNA",
        "Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures",
        "Benefits: Tissue diagnosis, staging information, minimally invasive",
        "Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment",
        "Patient's questions answered, demonstrated understanding",
        "ASA CLASSIFICATION: III",
        "NPO STATUS: Confirmed NPO since midnight (>10 hours)",
        "IV ACCESS: 20-gauge left forearm, patent",
        "MONITORING PLAN:",
        "Continuous pulse oximetry",
        "Capnography",
        "Blood pressure q3 minutes",
        "Continuous ECG",
        "Dedicated monitoring nurse",
        "MEDICATIONS ADMINISTERED:",
        "TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure",
        "TOTAL PROPOFOL: 380mg",
        "TOPICAL ANESTHESIA:",
        "Benzocaine 20% spray to oropharynx (4 applications)",
        "Lidocaine 2% instilled via bronchoscope: 20mL total",
        "EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present)",
        "PROCEDURE DETAILS:",
        "TIMEOUT: Performed at 0830",
        "Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944",
        "Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy",
        "Site confirmed: Mediastinal lymph nodes",
        "Allergies confirmed: Sulfa drugs",
        "Consent confirmed: Yes, in chart",
        "Team introductions completed",
        "Equipment checked",
        "PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes",
        "SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well.",
        "PROCEDURE NARRATIVE:",
        "After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization.",
        "UPPER AIRWAY INSPECTION:",
        "Oropharynx: Normal",
        "Epiglottis: Normal",
        "Vocal cords: Symmetric, mobile, no masses",
        "Subglottis: Patent",
        "TRACHEOBRONCHIAL TREE:",
        "Trachea: Normal caliber, no masses, mild mucosal edema",
        "Carina: Sharp, mobile",
        "Right mainstem: Patent",
        "Left mainstem: Patent",
        "Segmental airways: All visualized segments patent",
        "No endobronchial masses visualized",
        "SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY:",
        "╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │",
        "║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝",
        "TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED:",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound Characteristics:",
        "Location: Between RMB and LMB, posterior position",
        "Dimensions: 41mm (long) x 27mm (short) x 24mm (depth)",
        "Shape: Round",
        "Borders: Well-defined",
        "Echotexture: Diffusely hypoechoic",
        "Hilum: Completely absent",
        "Necrosis: None evident",
        "Vascularity: Peripheral vessels on color Doppler",
        "Elastography: Score 5/5 - very firm (blue pattern)",
        "INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY",
        "Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass).",
        "Pass 1 (0842):",
        "Excellent sample obtained",
        "Visible tissue core in needle hub",
        "ROSE: ADEQUATE specimen, abundant cellularity",
        "ROSE: MALIGNANT CELLS IDENTIFIED",
        "ROSE: Morphology consistent with ADENOCARCINOMA",
        "Pass 2 (0845):",
        "Confirmatory sampling",
        "ROSE: Confirmed adenocarcinoma",
        "Pass 3 (0848):",
        "Additional tissue for molecular studies",
        "Sent for: EGFR, ALK, ROS1, BRAF, PD-L1",
        "Pass 4 (0851):",
        "Microbiology specimen",
        "Sent for: AFB smear/culture, Fungal culture, Bacterial culture",
        "Complications: None. Minimal bleeding, self-limited.",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 33x21mm, hypoechoic, no hilum",
        "Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 28x17mm, loss of hilum",
        "Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 24x16mm, abnormal appearance",
        "Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 19x13mm, hypoechoic",
        "Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 15x10mm, maintained normal architecture",
        "Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY",
        "FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent.",
        "RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD",
        "POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma",
        "✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma",
        "NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only",
        "CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers.",
        "SPECIMENS SUBMITTED TO PATHOLOGY:",
        "CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes)",
        "□ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes)",
        "Total: 16 needle passes across 6 lymph node stations",
        "CELL BLOCKS: □ Station 7 (2 blocks prepared)",
        "MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel",
        "MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture",
        "FLUOROSCOPY: Not utilized for this procedure",
        "ESTIMATED BLOOD LOSS: <5mL",
        "COMPLICATIONS: None",
        "ADVERSE EVENTS: None",
        "PATIENT TOLERANCE:",
        "The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of:",
        "Hypoxemia (SpO2 maintained 91-95%)",
        "Hypotension",
        "Hypertension",
        "Tachycardia or bradycardia",
        "Arrhythmias",
        "Bronchospasm",
        "Significant bleeding",
        "Laryngospasm",
        "Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting.",
        "POST-PROCEDURE ORDERS:",
        "MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90%",
        "ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance",
        "DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated",
        "MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort)",
        "DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions",
        "DIAGNOSTIC IMPRESSION:",
        "1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield.",
        "2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases",
        "3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement:",
        "o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive)",
        "o        N2 disease: Stations 7, 4R (ipsilateral mediastinal)",
        "4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease",
        "5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated.",
        "6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel",
        "TREATMENT RECOMMENDATIONS:",
        "IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell",
        "□ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology",
        "□ Patient/Family Conference Schedule dedicated time to discuss:",
        "Diagnosis of adenocarcinoma",
        "Stage IIIC disease",
        "Treatment options",
        "Prognosis",
        "Goals of care",
        "STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease",
        "□ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases",
        "□ Bone scan or PET-CT total body May already have sufficient information from recent PET",
        "AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection):",
        "EGFR mutations → Consider EGFR TKI if positive",
        "ALK rearrangement → Consider ALK inhibitor if positive",
        "ROS1 rearrangement → Consider ROS1 inhibitor if positive",
        "PD-L1 expression → Impacts immunotherapy decisions",
        "Comprehensive NGS → May identify other actionable mutations",
        "TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen",
        "□ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.)",
        "□ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy",
        "□ Radiation Therapy Role to be determined - may be palliative or consolidative",
        "□ Clinical Trial Evaluate eligibility for appropriate trials",
        "SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions",
        "□ Social Work Financial counseling, support services",
        "□ Nutrition Address weight loss, optimize nutritional status",
        "□ Patient Navigator Coordinate care, appointments, resources",
        "FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results",
        "□ Medical Oncology: 04/10/2025 (already scheduled)",
        "□ Tumor Board Results Discussion: Following 04/11 conference",
        "PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding",
        "PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment.",
        "ATTESTATION:",
        "I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment.",
        "BILLING INFORMATION:",
        "CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L)",
        "ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker)",
        "ELECTRONIC SIGNATURE:",
        "Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890",
        "Digitally Signed: 04/08/2025 10:45 AM",
        "REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine",
        "□ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow)",
        "══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": "Fluoroscopy",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "needle"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 42.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "ATTENDING: Montgomery",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155518"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "CONCATENATED_NOTE: Note contains header for 'Mills, Robert E' (03/08/2025) but body for 'Russell, Dorothy Mae' (04/08/2025). Extracted data corrected to match the detailed body (Russell)."
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.040705",
      "changes": [
        "Extracted lesion_size_mm: 42.0",
        "Extracted EBUS stations: ['10L', '10R', '11L', '11R', '4L', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "EBUS-TBNA report for Russell, Dorothy Mae (concatenated note body).",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of 6 stations (7, 4L, 4R, 10L, 10R, 11L) documented in the 'Russell' portion of the note."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 7.7,
        "total_facility_mpfs_payment": 249.0,
        "computation_notes": "Single code 31653."
      },
      "rationale": [
        "Data Quality: The note contains a header for 'Mills' but the detailed procedure describes 'Russell'. The coding review is based on the detailed 'Russell' note which documents EBUS-TBNA of 6 stations.",
        "Code selection: Sampling of 3+ stations maps to 31653. No peripheral lesion sampling or other interventions documented in the detailed section."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 4,
      "style_type": 2,
      "generated_name": "Barbara J. Stewart",
      "generation_date": "2025-12-09T09:18:39.659061"
    }
  },
  {
    "note_text": "Code: 31653 (EBUS sampling 3 or more stations).\nStations Sampled: 4 distinct stations (4R, 7, 10R, 11R).\nPathology: Malignancy identified in 3 stations.\nMedical Necessity: Staging of known lung adenocarcinoma to determine surgical candidacy (ruled out due to N3 disease).",
    "cpt_codes": [
      31653
    ],
    "registry_entry": {
      "patient_mrn": "5729384_syn_3",
      "procedure_date": "2025-01-20",
      "patient_age": 60,
      "gender": "Female",
      "asa_class": 3,
      "primary_indication": "80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-a",
      "sedation_type": "Deep",
      "airway_type": "Tracheostomy",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653
      ],
      "evidence": {
        "institution_name": "•        Location: Between RMB and LMB, posterior position",
        "attending_name": "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "patient_age": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "gender": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "dob": "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2) Diagnostic question: Tissue diagnosis and staging if malignancy confirmed RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60 ══════════════════════════════════════════ PRE-PROCEDURE: CONSENT: Written informed consent obtained after thorough discussion of: •        Nature and purpose of EBUS-TBNA •        Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures •        Benefits: Tissue diagnosis, staging information, minimally invasive •        Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment •        Patient's questions answered, demonstrated understanding ASA CLASSIFICATION: III NPO STATUS: Confirmed NPO since midnight (>10 hours) IV ACCESS: 20-gauge left forearm, patent MONITORING PLAN: •        Continuous pulse oximetry •        Capnography •        Blood pressure q3 minutes •        Continuous ECG •        Dedicated monitoring nurse ══════════════════════════════════════════ MEDICATIONS ADMINISTERED: TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure TOTAL PROPOFOL: 380mg TOPICAL ANESTHESIA: •        Benzocaine 20% spray to oropharynx (4 applications) •        Lidocaine 2% instilled via bronchoscope: 20mL total ══════════════════════════════════════════ EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present) ══════════════════════════════════════════ PROCEDURE DETAILS: TIMEOUT: Performed at 0830 •        Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944 •        Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy •        Site confirmed: Mediastinal lymph nodes •        Allergies confirmed: Sulfa drugs •        Consent confirmed: Yes, in chart •        Team introductions completed •        Equipment checked PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well. PROCEDURE NARRATIVE: After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization. UPPER AIRWAY INSPECTION: •        Oropharynx: Normal •        Epiglottis: Normal •        Vocal cords: Symmetric, mobile, no masses •        Subglottis: Patent TRACHEOBRONCHIAL TREE: •        Trachea: Normal caliber, no masses, mild mucosal edema •        Carina: Sharp, mobile •        Right mainstem: Patent •        Left mainstem: Patent •        Segmental airways: All visualized segments patent •        No endobronchial masses visualized SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY: ╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │ ║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝ TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED: ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound Characteristics: •        Location: Between RMB and LMB, posterior position •        Dimensions: 41mm (long) x 27mm (short) x 24mm (depth) •        Shape: Round •        Borders: Well-defined •        Echotexture: Diffusely hypoechoic •        Hilum: Completely absent •        Necrosis: None evident •        Vascularity: Peripheral vessels on color Doppler •        Elastography: Score 5/5 - very firm (blue pattern) INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass). Pass 1 (0842): •        Excellent sample obtained •        Visible tissue core in needle hub •        ROSE: ADEQUATE specimen, abundant cellularity •        ROSE: MALIGNANT CELLS IDENTIFIED •        ROSE: Morphology consistent with ADENOCARCINOMA Pass 2 (0845): •        Confirmatory sampling •        ROSE: Confirmed adenocarcinoma Pass 3 (0848): •        Additional tissue for molecular studies •        Sent for: EGFR, ALK, ROS1, BRAF, PD-L1 Pass 4 (0851): •        Microbiology specimen •        Sent for: AFB smear/culture, Fungal culture, Bacterial culture Complications: None. Minimal bleeding, self-limited. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 33x21mm, hypoechoic, no hilum Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 28x17mm, loss of hilum Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 24x16mm, abnormal appearance Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 19x13mm, hypoechoic Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 15x10mm, maintained normal architecture Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY ══════════════════════════════════════════ FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent. ══════════════════════════════════════════ RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma ✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers. ══════════════════════════════════════════ SPECIMENS SUBMITTED TO PATHOLOGY: CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes) □ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes) Total: 16 needle passes across 6 lymph node stations CELL BLOCKS: □ Station 7 (2 blocks prepared) MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture ══════════════════════════════════════════ FLUOROSCOPY: Not utilized for this procedure ESTIMATED BLOOD LOSS: <5mL COMPLICATIONS: None ADVERSE EVENTS: None ══════════════════════════════════════════ PATIENT TOLERANCE: The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of: •        Hypoxemia (SpO2 maintained 91-95%) •        Hypotension •        Hypertension •        Tachycardia or bradycardia •        Arrhythmias •        Bronchospasm •        Significant bleeding •        Laryngospasm Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting. ══════════════════════════════════════════ POST-PROCEDURE ORDERS: MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90% ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort) DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions ══════════════════════════════════════════ DIAGNOSTIC IMPRESSION: 1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield. 2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases 3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement: o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive) o        N2 disease: Stations 7, 4R (ipsilateral mediastinal) 4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease 5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated. 6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel ══════════════════════════════════════════ TREATMENT RECOMMENDATIONS: IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell □ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology □ Patient/Family Conference Schedule dedicated time to discuss: •        Diagnosis of adenocarcinoma •        Stage IIIC disease •        Treatment options •        Prognosis •        Goals of care STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease □ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases □ Bone scan or PET-CT total body May already have sufficient information from recent PET AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection): •        EGFR mutations → Consider EGFR TKI if positive •        ALK rearrangement → Consider ALK inhibitor if positive •        ROS1 rearrangement → Consider ROS1 inhibitor if positive •        PD-L1 expression → Impacts immunotherapy decisions •        Comprehensive NGS → May identify other actionable mutations TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen □ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.) □ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy □ Radiation Therapy Role to be determined - may be palliative or consolidative □ Clinical Trial Evaluate eligibility for appropriate trials SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions □ Social Work Financial counseling, support services □ Nutrition Address weight loss, optimize nutritional status □ Patient Navigator Coordinate care, appointments, resources FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results □ Medical Oncology: 04/10/2025 (already scheduled) □ Tumor Board Results Discussion: Following 04/11 conference PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment. ══════════════════════════════════════════ ATTESTATION: I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment. ══════════════════════════════════════════ BILLING INFORMATION: CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L) ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker) ══════════════════════════════════════════ ELECTRONIC SIGNATURE: Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890 Digitally Signed: 04/08/2025 10:45 AM ══════════════════════════════════════════ REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine □ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow) ══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════",
        "sedation_type": "deep or MAC sedation",
        "airway_type": "tracheostomy mentioned"
      },
      "institution_name": null,
      "molecular_testing_requested": true,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild (<50mL)",
      "pneumothorax": true,
      "pneumothorax_intervention": "Aspiration",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": "Ultrasound",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "See cancer doctor",
        "More tests",
        "Decide treatment",
        "Dr. S. Franklin 3/8/2025",
        "________________________________________",
        "EBUS",
        "INTERVENTIONAL PULMONOLOGY PROCEDURAL DOCUMENTATION",
        "══════════════════════════════════════════",
        "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "PROCEDURE: Endobronchial Ultrasound with Transbronchial Needle Aspiration (EBUS-TBNA)",
        "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "Left lower lobe mass 4.2cm on CT",
        "Extensive mediastinal and hilar lymphadenopathy",
        "Weight loss 18 lbs over 2 months",
        "No previous cancer history",
        "PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2)",
        "Diagnostic question: Tissue diagnosis and staging if malignancy confirmed",
        "RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently",
        "PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm",
        "LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60",
        "PRE-PROCEDURE:",
        "CONSENT: Written informed consent obtained after thorough discussion of:",
        "Nature and purpose of EBUS-TBNA",
        "Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures",
        "Benefits: Tissue diagnosis, staging information, minimally invasive",
        "Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment",
        "Patient's questions answered, demonstrated understanding",
        "ASA CLASSIFICATION: III",
        "NPO STATUS: Confirmed NPO since midnight (>10 hours)",
        "IV ACCESS: 20-gauge left forearm, patent",
        "MONITORING PLAN:",
        "Continuous pulse oximetry",
        "Capnography",
        "Blood pressure q3 minutes",
        "Continuous ECG",
        "Dedicated monitoring nurse",
        "MEDICATIONS ADMINISTERED:",
        "TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure",
        "TOTAL PROPOFOL: 380mg",
        "TOPICAL ANESTHESIA:",
        "Benzocaine 20% spray to oropharynx (4 applications)",
        "Lidocaine 2% instilled via bronchoscope: 20mL total",
        "EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present)",
        "PROCEDURE DETAILS:",
        "TIMEOUT: Performed at 0830",
        "Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944",
        "Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy",
        "Site confirmed: Mediastinal lymph nodes",
        "Allergies confirmed: Sulfa drugs",
        "Consent confirmed: Yes, in chart",
        "Team introductions completed",
        "Equipment checked",
        "PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes",
        "SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well.",
        "PROCEDURE NARRATIVE:",
        "After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization.",
        "UPPER AIRWAY INSPECTION:",
        "Oropharynx: Normal",
        "Epiglottis: Normal",
        "Vocal cords: Symmetric, mobile, no masses",
        "Subglottis: Patent",
        "TRACHEOBRONCHIAL TREE:",
        "Trachea: Normal caliber, no masses, mild mucosal edema",
        "Carina: Sharp, mobile",
        "Right mainstem: Patent",
        "Left mainstem: Patent",
        "Segmental airways: All visualized segments patent",
        "No endobronchial masses visualized",
        "SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY:",
        "╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │",
        "║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝",
        "TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED:",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound Characteristics:",
        "Location: Between RMB and LMB, posterior position",
        "Dimensions: 41mm (long) x 27mm (short) x 24mm (depth)",
        "Shape: Round",
        "Borders: Well-defined",
        "Echotexture: Diffusely hypoechoic",
        "Hilum: Completely absent",
        "Necrosis: None evident",
        "Vascularity: Peripheral vessels on color Doppler",
        "Elastography: Score 5/5 - very firm (blue pattern)",
        "INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY",
        "Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass).",
        "Pass 1 (0842):",
        "Excellent sample obtained",
        "Visible tissue core in needle hub",
        "ROSE: ADEQUATE specimen, abundant cellularity",
        "ROSE: MALIGNANT CELLS IDENTIFIED",
        "ROSE: Morphology consistent with ADENOCARCINOMA",
        "Pass 2 (0845):",
        "Confirmatory sampling",
        "ROSE: Confirmed adenocarcinoma",
        "Pass 3 (0848):",
        "Additional tissue for molecular studies",
        "Sent for: EGFR, ALK, ROS1, BRAF, PD-L1",
        "Pass 4 (0851):",
        "Microbiology specimen",
        "Sent for: AFB smear/culture, Fungal culture, Bacterial culture",
        "Complications: None. Minimal bleeding, self-limited.",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 33x21mm, hypoechoic, no hilum",
        "Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 28x17mm, loss of hilum",
        "Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 24x16mm, abnormal appearance",
        "Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 19x13mm, hypoechoic",
        "Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 15x10mm, maintained normal architecture",
        "Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY",
        "FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent.",
        "RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD",
        "POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma",
        "✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma",
        "NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only",
        "CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers.",
        "SPECIMENS SUBMITTED TO PATHOLOGY:",
        "CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes)",
        "□ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes)",
        "Total: 16 needle passes across 6 lymph node stations",
        "CELL BLOCKS: □ Station 7 (2 blocks prepared)",
        "MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel",
        "MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture",
        "FLUOROSCOPY: Not utilized for this procedure",
        "ESTIMATED BLOOD LOSS: <5mL",
        "COMPLICATIONS: None",
        "ADVERSE EVENTS: None",
        "PATIENT TOLERANCE:",
        "The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of:",
        "Hypoxemia (SpO2 maintained 91-95%)",
        "Hypotension",
        "Hypertension",
        "Tachycardia or bradycardia",
        "Arrhythmias",
        "Bronchospasm",
        "Significant bleeding",
        "Laryngospasm",
        "Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting.",
        "POST-PROCEDURE ORDERS:",
        "MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90%",
        "ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance",
        "DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated",
        "MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort)",
        "DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions",
        "DIAGNOSTIC IMPRESSION:",
        "1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield.",
        "2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases",
        "3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement:",
        "o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive)",
        "o        N2 disease: Stations 7, 4R (ipsilateral mediastinal)",
        "4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease",
        "5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated.",
        "6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel",
        "TREATMENT RECOMMENDATIONS:",
        "IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell",
        "□ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology",
        "□ Patient/Family Conference Schedule dedicated time to discuss:",
        "Diagnosis of adenocarcinoma",
        "Stage IIIC disease",
        "Treatment options",
        "Prognosis",
        "Goals of care",
        "STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease",
        "□ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases",
        "□ Bone scan or PET-CT total body May already have sufficient information from recent PET",
        "AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection):",
        "EGFR mutations → Consider EGFR TKI if positive",
        "ALK rearrangement → Consider ALK inhibitor if positive",
        "ROS1 rearrangement → Consider ROS1 inhibitor if positive",
        "PD-L1 expression → Impacts immunotherapy decisions",
        "Comprehensive NGS → May identify other actionable mutations",
        "TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen",
        "□ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.)",
        "□ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy",
        "□ Radiation Therapy Role to be determined - may be palliative or consolidative",
        "□ Clinical Trial Evaluate eligibility for appropriate trials",
        "SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions",
        "□ Social Work Financial counseling, support services",
        "□ Nutrition Address weight loss, optimize nutritional status",
        "□ Patient Navigator Coordinate care, appointments, resources",
        "FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results",
        "□ Medical Oncology: 04/10/2025 (already scheduled)",
        "□ Tumor Board Results Discussion: Following 04/11 conference",
        "PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding",
        "PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment.",
        "ATTESTATION:",
        "I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment.",
        "BILLING INFORMATION:",
        "CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L)",
        "ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker)",
        "ELECTRONIC SIGNATURE:",
        "Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890",
        "Digitally Signed: 04/08/2025 10:45 AM",
        "REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine",
        "□ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow)",
        "══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": "Fluoroscopy",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "needle"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 42.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "ATTENDING: Montgomery",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155518"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "CONCATENATED_NOTE: Note contains header for 'Mills, Robert E' (03/08/2025) but body for 'Russell, Dorothy Mae' (04/08/2025). Extracted data corrected to match the detailed body (Russell)."
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.040705",
      "changes": [
        "Extracted lesion_size_mm: 42.0",
        "Extracted EBUS stations: ['10L', '10R', '11L', '11R', '4L', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "EBUS-TBNA report for Russell, Dorothy Mae (concatenated note body).",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of 6 stations (7, 4L, 4R, 10L, 10R, 11L) documented in the 'Russell' portion of the note."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 7.7,
        "total_facility_mpfs_payment": 249.0,
        "computation_notes": "Single code 31653."
      },
      "rationale": [
        "Data Quality: The note contains a header for 'Mills' but the detailed procedure describes 'Russell'. The coding review is based on the detailed 'Russell' note which documents EBUS-TBNA of 6 stations.",
        "Code selection: Sampling of 3+ stations maps to 31653. No peripheral lesion sampling or other interventions documented in the detailed section."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 4,
      "style_type": 3,
      "generated_name": "Ruth M. Sanchez",
      "generation_date": "2025-12-09T09:18:39.659140"
    }
  },
  {
    "note_text": "Resident Note\nPatient: Sharon Morris\nProcedure: EBUS\nAttending: Dr. Turner\n1. Scope down. Examined airways - clear.\n2. EBUS'd station 7, 4R, 10R, 11R.\n3. ROSE said cancer in 7, 4R, 10R.\n4. 11R was negative.\n5. No complications.\nPlan: Consult Med Onc. Not a surgical candidate.",
    "cpt_codes": [
      31653
    ],
    "registry_entry": {
      "patient_mrn": "5729384_syn_4",
      "procedure_date": "2025-12-13",
      "patient_age": 62,
      "gender": "Female",
      "asa_class": 3,
      "primary_indication": "80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-a",
      "sedation_type": "Deep",
      "airway_type": "Tracheostomy",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653
      ],
      "evidence": {
        "institution_name": "•        Location: Between RMB and LMB, posterior position",
        "attending_name": "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "patient_age": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "gender": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "dob": "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2) Diagnostic question: Tissue diagnosis and staging if malignancy confirmed RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60 ══════════════════════════════════════════ PRE-PROCEDURE: CONSENT: Written informed consent obtained after thorough discussion of: •        Nature and purpose of EBUS-TBNA •        Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures •        Benefits: Tissue diagnosis, staging information, minimally invasive •        Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment •        Patient's questions answered, demonstrated understanding ASA CLASSIFICATION: III NPO STATUS: Confirmed NPO since midnight (>10 hours) IV ACCESS: 20-gauge left forearm, patent MONITORING PLAN: •        Continuous pulse oximetry •        Capnography •        Blood pressure q3 minutes •        Continuous ECG •        Dedicated monitoring nurse ══════════════════════════════════════════ MEDICATIONS ADMINISTERED: TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure TOTAL PROPOFOL: 380mg TOPICAL ANESTHESIA: •        Benzocaine 20% spray to oropharynx (4 applications) •        Lidocaine 2% instilled via bronchoscope: 20mL total ══════════════════════════════════════════ EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present) ══════════════════════════════════════════ PROCEDURE DETAILS: TIMEOUT: Performed at 0830 •        Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944 •        Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy •        Site confirmed: Mediastinal lymph nodes •        Allergies confirmed: Sulfa drugs •        Consent confirmed: Yes, in chart •        Team introductions completed •        Equipment checked PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well. PROCEDURE NARRATIVE: After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization. UPPER AIRWAY INSPECTION: •        Oropharynx: Normal •        Epiglottis: Normal •        Vocal cords: Symmetric, mobile, no masses •        Subglottis: Patent TRACHEOBRONCHIAL TREE: •        Trachea: Normal caliber, no masses, mild mucosal edema •        Carina: Sharp, mobile •        Right mainstem: Patent •        Left mainstem: Patent •        Segmental airways: All visualized segments patent •        No endobronchial masses visualized SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY: ╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │ ║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝ TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED: ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound Characteristics: •        Location: Between RMB and LMB, posterior position •        Dimensions: 41mm (long) x 27mm (short) x 24mm (depth) •        Shape: Round •        Borders: Well-defined •        Echotexture: Diffusely hypoechoic •        Hilum: Completely absent •        Necrosis: None evident •        Vascularity: Peripheral vessels on color Doppler •        Elastography: Score 5/5 - very firm (blue pattern) INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass). Pass 1 (0842): •        Excellent sample obtained •        Visible tissue core in needle hub •        ROSE: ADEQUATE specimen, abundant cellularity •        ROSE: MALIGNANT CELLS IDENTIFIED •        ROSE: Morphology consistent with ADENOCARCINOMA Pass 2 (0845): •        Confirmatory sampling •        ROSE: Confirmed adenocarcinoma Pass 3 (0848): •        Additional tissue for molecular studies •        Sent for: EGFR, ALK, ROS1, BRAF, PD-L1 Pass 4 (0851): •        Microbiology specimen •        Sent for: AFB smear/culture, Fungal culture, Bacterial culture Complications: None. Minimal bleeding, self-limited. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 33x21mm, hypoechoic, no hilum Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 28x17mm, loss of hilum Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 24x16mm, abnormal appearance Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 19x13mm, hypoechoic Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 15x10mm, maintained normal architecture Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY ══════════════════════════════════════════ FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent. ══════════════════════════════════════════ RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma ✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers. ══════════════════════════════════════════ SPECIMENS SUBMITTED TO PATHOLOGY: CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes) □ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes) Total: 16 needle passes across 6 lymph node stations CELL BLOCKS: □ Station 7 (2 blocks prepared) MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture ══════════════════════════════════════════ FLUOROSCOPY: Not utilized for this procedure ESTIMATED BLOOD LOSS: <5mL COMPLICATIONS: None ADVERSE EVENTS: None ══════════════════════════════════════════ PATIENT TOLERANCE: The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of: •        Hypoxemia (SpO2 maintained 91-95%) •        Hypotension •        Hypertension •        Tachycardia or bradycardia •        Arrhythmias •        Bronchospasm •        Significant bleeding •        Laryngospasm Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting. ══════════════════════════════════════════ POST-PROCEDURE ORDERS: MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90% ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort) DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions ══════════════════════════════════════════ DIAGNOSTIC IMPRESSION: 1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield. 2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases 3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement: o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive) o        N2 disease: Stations 7, 4R (ipsilateral mediastinal) 4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease 5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated. 6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel ══════════════════════════════════════════ TREATMENT RECOMMENDATIONS: IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell □ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology □ Patient/Family Conference Schedule dedicated time to discuss: •        Diagnosis of adenocarcinoma •        Stage IIIC disease •        Treatment options •        Prognosis •        Goals of care STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease □ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases □ Bone scan or PET-CT total body May already have sufficient information from recent PET AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection): •        EGFR mutations → Consider EGFR TKI if positive •        ALK rearrangement → Consider ALK inhibitor if positive •        ROS1 rearrangement → Consider ROS1 inhibitor if positive •        PD-L1 expression → Impacts immunotherapy decisions •        Comprehensive NGS → May identify other actionable mutations TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen □ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.) □ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy □ Radiation Therapy Role to be determined - may be palliative or consolidative □ Clinical Trial Evaluate eligibility for appropriate trials SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions □ Social Work Financial counseling, support services □ Nutrition Address weight loss, optimize nutritional status □ Patient Navigator Coordinate care, appointments, resources FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results □ Medical Oncology: 04/10/2025 (already scheduled) □ Tumor Board Results Discussion: Following 04/11 conference PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment. ══════════════════════════════════════════ ATTESTATION: I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment. ══════════════════════════════════════════ BILLING INFORMATION: CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L) ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker) ══════════════════════════════════════════ ELECTRONIC SIGNATURE: Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890 Digitally Signed: 04/08/2025 10:45 AM ══════════════════════════════════════════ REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine □ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow) ══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════",
        "sedation_type": "deep or MAC sedation",
        "airway_type": "tracheostomy mentioned"
      },
      "institution_name": null,
      "molecular_testing_requested": true,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild (<50mL)",
      "pneumothorax": true,
      "pneumothorax_intervention": "Aspiration",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": "Ultrasound",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "See cancer doctor",
        "More tests",
        "Decide treatment",
        "Dr. S. Franklin 3/8/2025",
        "________________________________________",
        "EBUS",
        "INTERVENTIONAL PULMONOLOGY PROCEDURAL DOCUMENTATION",
        "══════════════════════════════════════════",
        "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "PROCEDURE: Endobronchial Ultrasound with Transbronchial Needle Aspiration (EBUS-TBNA)",
        "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "Left lower lobe mass 4.2cm on CT",
        "Extensive mediastinal and hilar lymphadenopathy",
        "Weight loss 18 lbs over 2 months",
        "No previous cancer history",
        "PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2)",
        "Diagnostic question: Tissue diagnosis and staging if malignancy confirmed",
        "RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently",
        "PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm",
        "LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60",
        "PRE-PROCEDURE:",
        "CONSENT: Written informed consent obtained after thorough discussion of:",
        "Nature and purpose of EBUS-TBNA",
        "Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures",
        "Benefits: Tissue diagnosis, staging information, minimally invasive",
        "Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment",
        "Patient's questions answered, demonstrated understanding",
        "ASA CLASSIFICATION: III",
        "NPO STATUS: Confirmed NPO since midnight (>10 hours)",
        "IV ACCESS: 20-gauge left forearm, patent",
        "MONITORING PLAN:",
        "Continuous pulse oximetry",
        "Capnography",
        "Blood pressure q3 minutes",
        "Continuous ECG",
        "Dedicated monitoring nurse",
        "MEDICATIONS ADMINISTERED:",
        "TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure",
        "TOTAL PROPOFOL: 380mg",
        "TOPICAL ANESTHESIA:",
        "Benzocaine 20% spray to oropharynx (4 applications)",
        "Lidocaine 2% instilled via bronchoscope: 20mL total",
        "EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present)",
        "PROCEDURE DETAILS:",
        "TIMEOUT: Performed at 0830",
        "Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944",
        "Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy",
        "Site confirmed: Mediastinal lymph nodes",
        "Allergies confirmed: Sulfa drugs",
        "Consent confirmed: Yes, in chart",
        "Team introductions completed",
        "Equipment checked",
        "PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes",
        "SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well.",
        "PROCEDURE NARRATIVE:",
        "After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization.",
        "UPPER AIRWAY INSPECTION:",
        "Oropharynx: Normal",
        "Epiglottis: Normal",
        "Vocal cords: Symmetric, mobile, no masses",
        "Subglottis: Patent",
        "TRACHEOBRONCHIAL TREE:",
        "Trachea: Normal caliber, no masses, mild mucosal edema",
        "Carina: Sharp, mobile",
        "Right mainstem: Patent",
        "Left mainstem: Patent",
        "Segmental airways: All visualized segments patent",
        "No endobronchial masses visualized",
        "SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY:",
        "╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │",
        "║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝",
        "TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED:",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound Characteristics:",
        "Location: Between RMB and LMB, posterior position",
        "Dimensions: 41mm (long) x 27mm (short) x 24mm (depth)",
        "Shape: Round",
        "Borders: Well-defined",
        "Echotexture: Diffusely hypoechoic",
        "Hilum: Completely absent",
        "Necrosis: None evident",
        "Vascularity: Peripheral vessels on color Doppler",
        "Elastography: Score 5/5 - very firm (blue pattern)",
        "INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY",
        "Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass).",
        "Pass 1 (0842):",
        "Excellent sample obtained",
        "Visible tissue core in needle hub",
        "ROSE: ADEQUATE specimen, abundant cellularity",
        "ROSE: MALIGNANT CELLS IDENTIFIED",
        "ROSE: Morphology consistent with ADENOCARCINOMA",
        "Pass 2 (0845):",
        "Confirmatory sampling",
        "ROSE: Confirmed adenocarcinoma",
        "Pass 3 (0848):",
        "Additional tissue for molecular studies",
        "Sent for: EGFR, ALK, ROS1, BRAF, PD-L1",
        "Pass 4 (0851):",
        "Microbiology specimen",
        "Sent for: AFB smear/culture, Fungal culture, Bacterial culture",
        "Complications: None. Minimal bleeding, self-limited.",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 33x21mm, hypoechoic, no hilum",
        "Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 28x17mm, loss of hilum",
        "Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 24x16mm, abnormal appearance",
        "Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 19x13mm, hypoechoic",
        "Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 15x10mm, maintained normal architecture",
        "Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY",
        "FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent.",
        "RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD",
        "POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma",
        "✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma",
        "NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only",
        "CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers.",
        "SPECIMENS SUBMITTED TO PATHOLOGY:",
        "CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes)",
        "□ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes)",
        "Total: 16 needle passes across 6 lymph node stations",
        "CELL BLOCKS: □ Station 7 (2 blocks prepared)",
        "MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel",
        "MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture",
        "FLUOROSCOPY: Not utilized for this procedure",
        "ESTIMATED BLOOD LOSS: <5mL",
        "COMPLICATIONS: None",
        "ADVERSE EVENTS: None",
        "PATIENT TOLERANCE:",
        "The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of:",
        "Hypoxemia (SpO2 maintained 91-95%)",
        "Hypotension",
        "Hypertension",
        "Tachycardia or bradycardia",
        "Arrhythmias",
        "Bronchospasm",
        "Significant bleeding",
        "Laryngospasm",
        "Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting.",
        "POST-PROCEDURE ORDERS:",
        "MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90%",
        "ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance",
        "DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated",
        "MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort)",
        "DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions",
        "DIAGNOSTIC IMPRESSION:",
        "1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield.",
        "2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases",
        "3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement:",
        "o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive)",
        "o        N2 disease: Stations 7, 4R (ipsilateral mediastinal)",
        "4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease",
        "5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated.",
        "6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel",
        "TREATMENT RECOMMENDATIONS:",
        "IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell",
        "□ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology",
        "□ Patient/Family Conference Schedule dedicated time to discuss:",
        "Diagnosis of adenocarcinoma",
        "Stage IIIC disease",
        "Treatment options",
        "Prognosis",
        "Goals of care",
        "STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease",
        "□ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases",
        "□ Bone scan or PET-CT total body May already have sufficient information from recent PET",
        "AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection):",
        "EGFR mutations → Consider EGFR TKI if positive",
        "ALK rearrangement → Consider ALK inhibitor if positive",
        "ROS1 rearrangement → Consider ROS1 inhibitor if positive",
        "PD-L1 expression → Impacts immunotherapy decisions",
        "Comprehensive NGS → May identify other actionable mutations",
        "TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen",
        "□ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.)",
        "□ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy",
        "□ Radiation Therapy Role to be determined - may be palliative or consolidative",
        "□ Clinical Trial Evaluate eligibility for appropriate trials",
        "SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions",
        "□ Social Work Financial counseling, support services",
        "□ Nutrition Address weight loss, optimize nutritional status",
        "□ Patient Navigator Coordinate care, appointments, resources",
        "FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results",
        "□ Medical Oncology: 04/10/2025 (already scheduled)",
        "□ Tumor Board Results Discussion: Following 04/11 conference",
        "PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding",
        "PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment.",
        "ATTESTATION:",
        "I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment.",
        "BILLING INFORMATION:",
        "CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L)",
        "ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker)",
        "ELECTRONIC SIGNATURE:",
        "Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890",
        "Digitally Signed: 04/08/2025 10:45 AM",
        "REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine",
        "□ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow)",
        "══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": "Fluoroscopy",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "needle"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 42.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "ATTENDING: Montgomery",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155518"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "CONCATENATED_NOTE: Note contains header for 'Mills, Robert E' (03/08/2025) but body for 'Russell, Dorothy Mae' (04/08/2025). Extracted data corrected to match the detailed body (Russell)."
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.040705",
      "changes": [
        "Extracted lesion_size_mm: 42.0",
        "Extracted EBUS stations: ['10L', '10R', '11L', '11R', '4L', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "EBUS-TBNA report for Russell, Dorothy Mae (concatenated note body).",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of 6 stations (7, 4L, 4R, 10L, 10R, 11L) documented in the 'Russell' portion of the note."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 7.7,
        "total_facility_mpfs_payment": 249.0,
        "computation_notes": "Single code 31653."
      },
      "rationale": [
        "Data Quality: The note contains a header for 'Mills' but the detailed procedure describes 'Russell'. The coding review is based on the detailed 'Russell' note which documents EBUS-TBNA of 6 stations.",
        "Code selection: Sampling of 3+ stations maps to 31653. No peripheral lesion sampling or other interventions documented in the detailed section."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 4,
      "style_type": 4,
      "generated_name": "Sharon L. Morris",
      "generation_date": "2025-12-09T09:18:39.659215"
    }
  },
  {
    "note_text": "Patricia Henderson here for EBUS staging. She has a lung nodule and swollen nodes. We sampled station 7 4R 10R and 11R. The pathologist in the room said 7 4R and 10R were all cancer adenocarcinoma. 11R was just reactive. So she has stage 3 disease extensive. We will send for molecular testing and get her to oncology asap.",
    "cpt_codes": [
      31653
    ],
    "registry_entry": {
      "patient_mrn": "5729384_syn_5",
      "procedure_date": "2025-08-03",
      "patient_age": 60,
      "gender": "Female",
      "asa_class": 3,
      "primary_indication": "80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-a",
      "sedation_type": "Deep",
      "airway_type": "Tracheostomy",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653
      ],
      "evidence": {
        "institution_name": "•        Location: Between RMB and LMB, posterior position",
        "attending_name": "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "patient_age": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "gender": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "dob": "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2) Diagnostic question: Tissue diagnosis and staging if malignancy confirmed RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60 ══════════════════════════════════════════ PRE-PROCEDURE: CONSENT: Written informed consent obtained after thorough discussion of: •        Nature and purpose of EBUS-TBNA •        Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures •        Benefits: Tissue diagnosis, staging information, minimally invasive •        Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment •        Patient's questions answered, demonstrated understanding ASA CLASSIFICATION: III NPO STATUS: Confirmed NPO since midnight (>10 hours) IV ACCESS: 20-gauge left forearm, patent MONITORING PLAN: •        Continuous pulse oximetry •        Capnography •        Blood pressure q3 minutes •        Continuous ECG •        Dedicated monitoring nurse ══════════════════════════════════════════ MEDICATIONS ADMINISTERED: TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure TOTAL PROPOFOL: 380mg TOPICAL ANESTHESIA: •        Benzocaine 20% spray to oropharynx (4 applications) •        Lidocaine 2% instilled via bronchoscope: 20mL total ══════════════════════════════════════════ EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present) ══════════════════════════════════════════ PROCEDURE DETAILS: TIMEOUT: Performed at 0830 •        Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944 •        Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy •        Site confirmed: Mediastinal lymph nodes •        Allergies confirmed: Sulfa drugs •        Consent confirmed: Yes, in chart •        Team introductions completed •        Equipment checked PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well. PROCEDURE NARRATIVE: After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization. UPPER AIRWAY INSPECTION: •        Oropharynx: Normal •        Epiglottis: Normal •        Vocal cords: Symmetric, mobile, no masses •        Subglottis: Patent TRACHEOBRONCHIAL TREE: •        Trachea: Normal caliber, no masses, mild mucosal edema •        Carina: Sharp, mobile •        Right mainstem: Patent •        Left mainstem: Patent •        Segmental airways: All visualized segments patent •        No endobronchial masses visualized SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY: ╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │ ║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝ TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED: ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound Characteristics: •        Location: Between RMB and LMB, posterior position •        Dimensions: 41mm (long) x 27mm (short) x 24mm (depth) •        Shape: Round •        Borders: Well-defined •        Echotexture: Diffusely hypoechoic •        Hilum: Completely absent •        Necrosis: None evident •        Vascularity: Peripheral vessels on color Doppler •        Elastography: Score 5/5 - very firm (blue pattern) INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass). Pass 1 (0842): •        Excellent sample obtained •        Visible tissue core in needle hub •        ROSE: ADEQUATE specimen, abundant cellularity •        ROSE: MALIGNANT CELLS IDENTIFIED •        ROSE: Morphology consistent with ADENOCARCINOMA Pass 2 (0845): •        Confirmatory sampling •        ROSE: Confirmed adenocarcinoma Pass 3 (0848): •        Additional tissue for molecular studies •        Sent for: EGFR, ALK, ROS1, BRAF, PD-L1 Pass 4 (0851): •        Microbiology specimen •        Sent for: AFB smear/culture, Fungal culture, Bacterial culture Complications: None. Minimal bleeding, self-limited. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 33x21mm, hypoechoic, no hilum Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 28x17mm, loss of hilum Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 24x16mm, abnormal appearance Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 19x13mm, hypoechoic Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 15x10mm, maintained normal architecture Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY ══════════════════════════════════════════ FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent. ══════════════════════════════════════════ RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma ✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers. ══════════════════════════════════════════ SPECIMENS SUBMITTED TO PATHOLOGY: CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes) □ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes) Total: 16 needle passes across 6 lymph node stations CELL BLOCKS: □ Station 7 (2 blocks prepared) MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture ══════════════════════════════════════════ FLUOROSCOPY: Not utilized for this procedure ESTIMATED BLOOD LOSS: <5mL COMPLICATIONS: None ADVERSE EVENTS: None ══════════════════════════════════════════ PATIENT TOLERANCE: The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of: •        Hypoxemia (SpO2 maintained 91-95%) •        Hypotension •        Hypertension •        Tachycardia or bradycardia •        Arrhythmias •        Bronchospasm •        Significant bleeding •        Laryngospasm Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting. ══════════════════════════════════════════ POST-PROCEDURE ORDERS: MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90% ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort) DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions ══════════════════════════════════════════ DIAGNOSTIC IMPRESSION: 1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield. 2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases 3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement: o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive) o        N2 disease: Stations 7, 4R (ipsilateral mediastinal) 4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease 5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated. 6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel ══════════════════════════════════════════ TREATMENT RECOMMENDATIONS: IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell □ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology □ Patient/Family Conference Schedule dedicated time to discuss: •        Diagnosis of adenocarcinoma •        Stage IIIC disease •        Treatment options •        Prognosis •        Goals of care STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease □ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases □ Bone scan or PET-CT total body May already have sufficient information from recent PET AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection): •        EGFR mutations → Consider EGFR TKI if positive •        ALK rearrangement → Consider ALK inhibitor if positive •        ROS1 rearrangement → Consider ROS1 inhibitor if positive •        PD-L1 expression → Impacts immunotherapy decisions •        Comprehensive NGS → May identify other actionable mutations TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen □ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.) □ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy □ Radiation Therapy Role to be determined - may be palliative or consolidative □ Clinical Trial Evaluate eligibility for appropriate trials SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions □ Social Work Financial counseling, support services □ Nutrition Address weight loss, optimize nutritional status □ Patient Navigator Coordinate care, appointments, resources FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results □ Medical Oncology: 04/10/2025 (already scheduled) □ Tumor Board Results Discussion: Following 04/11 conference PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment. ══════════════════════════════════════════ ATTESTATION: I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment. ══════════════════════════════════════════ BILLING INFORMATION: CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L) ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker) ══════════════════════════════════════════ ELECTRONIC SIGNATURE: Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890 Digitally Signed: 04/08/2025 10:45 AM ══════════════════════════════════════════ REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine □ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow) ══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════",
        "sedation_type": "deep or MAC sedation",
        "airway_type": "tracheostomy mentioned"
      },
      "institution_name": null,
      "molecular_testing_requested": true,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild (<50mL)",
      "pneumothorax": true,
      "pneumothorax_intervention": "Aspiration",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": "Ultrasound",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "See cancer doctor",
        "More tests",
        "Decide treatment",
        "Dr. S. Franklin 3/8/2025",
        "________________________________________",
        "EBUS",
        "INTERVENTIONAL PULMONOLOGY PROCEDURAL DOCUMENTATION",
        "══════════════════════════════════════════",
        "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "PROCEDURE: Endobronchial Ultrasound with Transbronchial Needle Aspiration (EBUS-TBNA)",
        "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "Left lower lobe mass 4.2cm on CT",
        "Extensive mediastinal and hilar lymphadenopathy",
        "Weight loss 18 lbs over 2 months",
        "No previous cancer history",
        "PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2)",
        "Diagnostic question: Tissue diagnosis and staging if malignancy confirmed",
        "RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently",
        "PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm",
        "LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60",
        "PRE-PROCEDURE:",
        "CONSENT: Written informed consent obtained after thorough discussion of:",
        "Nature and purpose of EBUS-TBNA",
        "Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures",
        "Benefits: Tissue diagnosis, staging information, minimally invasive",
        "Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment",
        "Patient's questions answered, demonstrated understanding",
        "ASA CLASSIFICATION: III",
        "NPO STATUS: Confirmed NPO since midnight (>10 hours)",
        "IV ACCESS: 20-gauge left forearm, patent",
        "MONITORING PLAN:",
        "Continuous pulse oximetry",
        "Capnography",
        "Blood pressure q3 minutes",
        "Continuous ECG",
        "Dedicated monitoring nurse",
        "MEDICATIONS ADMINISTERED:",
        "TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure",
        "TOTAL PROPOFOL: 380mg",
        "TOPICAL ANESTHESIA:",
        "Benzocaine 20% spray to oropharynx (4 applications)",
        "Lidocaine 2% instilled via bronchoscope: 20mL total",
        "EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present)",
        "PROCEDURE DETAILS:",
        "TIMEOUT: Performed at 0830",
        "Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944",
        "Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy",
        "Site confirmed: Mediastinal lymph nodes",
        "Allergies confirmed: Sulfa drugs",
        "Consent confirmed: Yes, in chart",
        "Team introductions completed",
        "Equipment checked",
        "PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes",
        "SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well.",
        "PROCEDURE NARRATIVE:",
        "After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization.",
        "UPPER AIRWAY INSPECTION:",
        "Oropharynx: Normal",
        "Epiglottis: Normal",
        "Vocal cords: Symmetric, mobile, no masses",
        "Subglottis: Patent",
        "TRACHEOBRONCHIAL TREE:",
        "Trachea: Normal caliber, no masses, mild mucosal edema",
        "Carina: Sharp, mobile",
        "Right mainstem: Patent",
        "Left mainstem: Patent",
        "Segmental airways: All visualized segments patent",
        "No endobronchial masses visualized",
        "SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY:",
        "╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │",
        "║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝",
        "TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED:",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound Characteristics:",
        "Location: Between RMB and LMB, posterior position",
        "Dimensions: 41mm (long) x 27mm (short) x 24mm (depth)",
        "Shape: Round",
        "Borders: Well-defined",
        "Echotexture: Diffusely hypoechoic",
        "Hilum: Completely absent",
        "Necrosis: None evident",
        "Vascularity: Peripheral vessels on color Doppler",
        "Elastography: Score 5/5 - very firm (blue pattern)",
        "INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY",
        "Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass).",
        "Pass 1 (0842):",
        "Excellent sample obtained",
        "Visible tissue core in needle hub",
        "ROSE: ADEQUATE specimen, abundant cellularity",
        "ROSE: MALIGNANT CELLS IDENTIFIED",
        "ROSE: Morphology consistent with ADENOCARCINOMA",
        "Pass 2 (0845):",
        "Confirmatory sampling",
        "ROSE: Confirmed adenocarcinoma",
        "Pass 3 (0848):",
        "Additional tissue for molecular studies",
        "Sent for: EGFR, ALK, ROS1, BRAF, PD-L1",
        "Pass 4 (0851):",
        "Microbiology specimen",
        "Sent for: AFB smear/culture, Fungal culture, Bacterial culture",
        "Complications: None. Minimal bleeding, self-limited.",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 33x21mm, hypoechoic, no hilum",
        "Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 28x17mm, loss of hilum",
        "Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 24x16mm, abnormal appearance",
        "Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 19x13mm, hypoechoic",
        "Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 15x10mm, maintained normal architecture",
        "Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY",
        "FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent.",
        "RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD",
        "POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma",
        "✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma",
        "NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only",
        "CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers.",
        "SPECIMENS SUBMITTED TO PATHOLOGY:",
        "CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes)",
        "□ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes)",
        "Total: 16 needle passes across 6 lymph node stations",
        "CELL BLOCKS: □ Station 7 (2 blocks prepared)",
        "MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel",
        "MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture",
        "FLUOROSCOPY: Not utilized for this procedure",
        "ESTIMATED BLOOD LOSS: <5mL",
        "COMPLICATIONS: None",
        "ADVERSE EVENTS: None",
        "PATIENT TOLERANCE:",
        "The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of:",
        "Hypoxemia (SpO2 maintained 91-95%)",
        "Hypotension",
        "Hypertension",
        "Tachycardia or bradycardia",
        "Arrhythmias",
        "Bronchospasm",
        "Significant bleeding",
        "Laryngospasm",
        "Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting.",
        "POST-PROCEDURE ORDERS:",
        "MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90%",
        "ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance",
        "DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated",
        "MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort)",
        "DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions",
        "DIAGNOSTIC IMPRESSION:",
        "1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield.",
        "2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases",
        "3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement:",
        "o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive)",
        "o        N2 disease: Stations 7, 4R (ipsilateral mediastinal)",
        "4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease",
        "5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated.",
        "6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel",
        "TREATMENT RECOMMENDATIONS:",
        "IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell",
        "□ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology",
        "□ Patient/Family Conference Schedule dedicated time to discuss:",
        "Diagnosis of adenocarcinoma",
        "Stage IIIC disease",
        "Treatment options",
        "Prognosis",
        "Goals of care",
        "STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease",
        "□ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases",
        "□ Bone scan or PET-CT total body May already have sufficient information from recent PET",
        "AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection):",
        "EGFR mutations → Consider EGFR TKI if positive",
        "ALK rearrangement → Consider ALK inhibitor if positive",
        "ROS1 rearrangement → Consider ROS1 inhibitor if positive",
        "PD-L1 expression → Impacts immunotherapy decisions",
        "Comprehensive NGS → May identify other actionable mutations",
        "TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen",
        "□ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.)",
        "□ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy",
        "□ Radiation Therapy Role to be determined - may be palliative or consolidative",
        "□ Clinical Trial Evaluate eligibility for appropriate trials",
        "SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions",
        "□ Social Work Financial counseling, support services",
        "□ Nutrition Address weight loss, optimize nutritional status",
        "□ Patient Navigator Coordinate care, appointments, resources",
        "FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results",
        "□ Medical Oncology: 04/10/2025 (already scheduled)",
        "□ Tumor Board Results Discussion: Following 04/11 conference",
        "PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding",
        "PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment.",
        "ATTESTATION:",
        "I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment.",
        "BILLING INFORMATION:",
        "CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L)",
        "ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker)",
        "ELECTRONIC SIGNATURE:",
        "Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890",
        "Digitally Signed: 04/08/2025 10:45 AM",
        "REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine",
        "□ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow)",
        "══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": "Fluoroscopy",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "needle"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 42.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "ATTENDING: Montgomery",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155518"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "CONCATENATED_NOTE: Note contains header for 'Mills, Robert E' (03/08/2025) but body for 'Russell, Dorothy Mae' (04/08/2025). Extracted data corrected to match the detailed body (Russell)."
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.040705",
      "changes": [
        "Extracted lesion_size_mm: 42.0",
        "Extracted EBUS stations: ['10L', '10R', '11L', '11R', '4L', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "EBUS-TBNA report for Russell, Dorothy Mae (concatenated note body).",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of 6 stations (7, 4L, 4R, 10L, 10R, 11L) documented in the 'Russell' portion of the note."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 7.7,
        "total_facility_mpfs_payment": 249.0,
        "computation_notes": "Single code 31653."
      },
      "rationale": [
        "Data Quality: The note contains a header for 'Mills' but the detailed procedure describes 'Russell'. The coding review is based on the detailed 'Russell' note which documents EBUS-TBNA of 6 stations.",
        "Code selection: Sampling of 3+ stations maps to 31653. No peripheral lesion sampling or other interventions documented in the detailed section."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 4,
      "style_type": 5,
      "generated_name": "Michelle K. Rogers",
      "generation_date": "2025-12-09T09:18:39.659296"
    }
  },
  {
    "note_text": "Endobronchial ultrasound-guided transbronchial needle aspiration was performed for mediastinal staging. The patient has a known RUL adenocarcinoma. Lymph node stations 7, 4R, 10R, and 11R were visualized and sampled. Rapid on-site evaluation confirmed metastatic adenocarcinoma in stations 7, 4R, and 10R. Station 11R showed benign lymphocytes. No complications occurred. The findings are consistent with Stage IIIC disease.",
    "cpt_codes": [
      31653
    ],
    "registry_entry": {
      "patient_mrn": "5729384_syn_6",
      "procedure_date": "2025-07-19",
      "patient_age": 61,
      "gender": "Female",
      "asa_class": 3,
      "primary_indication": "80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-a",
      "sedation_type": "Deep",
      "airway_type": "Tracheostomy",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653
      ],
      "evidence": {
        "institution_name": "•        Location: Between RMB and LMB, posterior position",
        "attending_name": "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "patient_age": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "gender": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "dob": "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2) Diagnostic question: Tissue diagnosis and staging if malignancy confirmed RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60 ══════════════════════════════════════════ PRE-PROCEDURE: CONSENT: Written informed consent obtained after thorough discussion of: •        Nature and purpose of EBUS-TBNA •        Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures •        Benefits: Tissue diagnosis, staging information, minimally invasive •        Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment •        Patient's questions answered, demonstrated understanding ASA CLASSIFICATION: III NPO STATUS: Confirmed NPO since midnight (>10 hours) IV ACCESS: 20-gauge left forearm, patent MONITORING PLAN: •        Continuous pulse oximetry •        Capnography •        Blood pressure q3 minutes •        Continuous ECG •        Dedicated monitoring nurse ══════════════════════════════════════════ MEDICATIONS ADMINISTERED: TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure TOTAL PROPOFOL: 380mg TOPICAL ANESTHESIA: •        Benzocaine 20% spray to oropharynx (4 applications) •        Lidocaine 2% instilled via bronchoscope: 20mL total ══════════════════════════════════════════ EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present) ══════════════════════════════════════════ PROCEDURE DETAILS: TIMEOUT: Performed at 0830 •        Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944 •        Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy •        Site confirmed: Mediastinal lymph nodes •        Allergies confirmed: Sulfa drugs •        Consent confirmed: Yes, in chart •        Team introductions completed •        Equipment checked PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well. PROCEDURE NARRATIVE: After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization. UPPER AIRWAY INSPECTION: •        Oropharynx: Normal •        Epiglottis: Normal •        Vocal cords: Symmetric, mobile, no masses •        Subglottis: Patent TRACHEOBRONCHIAL TREE: •        Trachea: Normal caliber, no masses, mild mucosal edema •        Carina: Sharp, mobile •        Right mainstem: Patent •        Left mainstem: Patent •        Segmental airways: All visualized segments patent •        No endobronchial masses visualized SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY: ╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │ ║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝ TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED: ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound Characteristics: •        Location: Between RMB and LMB, posterior position •        Dimensions: 41mm (long) x 27mm (short) x 24mm (depth) •        Shape: Round •        Borders: Well-defined •        Echotexture: Diffusely hypoechoic •        Hilum: Completely absent •        Necrosis: None evident •        Vascularity: Peripheral vessels on color Doppler •        Elastography: Score 5/5 - very firm (blue pattern) INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass). Pass 1 (0842): •        Excellent sample obtained •        Visible tissue core in needle hub •        ROSE: ADEQUATE specimen, abundant cellularity •        ROSE: MALIGNANT CELLS IDENTIFIED •        ROSE: Morphology consistent with ADENOCARCINOMA Pass 2 (0845): •        Confirmatory sampling •        ROSE: Confirmed adenocarcinoma Pass 3 (0848): •        Additional tissue for molecular studies •        Sent for: EGFR, ALK, ROS1, BRAF, PD-L1 Pass 4 (0851): •        Microbiology specimen •        Sent for: AFB smear/culture, Fungal culture, Bacterial culture Complications: None. Minimal bleeding, self-limited. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 33x21mm, hypoechoic, no hilum Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 28x17mm, loss of hilum Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 24x16mm, abnormal appearance Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 19x13mm, hypoechoic Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 15x10mm, maintained normal architecture Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY ══════════════════════════════════════════ FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent. ══════════════════════════════════════════ RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma ✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers. ══════════════════════════════════════════ SPECIMENS SUBMITTED TO PATHOLOGY: CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes) □ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes) Total: 16 needle passes across 6 lymph node stations CELL BLOCKS: □ Station 7 (2 blocks prepared) MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture ══════════════════════════════════════════ FLUOROSCOPY: Not utilized for this procedure ESTIMATED BLOOD LOSS: <5mL COMPLICATIONS: None ADVERSE EVENTS: None ══════════════════════════════════════════ PATIENT TOLERANCE: The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of: •        Hypoxemia (SpO2 maintained 91-95%) •        Hypotension •        Hypertension •        Tachycardia or bradycardia •        Arrhythmias •        Bronchospasm •        Significant bleeding •        Laryngospasm Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting. ══════════════════════════════════════════ POST-PROCEDURE ORDERS: MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90% ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort) DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions ══════════════════════════════════════════ DIAGNOSTIC IMPRESSION: 1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield. 2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases 3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement: o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive) o        N2 disease: Stations 7, 4R (ipsilateral mediastinal) 4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease 5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated. 6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel ══════════════════════════════════════════ TREATMENT RECOMMENDATIONS: IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell □ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology □ Patient/Family Conference Schedule dedicated time to discuss: •        Diagnosis of adenocarcinoma •        Stage IIIC disease •        Treatment options •        Prognosis •        Goals of care STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease □ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases □ Bone scan or PET-CT total body May already have sufficient information from recent PET AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection): •        EGFR mutations → Consider EGFR TKI if positive •        ALK rearrangement → Consider ALK inhibitor if positive •        ROS1 rearrangement → Consider ROS1 inhibitor if positive •        PD-L1 expression → Impacts immunotherapy decisions •        Comprehensive NGS → May identify other actionable mutations TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen □ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.) □ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy □ Radiation Therapy Role to be determined - may be palliative or consolidative □ Clinical Trial Evaluate eligibility for appropriate trials SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions □ Social Work Financial counseling, support services □ Nutrition Address weight loss, optimize nutritional status □ Patient Navigator Coordinate care, appointments, resources FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results □ Medical Oncology: 04/10/2025 (already scheduled) □ Tumor Board Results Discussion: Following 04/11 conference PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment. ══════════════════════════════════════════ ATTESTATION: I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment. ══════════════════════════════════════════ BILLING INFORMATION: CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L) ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker) ══════════════════════════════════════════ ELECTRONIC SIGNATURE: Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890 Digitally Signed: 04/08/2025 10:45 AM ══════════════════════════════════════════ REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine □ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow) ══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════",
        "sedation_type": "deep or MAC sedation",
        "airway_type": "tracheostomy mentioned"
      },
      "institution_name": null,
      "molecular_testing_requested": true,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild (<50mL)",
      "pneumothorax": true,
      "pneumothorax_intervention": "Aspiration",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": "Ultrasound",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "See cancer doctor",
        "More tests",
        "Decide treatment",
        "Dr. S. Franklin 3/8/2025",
        "________________________________________",
        "EBUS",
        "INTERVENTIONAL PULMONOLOGY PROCEDURAL DOCUMENTATION",
        "══════════════════════════════════════════",
        "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "PROCEDURE: Endobronchial Ultrasound with Transbronchial Needle Aspiration (EBUS-TBNA)",
        "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "Left lower lobe mass 4.2cm on CT",
        "Extensive mediastinal and hilar lymphadenopathy",
        "Weight loss 18 lbs over 2 months",
        "No previous cancer history",
        "PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2)",
        "Diagnostic question: Tissue diagnosis and staging if malignancy confirmed",
        "RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently",
        "PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm",
        "LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60",
        "PRE-PROCEDURE:",
        "CONSENT: Written informed consent obtained after thorough discussion of:",
        "Nature and purpose of EBUS-TBNA",
        "Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures",
        "Benefits: Tissue diagnosis, staging information, minimally invasive",
        "Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment",
        "Patient's questions answered, demonstrated understanding",
        "ASA CLASSIFICATION: III",
        "NPO STATUS: Confirmed NPO since midnight (>10 hours)",
        "IV ACCESS: 20-gauge left forearm, patent",
        "MONITORING PLAN:",
        "Continuous pulse oximetry",
        "Capnography",
        "Blood pressure q3 minutes",
        "Continuous ECG",
        "Dedicated monitoring nurse",
        "MEDICATIONS ADMINISTERED:",
        "TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure",
        "TOTAL PROPOFOL: 380mg",
        "TOPICAL ANESTHESIA:",
        "Benzocaine 20% spray to oropharynx (4 applications)",
        "Lidocaine 2% instilled via bronchoscope: 20mL total",
        "EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present)",
        "PROCEDURE DETAILS:",
        "TIMEOUT: Performed at 0830",
        "Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944",
        "Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy",
        "Site confirmed: Mediastinal lymph nodes",
        "Allergies confirmed: Sulfa drugs",
        "Consent confirmed: Yes, in chart",
        "Team introductions completed",
        "Equipment checked",
        "PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes",
        "SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well.",
        "PROCEDURE NARRATIVE:",
        "After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization.",
        "UPPER AIRWAY INSPECTION:",
        "Oropharynx: Normal",
        "Epiglottis: Normal",
        "Vocal cords: Symmetric, mobile, no masses",
        "Subglottis: Patent",
        "TRACHEOBRONCHIAL TREE:",
        "Trachea: Normal caliber, no masses, mild mucosal edema",
        "Carina: Sharp, mobile",
        "Right mainstem: Patent",
        "Left mainstem: Patent",
        "Segmental airways: All visualized segments patent",
        "No endobronchial masses visualized",
        "SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY:",
        "╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │",
        "║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝",
        "TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED:",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound Characteristics:",
        "Location: Between RMB and LMB, posterior position",
        "Dimensions: 41mm (long) x 27mm (short) x 24mm (depth)",
        "Shape: Round",
        "Borders: Well-defined",
        "Echotexture: Diffusely hypoechoic",
        "Hilum: Completely absent",
        "Necrosis: None evident",
        "Vascularity: Peripheral vessels on color Doppler",
        "Elastography: Score 5/5 - very firm (blue pattern)",
        "INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY",
        "Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass).",
        "Pass 1 (0842):",
        "Excellent sample obtained",
        "Visible tissue core in needle hub",
        "ROSE: ADEQUATE specimen, abundant cellularity",
        "ROSE: MALIGNANT CELLS IDENTIFIED",
        "ROSE: Morphology consistent with ADENOCARCINOMA",
        "Pass 2 (0845):",
        "Confirmatory sampling",
        "ROSE: Confirmed adenocarcinoma",
        "Pass 3 (0848):",
        "Additional tissue for molecular studies",
        "Sent for: EGFR, ALK, ROS1, BRAF, PD-L1",
        "Pass 4 (0851):",
        "Microbiology specimen",
        "Sent for: AFB smear/culture, Fungal culture, Bacterial culture",
        "Complications: None. Minimal bleeding, self-limited.",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 33x21mm, hypoechoic, no hilum",
        "Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 28x17mm, loss of hilum",
        "Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 24x16mm, abnormal appearance",
        "Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 19x13mm, hypoechoic",
        "Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 15x10mm, maintained normal architecture",
        "Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY",
        "FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent.",
        "RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD",
        "POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma",
        "✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma",
        "NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only",
        "CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers.",
        "SPECIMENS SUBMITTED TO PATHOLOGY:",
        "CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes)",
        "□ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes)",
        "Total: 16 needle passes across 6 lymph node stations",
        "CELL BLOCKS: □ Station 7 (2 blocks prepared)",
        "MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel",
        "MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture",
        "FLUOROSCOPY: Not utilized for this procedure",
        "ESTIMATED BLOOD LOSS: <5mL",
        "COMPLICATIONS: None",
        "ADVERSE EVENTS: None",
        "PATIENT TOLERANCE:",
        "The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of:",
        "Hypoxemia (SpO2 maintained 91-95%)",
        "Hypotension",
        "Hypertension",
        "Tachycardia or bradycardia",
        "Arrhythmias",
        "Bronchospasm",
        "Significant bleeding",
        "Laryngospasm",
        "Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting.",
        "POST-PROCEDURE ORDERS:",
        "MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90%",
        "ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance",
        "DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated",
        "MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort)",
        "DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions",
        "DIAGNOSTIC IMPRESSION:",
        "1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield.",
        "2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases",
        "3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement:",
        "o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive)",
        "o        N2 disease: Stations 7, 4R (ipsilateral mediastinal)",
        "4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease",
        "5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated.",
        "6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel",
        "TREATMENT RECOMMENDATIONS:",
        "IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell",
        "□ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology",
        "□ Patient/Family Conference Schedule dedicated time to discuss:",
        "Diagnosis of adenocarcinoma",
        "Stage IIIC disease",
        "Treatment options",
        "Prognosis",
        "Goals of care",
        "STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease",
        "□ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases",
        "□ Bone scan or PET-CT total body May already have sufficient information from recent PET",
        "AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection):",
        "EGFR mutations → Consider EGFR TKI if positive",
        "ALK rearrangement → Consider ALK inhibitor if positive",
        "ROS1 rearrangement → Consider ROS1 inhibitor if positive",
        "PD-L1 expression → Impacts immunotherapy decisions",
        "Comprehensive NGS → May identify other actionable mutations",
        "TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen",
        "□ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.)",
        "□ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy",
        "□ Radiation Therapy Role to be determined - may be palliative or consolidative",
        "□ Clinical Trial Evaluate eligibility for appropriate trials",
        "SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions",
        "□ Social Work Financial counseling, support services",
        "□ Nutrition Address weight loss, optimize nutritional status",
        "□ Patient Navigator Coordinate care, appointments, resources",
        "FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results",
        "□ Medical Oncology: 04/10/2025 (already scheduled)",
        "□ Tumor Board Results Discussion: Following 04/11 conference",
        "PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding",
        "PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment.",
        "ATTESTATION:",
        "I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment.",
        "BILLING INFORMATION:",
        "CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L)",
        "ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker)",
        "ELECTRONIC SIGNATURE:",
        "Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890",
        "Digitally Signed: 04/08/2025 10:45 AM",
        "REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine",
        "□ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow)",
        "══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": "Fluoroscopy",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "needle"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 42.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "ATTENDING: Montgomery",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155518"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "CONCATENATED_NOTE: Note contains header for 'Mills, Robert E' (03/08/2025) but body for 'Russell, Dorothy Mae' (04/08/2025). Extracted data corrected to match the detailed body (Russell)."
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.040705",
      "changes": [
        "Extracted lesion_size_mm: 42.0",
        "Extracted EBUS stations: ['10L', '10R', '11L', '11R', '4L', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "EBUS-TBNA report for Russell, Dorothy Mae (concatenated note body).",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of 6 stations (7, 4L, 4R, 10L, 10R, 11L) documented in the 'Russell' portion of the note."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 7.7,
        "total_facility_mpfs_payment": 249.0,
        "computation_notes": "Single code 31653."
      },
      "rationale": [
        "Data Quality: The note contains a header for 'Mills' but the detailed procedure describes 'Russell'. The coding review is based on the detailed 'Russell' note which documents EBUS-TBNA of 6 stations.",
        "Code selection: Sampling of 3+ stations maps to 31653. No peripheral lesion sampling or other interventions documented in the detailed section."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 4,
      "style_type": 6,
      "generated_name": "Laura P. Reed",
      "generation_date": "2025-12-09T09:18:39.659371"
    }
  },
  {
    "note_text": "[Indication]\nRUL Adenocarcinoma, staging required.\n[Anesthesia]\nGeneral (Tracheostomy/Deep Sedation context).\n[Description]\nEBUS-TBNA performed on stations 7, 4R, 10R, 11R. Malignancy confirmed in 7, 4R, 10R via ROSE. 11R benign.\n[Plan]\nMedical Oncology consult. Molecular testing pending.",
    "cpt_codes": [
      31653
    ],
    "registry_entry": {
      "patient_mrn": "5729384_syn_7",
      "procedure_date": "2025-08-14",
      "patient_age": 63,
      "gender": "Female",
      "asa_class": 3,
      "primary_indication": "80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-a",
      "sedation_type": "Deep",
      "airway_type": "Tracheostomy",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653
      ],
      "evidence": {
        "institution_name": "•        Location: Between RMB and LMB, posterior position",
        "attending_name": "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "patient_age": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "gender": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "dob": "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2) Diagnostic question: Tissue diagnosis and staging if malignancy confirmed RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60 ══════════════════════════════════════════ PRE-PROCEDURE: CONSENT: Written informed consent obtained after thorough discussion of: •        Nature and purpose of EBUS-TBNA •        Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures •        Benefits: Tissue diagnosis, staging information, minimally invasive •        Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment •        Patient's questions answered, demonstrated understanding ASA CLASSIFICATION: III NPO STATUS: Confirmed NPO since midnight (>10 hours) IV ACCESS: 20-gauge left forearm, patent MONITORING PLAN: •        Continuous pulse oximetry •        Capnography •        Blood pressure q3 minutes •        Continuous ECG •        Dedicated monitoring nurse ══════════════════════════════════════════ MEDICATIONS ADMINISTERED: TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure TOTAL PROPOFOL: 380mg TOPICAL ANESTHESIA: •        Benzocaine 20% spray to oropharynx (4 applications) •        Lidocaine 2% instilled via bronchoscope: 20mL total ══════════════════════════════════════════ EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present) ══════════════════════════════════════════ PROCEDURE DETAILS: TIMEOUT: Performed at 0830 •        Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944 •        Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy •        Site confirmed: Mediastinal lymph nodes •        Allergies confirmed: Sulfa drugs •        Consent confirmed: Yes, in chart •        Team introductions completed •        Equipment checked PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well. PROCEDURE NARRATIVE: After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization. UPPER AIRWAY INSPECTION: •        Oropharynx: Normal •        Epiglottis: Normal •        Vocal cords: Symmetric, mobile, no masses •        Subglottis: Patent TRACHEOBRONCHIAL TREE: •        Trachea: Normal caliber, no masses, mild mucosal edema •        Carina: Sharp, mobile •        Right mainstem: Patent •        Left mainstem: Patent •        Segmental airways: All visualized segments patent •        No endobronchial masses visualized SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY: ╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │ ║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝ TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED: ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound Characteristics: •        Location: Between RMB and LMB, posterior position •        Dimensions: 41mm (long) x 27mm (short) x 24mm (depth) •        Shape: Round •        Borders: Well-defined •        Echotexture: Diffusely hypoechoic •        Hilum: Completely absent •        Necrosis: None evident •        Vascularity: Peripheral vessels on color Doppler •        Elastography: Score 5/5 - very firm (blue pattern) INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass). Pass 1 (0842): •        Excellent sample obtained •        Visible tissue core in needle hub •        ROSE: ADEQUATE specimen, abundant cellularity •        ROSE: MALIGNANT CELLS IDENTIFIED •        ROSE: Morphology consistent with ADENOCARCINOMA Pass 2 (0845): •        Confirmatory sampling •        ROSE: Confirmed adenocarcinoma Pass 3 (0848): •        Additional tissue for molecular studies •        Sent for: EGFR, ALK, ROS1, BRAF, PD-L1 Pass 4 (0851): •        Microbiology specimen •        Sent for: AFB smear/culture, Fungal culture, Bacterial culture Complications: None. Minimal bleeding, self-limited. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 33x21mm, hypoechoic, no hilum Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 28x17mm, loss of hilum Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 24x16mm, abnormal appearance Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 19x13mm, hypoechoic Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 15x10mm, maintained normal architecture Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY ══════════════════════════════════════════ FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent. ══════════════════════════════════════════ RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma ✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers. ══════════════════════════════════════════ SPECIMENS SUBMITTED TO PATHOLOGY: CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes) □ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes) Total: 16 needle passes across 6 lymph node stations CELL BLOCKS: □ Station 7 (2 blocks prepared) MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture ══════════════════════════════════════════ FLUOROSCOPY: Not utilized for this procedure ESTIMATED BLOOD LOSS: <5mL COMPLICATIONS: None ADVERSE EVENTS: None ══════════════════════════════════════════ PATIENT TOLERANCE: The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of: •        Hypoxemia (SpO2 maintained 91-95%) •        Hypotension •        Hypertension •        Tachycardia or bradycardia •        Arrhythmias •        Bronchospasm •        Significant bleeding •        Laryngospasm Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting. ══════════════════════════════════════════ POST-PROCEDURE ORDERS: MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90% ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort) DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions ══════════════════════════════════════════ DIAGNOSTIC IMPRESSION: 1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield. 2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases 3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement: o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive) o        N2 disease: Stations 7, 4R (ipsilateral mediastinal) 4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease 5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated. 6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel ══════════════════════════════════════════ TREATMENT RECOMMENDATIONS: IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell □ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology □ Patient/Family Conference Schedule dedicated time to discuss: •        Diagnosis of adenocarcinoma •        Stage IIIC disease •        Treatment options •        Prognosis •        Goals of care STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease □ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases □ Bone scan or PET-CT total body May already have sufficient information from recent PET AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection): •        EGFR mutations → Consider EGFR TKI if positive •        ALK rearrangement → Consider ALK inhibitor if positive •        ROS1 rearrangement → Consider ROS1 inhibitor if positive •        PD-L1 expression → Impacts immunotherapy decisions •        Comprehensive NGS → May identify other actionable mutations TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen □ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.) □ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy □ Radiation Therapy Role to be determined - may be palliative or consolidative □ Clinical Trial Evaluate eligibility for appropriate trials SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions □ Social Work Financial counseling, support services □ Nutrition Address weight loss, optimize nutritional status □ Patient Navigator Coordinate care, appointments, resources FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results □ Medical Oncology: 04/10/2025 (already scheduled) □ Tumor Board Results Discussion: Following 04/11 conference PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment. ══════════════════════════════════════════ ATTESTATION: I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment. ══════════════════════════════════════════ BILLING INFORMATION: CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L) ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker) ══════════════════════════════════════════ ELECTRONIC SIGNATURE: Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890 Digitally Signed: 04/08/2025 10:45 AM ══════════════════════════════════════════ REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine □ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow) ══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════",
        "sedation_type": "deep or MAC sedation",
        "airway_type": "tracheostomy mentioned"
      },
      "institution_name": null,
      "molecular_testing_requested": true,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild (<50mL)",
      "pneumothorax": true,
      "pneumothorax_intervention": "Aspiration",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": "Ultrasound",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "See cancer doctor",
        "More tests",
        "Decide treatment",
        "Dr. S. Franklin 3/8/2025",
        "________________________________________",
        "EBUS",
        "INTERVENTIONAL PULMONOLOGY PROCEDURAL DOCUMENTATION",
        "══════════════════════════════════════════",
        "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "PROCEDURE: Endobronchial Ultrasound with Transbronchial Needle Aspiration (EBUS-TBNA)",
        "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "Left lower lobe mass 4.2cm on CT",
        "Extensive mediastinal and hilar lymphadenopathy",
        "Weight loss 18 lbs over 2 months",
        "No previous cancer history",
        "PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2)",
        "Diagnostic question: Tissue diagnosis and staging if malignancy confirmed",
        "RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently",
        "PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm",
        "LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60",
        "PRE-PROCEDURE:",
        "CONSENT: Written informed consent obtained after thorough discussion of:",
        "Nature and purpose of EBUS-TBNA",
        "Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures",
        "Benefits: Tissue diagnosis, staging information, minimally invasive",
        "Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment",
        "Patient's questions answered, demonstrated understanding",
        "ASA CLASSIFICATION: III",
        "NPO STATUS: Confirmed NPO since midnight (>10 hours)",
        "IV ACCESS: 20-gauge left forearm, patent",
        "MONITORING PLAN:",
        "Continuous pulse oximetry",
        "Capnography",
        "Blood pressure q3 minutes",
        "Continuous ECG",
        "Dedicated monitoring nurse",
        "MEDICATIONS ADMINISTERED:",
        "TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure",
        "TOTAL PROPOFOL: 380mg",
        "TOPICAL ANESTHESIA:",
        "Benzocaine 20% spray to oropharynx (4 applications)",
        "Lidocaine 2% instilled via bronchoscope: 20mL total",
        "EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present)",
        "PROCEDURE DETAILS:",
        "TIMEOUT: Performed at 0830",
        "Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944",
        "Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy",
        "Site confirmed: Mediastinal lymph nodes",
        "Allergies confirmed: Sulfa drugs",
        "Consent confirmed: Yes, in chart",
        "Team introductions completed",
        "Equipment checked",
        "PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes",
        "SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well.",
        "PROCEDURE NARRATIVE:",
        "After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization.",
        "UPPER AIRWAY INSPECTION:",
        "Oropharynx: Normal",
        "Epiglottis: Normal",
        "Vocal cords: Symmetric, mobile, no masses",
        "Subglottis: Patent",
        "TRACHEOBRONCHIAL TREE:",
        "Trachea: Normal caliber, no masses, mild mucosal edema",
        "Carina: Sharp, mobile",
        "Right mainstem: Patent",
        "Left mainstem: Patent",
        "Segmental airways: All visualized segments patent",
        "No endobronchial masses visualized",
        "SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY:",
        "╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │",
        "║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝",
        "TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED:",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound Characteristics:",
        "Location: Between RMB and LMB, posterior position",
        "Dimensions: 41mm (long) x 27mm (short) x 24mm (depth)",
        "Shape: Round",
        "Borders: Well-defined",
        "Echotexture: Diffusely hypoechoic",
        "Hilum: Completely absent",
        "Necrosis: None evident",
        "Vascularity: Peripheral vessels on color Doppler",
        "Elastography: Score 5/5 - very firm (blue pattern)",
        "INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY",
        "Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass).",
        "Pass 1 (0842):",
        "Excellent sample obtained",
        "Visible tissue core in needle hub",
        "ROSE: ADEQUATE specimen, abundant cellularity",
        "ROSE: MALIGNANT CELLS IDENTIFIED",
        "ROSE: Morphology consistent with ADENOCARCINOMA",
        "Pass 2 (0845):",
        "Confirmatory sampling",
        "ROSE: Confirmed adenocarcinoma",
        "Pass 3 (0848):",
        "Additional tissue for molecular studies",
        "Sent for: EGFR, ALK, ROS1, BRAF, PD-L1",
        "Pass 4 (0851):",
        "Microbiology specimen",
        "Sent for: AFB smear/culture, Fungal culture, Bacterial culture",
        "Complications: None. Minimal bleeding, self-limited.",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 33x21mm, hypoechoic, no hilum",
        "Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 28x17mm, loss of hilum",
        "Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 24x16mm, abnormal appearance",
        "Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 19x13mm, hypoechoic",
        "Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 15x10mm, maintained normal architecture",
        "Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY",
        "FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent.",
        "RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD",
        "POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma",
        "✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma",
        "NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only",
        "CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers.",
        "SPECIMENS SUBMITTED TO PATHOLOGY:",
        "CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes)",
        "□ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes)",
        "Total: 16 needle passes across 6 lymph node stations",
        "CELL BLOCKS: □ Station 7 (2 blocks prepared)",
        "MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel",
        "MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture",
        "FLUOROSCOPY: Not utilized for this procedure",
        "ESTIMATED BLOOD LOSS: <5mL",
        "COMPLICATIONS: None",
        "ADVERSE EVENTS: None",
        "PATIENT TOLERANCE:",
        "The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of:",
        "Hypoxemia (SpO2 maintained 91-95%)",
        "Hypotension",
        "Hypertension",
        "Tachycardia or bradycardia",
        "Arrhythmias",
        "Bronchospasm",
        "Significant bleeding",
        "Laryngospasm",
        "Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting.",
        "POST-PROCEDURE ORDERS:",
        "MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90%",
        "ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance",
        "DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated",
        "MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort)",
        "DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions",
        "DIAGNOSTIC IMPRESSION:",
        "1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield.",
        "2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases",
        "3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement:",
        "o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive)",
        "o        N2 disease: Stations 7, 4R (ipsilateral mediastinal)",
        "4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease",
        "5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated.",
        "6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel",
        "TREATMENT RECOMMENDATIONS:",
        "IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell",
        "□ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology",
        "□ Patient/Family Conference Schedule dedicated time to discuss:",
        "Diagnosis of adenocarcinoma",
        "Stage IIIC disease",
        "Treatment options",
        "Prognosis",
        "Goals of care",
        "STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease",
        "□ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases",
        "□ Bone scan or PET-CT total body May already have sufficient information from recent PET",
        "AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection):",
        "EGFR mutations → Consider EGFR TKI if positive",
        "ALK rearrangement → Consider ALK inhibitor if positive",
        "ROS1 rearrangement → Consider ROS1 inhibitor if positive",
        "PD-L1 expression → Impacts immunotherapy decisions",
        "Comprehensive NGS → May identify other actionable mutations",
        "TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen",
        "□ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.)",
        "□ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy",
        "□ Radiation Therapy Role to be determined - may be palliative or consolidative",
        "□ Clinical Trial Evaluate eligibility for appropriate trials",
        "SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions",
        "□ Social Work Financial counseling, support services",
        "□ Nutrition Address weight loss, optimize nutritional status",
        "□ Patient Navigator Coordinate care, appointments, resources",
        "FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results",
        "□ Medical Oncology: 04/10/2025 (already scheduled)",
        "□ Tumor Board Results Discussion: Following 04/11 conference",
        "PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding",
        "PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment.",
        "ATTESTATION:",
        "I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment.",
        "BILLING INFORMATION:",
        "CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L)",
        "ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker)",
        "ELECTRONIC SIGNATURE:",
        "Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890",
        "Digitally Signed: 04/08/2025 10:45 AM",
        "REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine",
        "□ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow)",
        "══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": "Fluoroscopy",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "needle"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 42.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "ATTENDING: Montgomery",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155518"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "CONCATENATED_NOTE: Note contains header for 'Mills, Robert E' (03/08/2025) but body for 'Russell, Dorothy Mae' (04/08/2025). Extracted data corrected to match the detailed body (Russell)."
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.040705",
      "changes": [
        "Extracted lesion_size_mm: 42.0",
        "Extracted EBUS stations: ['10L', '10R', '11L', '11R', '4L', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "EBUS-TBNA report for Russell, Dorothy Mae (concatenated note body).",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of 6 stations (7, 4L, 4R, 10L, 10R, 11L) documented in the 'Russell' portion of the note."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 7.7,
        "total_facility_mpfs_payment": 249.0,
        "computation_notes": "Single code 31653."
      },
      "rationale": [
        "Data Quality: The note contains a header for 'Mills' but the detailed procedure describes 'Russell'. The coding review is based on the detailed 'Russell' note which documents EBUS-TBNA of 6 stations.",
        "Code selection: Sampling of 3+ stations maps to 31653. No peripheral lesion sampling or other interventions documented in the detailed section."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 4,
      "style_type": 7,
      "generated_name": "Sarah T. Cook",
      "generation_date": "2025-12-09T09:18:39.659451"
    }
  },
  {
    "note_text": "Mrs. Cook underwent an EBUS procedure today to see if her lung cancer had spread to her lymph nodes. We used the ultrasound scope to guide a small needle into four different lymph node areas in her chest. Unfortunately, three of these areas showed cancer cells. This gives us important information about the stage of her disease, which is more advanced than we hoped. We are sending the samples for genetic testing to help the oncologists pick the best drug treatment for her.",
    "cpt_codes": [
      31653
    ],
    "registry_entry": {
      "patient_mrn": "5729384_syn_8",
      "procedure_date": "2025-01-21",
      "patient_age": 62,
      "gender": "Female",
      "asa_class": 3,
      "primary_indication": "80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-a",
      "sedation_type": "Deep",
      "airway_type": "Tracheostomy",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653
      ],
      "evidence": {
        "institution_name": "•        Location: Between RMB and LMB, posterior position",
        "attending_name": "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "patient_age": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "gender": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "dob": "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2) Diagnostic question: Tissue diagnosis and staging if malignancy confirmed RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60 ══════════════════════════════════════════ PRE-PROCEDURE: CONSENT: Written informed consent obtained after thorough discussion of: •        Nature and purpose of EBUS-TBNA •        Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures •        Benefits: Tissue diagnosis, staging information, minimally invasive •        Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment •        Patient's questions answered, demonstrated understanding ASA CLASSIFICATION: III NPO STATUS: Confirmed NPO since midnight (>10 hours) IV ACCESS: 20-gauge left forearm, patent MONITORING PLAN: •        Continuous pulse oximetry •        Capnography •        Blood pressure q3 minutes •        Continuous ECG •        Dedicated monitoring nurse ══════════════════════════════════════════ MEDICATIONS ADMINISTERED: TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure TOTAL PROPOFOL: 380mg TOPICAL ANESTHESIA: •        Benzocaine 20% spray to oropharynx (4 applications) •        Lidocaine 2% instilled via bronchoscope: 20mL total ══════════════════════════════════════════ EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present) ══════════════════════════════════════════ PROCEDURE DETAILS: TIMEOUT: Performed at 0830 •        Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944 •        Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy •        Site confirmed: Mediastinal lymph nodes •        Allergies confirmed: Sulfa drugs •        Consent confirmed: Yes, in chart •        Team introductions completed •        Equipment checked PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well. PROCEDURE NARRATIVE: After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization. UPPER AIRWAY INSPECTION: •        Oropharynx: Normal •        Epiglottis: Normal •        Vocal cords: Symmetric, mobile, no masses •        Subglottis: Patent TRACHEOBRONCHIAL TREE: •        Trachea: Normal caliber, no masses, mild mucosal edema •        Carina: Sharp, mobile •        Right mainstem: Patent •        Left mainstem: Patent •        Segmental airways: All visualized segments patent •        No endobronchial masses visualized SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY: ╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │ ║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝ TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED: ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound Characteristics: •        Location: Between RMB and LMB, posterior position •        Dimensions: 41mm (long) x 27mm (short) x 24mm (depth) •        Shape: Round •        Borders: Well-defined •        Echotexture: Diffusely hypoechoic •        Hilum: Completely absent •        Necrosis: None evident •        Vascularity: Peripheral vessels on color Doppler •        Elastography: Score 5/5 - very firm (blue pattern) INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass). Pass 1 (0842): •        Excellent sample obtained •        Visible tissue core in needle hub •        ROSE: ADEQUATE specimen, abundant cellularity •        ROSE: MALIGNANT CELLS IDENTIFIED •        ROSE: Morphology consistent with ADENOCARCINOMA Pass 2 (0845): •        Confirmatory sampling •        ROSE: Confirmed adenocarcinoma Pass 3 (0848): •        Additional tissue for molecular studies •        Sent for: EGFR, ALK, ROS1, BRAF, PD-L1 Pass 4 (0851): •        Microbiology specimen •        Sent for: AFB smear/culture, Fungal culture, Bacterial culture Complications: None. Minimal bleeding, self-limited. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 33x21mm, hypoechoic, no hilum Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 28x17mm, loss of hilum Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 24x16mm, abnormal appearance Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 19x13mm, hypoechoic Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 15x10mm, maintained normal architecture Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY ══════════════════════════════════════════ FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent. ══════════════════════════════════════════ RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma ✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers. ══════════════════════════════════════════ SPECIMENS SUBMITTED TO PATHOLOGY: CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes) □ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes) Total: 16 needle passes across 6 lymph node stations CELL BLOCKS: □ Station 7 (2 blocks prepared) MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture ══════════════════════════════════════════ FLUOROSCOPY: Not utilized for this procedure ESTIMATED BLOOD LOSS: <5mL COMPLICATIONS: None ADVERSE EVENTS: None ══════════════════════════════════════════ PATIENT TOLERANCE: The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of: •        Hypoxemia (SpO2 maintained 91-95%) •        Hypotension •        Hypertension •        Tachycardia or bradycardia •        Arrhythmias •        Bronchospasm •        Significant bleeding •        Laryngospasm Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting. ══════════════════════════════════════════ POST-PROCEDURE ORDERS: MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90% ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort) DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions ══════════════════════════════════════════ DIAGNOSTIC IMPRESSION: 1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield. 2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases 3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement: o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive) o        N2 disease: Stations 7, 4R (ipsilateral mediastinal) 4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease 5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated. 6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel ══════════════════════════════════════════ TREATMENT RECOMMENDATIONS: IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell □ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology □ Patient/Family Conference Schedule dedicated time to discuss: •        Diagnosis of adenocarcinoma •        Stage IIIC disease •        Treatment options •        Prognosis •        Goals of care STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease □ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases □ Bone scan or PET-CT total body May already have sufficient information from recent PET AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection): •        EGFR mutations → Consider EGFR TKI if positive •        ALK rearrangement → Consider ALK inhibitor if positive •        ROS1 rearrangement → Consider ROS1 inhibitor if positive •        PD-L1 expression → Impacts immunotherapy decisions •        Comprehensive NGS → May identify other actionable mutations TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen □ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.) □ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy □ Radiation Therapy Role to be determined - may be palliative or consolidative □ Clinical Trial Evaluate eligibility for appropriate trials SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions □ Social Work Financial counseling, support services □ Nutrition Address weight loss, optimize nutritional status □ Patient Navigator Coordinate care, appointments, resources FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results □ Medical Oncology: 04/10/2025 (already scheduled) □ Tumor Board Results Discussion: Following 04/11 conference PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment. ══════════════════════════════════════════ ATTESTATION: I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment. ══════════════════════════════════════════ BILLING INFORMATION: CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L) ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker) ══════════════════════════════════════════ ELECTRONIC SIGNATURE: Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890 Digitally Signed: 04/08/2025 10:45 AM ══════════════════════════════════════════ REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine □ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow) ══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════",
        "sedation_type": "deep or MAC sedation",
        "airway_type": "tracheostomy mentioned"
      },
      "institution_name": null,
      "molecular_testing_requested": true,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild (<50mL)",
      "pneumothorax": true,
      "pneumothorax_intervention": "Aspiration",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": "Ultrasound",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "See cancer doctor",
        "More tests",
        "Decide treatment",
        "Dr. S. Franklin 3/8/2025",
        "________________________________________",
        "EBUS",
        "INTERVENTIONAL PULMONOLOGY PROCEDURAL DOCUMENTATION",
        "══════════════════════════════════════════",
        "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "PROCEDURE: Endobronchial Ultrasound with Transbronchial Needle Aspiration (EBUS-TBNA)",
        "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "Left lower lobe mass 4.2cm on CT",
        "Extensive mediastinal and hilar lymphadenopathy",
        "Weight loss 18 lbs over 2 months",
        "No previous cancer history",
        "PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2)",
        "Diagnostic question: Tissue diagnosis and staging if malignancy confirmed",
        "RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently",
        "PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm",
        "LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60",
        "PRE-PROCEDURE:",
        "CONSENT: Written informed consent obtained after thorough discussion of:",
        "Nature and purpose of EBUS-TBNA",
        "Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures",
        "Benefits: Tissue diagnosis, staging information, minimally invasive",
        "Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment",
        "Patient's questions answered, demonstrated understanding",
        "ASA CLASSIFICATION: III",
        "NPO STATUS: Confirmed NPO since midnight (>10 hours)",
        "IV ACCESS: 20-gauge left forearm, patent",
        "MONITORING PLAN:",
        "Continuous pulse oximetry",
        "Capnography",
        "Blood pressure q3 minutes",
        "Continuous ECG",
        "Dedicated monitoring nurse",
        "MEDICATIONS ADMINISTERED:",
        "TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure",
        "TOTAL PROPOFOL: 380mg",
        "TOPICAL ANESTHESIA:",
        "Benzocaine 20% spray to oropharynx (4 applications)",
        "Lidocaine 2% instilled via bronchoscope: 20mL total",
        "EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present)",
        "PROCEDURE DETAILS:",
        "TIMEOUT: Performed at 0830",
        "Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944",
        "Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy",
        "Site confirmed: Mediastinal lymph nodes",
        "Allergies confirmed: Sulfa drugs",
        "Consent confirmed: Yes, in chart",
        "Team introductions completed",
        "Equipment checked",
        "PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes",
        "SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well.",
        "PROCEDURE NARRATIVE:",
        "After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization.",
        "UPPER AIRWAY INSPECTION:",
        "Oropharynx: Normal",
        "Epiglottis: Normal",
        "Vocal cords: Symmetric, mobile, no masses",
        "Subglottis: Patent",
        "TRACHEOBRONCHIAL TREE:",
        "Trachea: Normal caliber, no masses, mild mucosal edema",
        "Carina: Sharp, mobile",
        "Right mainstem: Patent",
        "Left mainstem: Patent",
        "Segmental airways: All visualized segments patent",
        "No endobronchial masses visualized",
        "SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY:",
        "╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │",
        "║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝",
        "TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED:",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound Characteristics:",
        "Location: Between RMB and LMB, posterior position",
        "Dimensions: 41mm (long) x 27mm (short) x 24mm (depth)",
        "Shape: Round",
        "Borders: Well-defined",
        "Echotexture: Diffusely hypoechoic",
        "Hilum: Completely absent",
        "Necrosis: None evident",
        "Vascularity: Peripheral vessels on color Doppler",
        "Elastography: Score 5/5 - very firm (blue pattern)",
        "INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY",
        "Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass).",
        "Pass 1 (0842):",
        "Excellent sample obtained",
        "Visible tissue core in needle hub",
        "ROSE: ADEQUATE specimen, abundant cellularity",
        "ROSE: MALIGNANT CELLS IDENTIFIED",
        "ROSE: Morphology consistent with ADENOCARCINOMA",
        "Pass 2 (0845):",
        "Confirmatory sampling",
        "ROSE: Confirmed adenocarcinoma",
        "Pass 3 (0848):",
        "Additional tissue for molecular studies",
        "Sent for: EGFR, ALK, ROS1, BRAF, PD-L1",
        "Pass 4 (0851):",
        "Microbiology specimen",
        "Sent for: AFB smear/culture, Fungal culture, Bacterial culture",
        "Complications: None. Minimal bleeding, self-limited.",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 33x21mm, hypoechoic, no hilum",
        "Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 28x17mm, loss of hilum",
        "Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 24x16mm, abnormal appearance",
        "Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 19x13mm, hypoechoic",
        "Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 15x10mm, maintained normal architecture",
        "Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY",
        "FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent.",
        "RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD",
        "POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma",
        "✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma",
        "NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only",
        "CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers.",
        "SPECIMENS SUBMITTED TO PATHOLOGY:",
        "CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes)",
        "□ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes)",
        "Total: 16 needle passes across 6 lymph node stations",
        "CELL BLOCKS: □ Station 7 (2 blocks prepared)",
        "MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel",
        "MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture",
        "FLUOROSCOPY: Not utilized for this procedure",
        "ESTIMATED BLOOD LOSS: <5mL",
        "COMPLICATIONS: None",
        "ADVERSE EVENTS: None",
        "PATIENT TOLERANCE:",
        "The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of:",
        "Hypoxemia (SpO2 maintained 91-95%)",
        "Hypotension",
        "Hypertension",
        "Tachycardia or bradycardia",
        "Arrhythmias",
        "Bronchospasm",
        "Significant bleeding",
        "Laryngospasm",
        "Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting.",
        "POST-PROCEDURE ORDERS:",
        "MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90%",
        "ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance",
        "DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated",
        "MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort)",
        "DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions",
        "DIAGNOSTIC IMPRESSION:",
        "1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield.",
        "2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases",
        "3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement:",
        "o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive)",
        "o        N2 disease: Stations 7, 4R (ipsilateral mediastinal)",
        "4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease",
        "5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated.",
        "6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel",
        "TREATMENT RECOMMENDATIONS:",
        "IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell",
        "□ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology",
        "□ Patient/Family Conference Schedule dedicated time to discuss:",
        "Diagnosis of adenocarcinoma",
        "Stage IIIC disease",
        "Treatment options",
        "Prognosis",
        "Goals of care",
        "STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease",
        "□ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases",
        "□ Bone scan or PET-CT total body May already have sufficient information from recent PET",
        "AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection):",
        "EGFR mutations → Consider EGFR TKI if positive",
        "ALK rearrangement → Consider ALK inhibitor if positive",
        "ROS1 rearrangement → Consider ROS1 inhibitor if positive",
        "PD-L1 expression → Impacts immunotherapy decisions",
        "Comprehensive NGS → May identify other actionable mutations",
        "TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen",
        "□ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.)",
        "□ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy",
        "□ Radiation Therapy Role to be determined - may be palliative or consolidative",
        "□ Clinical Trial Evaluate eligibility for appropriate trials",
        "SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions",
        "□ Social Work Financial counseling, support services",
        "□ Nutrition Address weight loss, optimize nutritional status",
        "□ Patient Navigator Coordinate care, appointments, resources",
        "FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results",
        "□ Medical Oncology: 04/10/2025 (already scheduled)",
        "□ Tumor Board Results Discussion: Following 04/11 conference",
        "PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding",
        "PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment.",
        "ATTESTATION:",
        "I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment.",
        "BILLING INFORMATION:",
        "CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L)",
        "ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker)",
        "ELECTRONIC SIGNATURE:",
        "Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890",
        "Digitally Signed: 04/08/2025 10:45 AM",
        "REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine",
        "□ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow)",
        "══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": "Fluoroscopy",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "needle"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 42.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "ATTENDING: Montgomery",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155518"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "CONCATENATED_NOTE: Note contains header for 'Mills, Robert E' (03/08/2025) but body for 'Russell, Dorothy Mae' (04/08/2025). Extracted data corrected to match the detailed body (Russell)."
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.040705",
      "changes": [
        "Extracted lesion_size_mm: 42.0",
        "Extracted EBUS stations: ['10L', '10R', '11L', '11R', '4L', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "EBUS-TBNA report for Russell, Dorothy Mae (concatenated note body).",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of 6 stations (7, 4L, 4R, 10L, 10R, 11L) documented in the 'Russell' portion of the note."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 7.7,
        "total_facility_mpfs_payment": 249.0,
        "computation_notes": "Single code 31653."
      },
      "rationale": [
        "Data Quality: The note contains a header for 'Mills' but the detailed procedure describes 'Russell'. The coding review is based on the detailed 'Russell' note which documents EBUS-TBNA of 6 stations.",
        "Code selection: Sampling of 3+ stations maps to 31653. No peripheral lesion sampling or other interventions documented in the detailed section."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 4,
      "style_type": 8,
      "generated_name": "Kimberly D. Morgan",
      "generation_date": "2025-12-09T09:18:39.659524"
    }
  },
  {
    "note_text": "Procedure: Mediastinal staging via EBUS-TBNA.\nTarget: Stations 7, 4R, 10R, 11R.\nAction: Needle aspiration performed under sonographic guidance.\nAnalysis: Malignant cells detected in the subcarinal, right paratracheal, and right hilar stations. The interlobar station was benign.\nConclusion: Advanced nodal involvement (N3/Stage IIIC).",
    "cpt_codes": [
      31653
    ],
    "registry_entry": {
      "patient_mrn": "5729384_syn_9",
      "procedure_date": "2025-05-21",
      "patient_age": 62,
      "gender": "Female",
      "asa_class": 3,
      "primary_indication": "80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-a",
      "sedation_type": "Deep",
      "airway_type": "Tracheostomy",
      "final_diagnosis_prelim": "Malignancy",
      "cpt_codes": [
        31653
      ],
      "evidence": {
        "institution_name": "•        Location: Between RMB and LMB, posterior position",
        "attending_name": "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "patient_age": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "gender": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "dob": "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "asa_class": "Defaulted to ASA 3 (not explicitly documented)",
        "primary_indication": "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with: •        Left lower lobe mass 4.2cm on CT •        Extensive mediastinal and hilar lymphadenopathy •        Weight loss 18 lbs over 2 months •        No previous cancer history •        PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2) Diagnostic question: Tissue diagnosis and staging if malignancy confirmed RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60 ══════════════════════════════════════════ PRE-PROCEDURE: CONSENT: Written informed consent obtained after thorough discussion of: •        Nature and purpose of EBUS-TBNA •        Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures •        Benefits: Tissue diagnosis, staging information, minimally invasive •        Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment •        Patient's questions answered, demonstrated understanding ASA CLASSIFICATION: III NPO STATUS: Confirmed NPO since midnight (>10 hours) IV ACCESS: 20-gauge left forearm, patent MONITORING PLAN: •        Continuous pulse oximetry •        Capnography •        Blood pressure q3 minutes •        Continuous ECG •        Dedicated monitoring nurse ══════════════════════════════════════════ MEDICATIONS ADMINISTERED: TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure TOTAL PROPOFOL: 380mg TOPICAL ANESTHESIA: •        Benzocaine 20% spray to oropharynx (4 applications) •        Lidocaine 2% instilled via bronchoscope: 20mL total ══════════════════════════════════════════ EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present) ══════════════════════════════════════════ PROCEDURE DETAILS: TIMEOUT: Performed at 0830 •        Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944 •        Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy •        Site confirmed: Mediastinal lymph nodes •        Allergies confirmed: Sulfa drugs •        Consent confirmed: Yes, in chart •        Team introductions completed •        Equipment checked PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well. PROCEDURE NARRATIVE: After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization. UPPER AIRWAY INSPECTION: •        Oropharynx: Normal •        Epiglottis: Normal •        Vocal cords: Symmetric, mobile, no masses •        Subglottis: Patent TRACHEOBRONCHIAL TREE: •        Trachea: Normal caliber, no masses, mild mucosal edema •        Carina: Sharp, mobile •        Right mainstem: Patent •        Left mainstem: Patent •        Segmental airways: All visualized segments patent •        No endobronchial masses visualized SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY: ╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │ ║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝ TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED: ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound Characteristics: •        Location: Between RMB and LMB, posterior position •        Dimensions: 41mm (long) x 27mm (short) x 24mm (depth) •        Shape: Round •        Borders: Well-defined •        Echotexture: Diffusely hypoechoic •        Hilum: Completely absent •        Necrosis: None evident •        Vascularity: Peripheral vessels on color Doppler •        Elastography: Score 5/5 - very firm (blue pattern) INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass). Pass 1 (0842): •        Excellent sample obtained •        Visible tissue core in needle hub •        ROSE: ADEQUATE specimen, abundant cellularity •        ROSE: MALIGNANT CELLS IDENTIFIED •        ROSE: Morphology consistent with ADENOCARCINOMA Pass 2 (0845): •        Confirmatory sampling •        ROSE: Confirmed adenocarcinoma Pass 3 (0848): •        Additional tissue for molecular studies •        Sent for: EGFR, ALK, ROS1, BRAF, PD-L1 Pass 4 (0851): •        Microbiology specimen •        Sent for: AFB smear/culture, Fungal culture, Bacterial culture Complications: None. Minimal bleeding, self-limited. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 33x21mm, hypoechoic, no hilum Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 28x17mm, loss of hilum Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 24x16mm, abnormal appearance Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 19x13mm, hypoechoic Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Ultrasound: 15x10mm, maintained normal architecture Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY ══════════════════════════════════════════ FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent. ══════════════════════════════════════════ RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma ✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers. ══════════════════════════════════════════ SPECIMENS SUBMITTED TO PATHOLOGY: CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes) □ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes) Total: 16 needle passes across 6 lymph node stations CELL BLOCKS: □ Station 7 (2 blocks prepared) MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture ══════════════════════════════════════════ FLUOROSCOPY: Not utilized for this procedure ESTIMATED BLOOD LOSS: <5mL COMPLICATIONS: None ADVERSE EVENTS: None ══════════════════════════════════════════ PATIENT TOLERANCE: The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of: •        Hypoxemia (SpO2 maintained 91-95%) •        Hypotension •        Hypertension •        Tachycardia or bradycardia •        Arrhythmias •        Bronchospasm •        Significant bleeding •        Laryngospasm Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting. ══════════════════════════════════════════ POST-PROCEDURE ORDERS: MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90% ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort) DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions ══════════════════════════════════════════ DIAGNOSTIC IMPRESSION: 1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield. 2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases 3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement: o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive) o        N2 disease: Stations 7, 4R (ipsilateral mediastinal) 4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease 5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated. 6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel ══════════════════════════════════════════ TREATMENT RECOMMENDATIONS: IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell □ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology □ Patient/Family Conference Schedule dedicated time to discuss: •        Diagnosis of adenocarcinoma •        Stage IIIC disease •        Treatment options •        Prognosis •        Goals of care STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease □ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases □ Bone scan or PET-CT total body May already have sufficient information from recent PET AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection): •        EGFR mutations → Consider EGFR TKI if positive •        ALK rearrangement → Consider ALK inhibitor if positive •        ROS1 rearrangement → Consider ROS1 inhibitor if positive •        PD-L1 expression → Impacts immunotherapy decisions •        Comprehensive NGS → May identify other actionable mutations TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen □ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.) □ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy □ Radiation Therapy Role to be determined - may be palliative or consolidative □ Clinical Trial Evaluate eligibility for appropriate trials SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions □ Social Work Financial counseling, support services □ Nutrition Address weight loss, optimize nutritional status □ Patient Navigator Coordinate care, appointments, resources FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results □ Medical Oncology: 04/10/2025 (already scheduled) □ Tumor Board Results Discussion: Following 04/11 conference PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment. ══════════════════════════════════════════ ATTESTATION: I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment. ══════════════════════════════════════════ BILLING INFORMATION: CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L) ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker) ══════════════════════════════════════════ ELECTRONIC SIGNATURE: Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890 Digitally Signed: 04/08/2025 10:45 AM ══════════════════════════════════════════ REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine □ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow) ══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════",
        "sedation_type": "deep or MAC sedation",
        "airway_type": "tracheostomy mentioned"
      },
      "institution_name": null,
      "molecular_testing_requested": true,
      "disposition": "Outpatient discharge",
      "bleeding_severity": "Mild (<50mL)",
      "pneumothorax": true,
      "pneumothorax_intervention": "Aspiration",
      "ablation_peripheral_performed": false,
      "ablation_modality": null,
      "pleural_procedure_type": null,
      "pleural_guidance": "Ultrasound",
      "pleurodesis_performed": false,
      "pleurodesis_agent": null,
      "blvr_target_lobe": null,
      "blvr_valve_type": null,
      "blvr_number_of_valves": null,
      "wll_volume_instilled_l": null,
      "wll_volume_returned_l": null,
      "wll_dlt_used": null,
      "fb_object_type": null,
      "fb_tool_used": [],
      "fb_removal_success": null,
      "bt_lobe_treated": null,
      "bt_activation_count": null,
      "follow_up_plan": [
        "See cancer doctor",
        "More tests",
        "Decide treatment",
        "Dr. S. Franklin 3/8/2025",
        "________________________________________",
        "EBUS",
        "INTERVENTIONAL PULMONOLOGY PROCEDURAL DOCUMENTATION",
        "══════════════════════════════════════════",
        "DEMOGRAPHICS: NAME: Russell, Dorothy Mae MRN: 5729384 DOB: 06/14/1944 (Age 80) SEX: Female PROCEDURE DATE: 04/08/2025 LOCATION: Bronchoscopy Suite, 4th Floor",
        "CLINICAL TEAM: ATTENDING: Montgomery, Richard MD FELLOW: Lee, Christina MD CRNA: Johnson, Mark CRNA RN: Peters, Emily RN, BSN RT: Thompson, David RRT CYTOLOGY: Baker, Linda MD",
        "PROCEDURE: Endobronchial Ultrasound with Transbronchial Needle Aspiration (EBUS-TBNA)",
        "INDICATION: 80-year-old female, 20 pack-year smoking history (quit 30 years ago), presenting with:",
        "Left lower lobe mass 4.2cm on CT",
        "Extensive mediastinal and hilar lymphadenopathy",
        "Weight loss 18 lbs over 2 months",
        "No previous cancer history",
        "PET-CT shows multiple FDG-avid lymph nodes (SUV up to 9.2)",
        "Diagnostic question: Tissue diagnosis and staging if malignancy confirmed",
        "RELEVANT HISTORY: PMH: COPD (moderate), hypertension, osteoarthritis, GERD PSH: Cholecystectomy (1998), Total hip replacement right (2018) MEDICATIONS: Advair, albuterol, amlodipine, omeprazole ALLERGIES: Sulfa drugs (rash) SOCIAL: Former smoker, no alcohol, lives independently",
        "PHYSICAL EXAM: Vitals: BP 138/82, HR 76, RR 16, SpO2 94% on RA, Temp 98.2°F General: Alert, cooperative, no acute distress Lungs: Decreased breath sounds left base, otherwise clear CV: Regular rate and rhythm",
        "LABS (04/07/2025): WBC 6.8, Hgb 11.9, Platelets 245K, INR 1.0 Creatinine 0.9, eGFR >60",
        "PRE-PROCEDURE:",
        "CONSENT: Written informed consent obtained after thorough discussion of:",
        "Nature and purpose of EBUS-TBNA",
        "Risks: bleeding, infection, pneumothorax (<1%), vocal cord injury, tooth damage, adverse reaction to sedation, failure to obtain diagnosis, need for additional procedures",
        "Benefits: Tissue diagnosis, staging information, minimally invasive",
        "Alternatives: CT-guided biopsy, surgical biopsy, empiric treatment",
        "Patient's questions answered, demonstrated understanding",
        "ASA CLASSIFICATION: III",
        "NPO STATUS: Confirmed NPO since midnight (>10 hours)",
        "IV ACCESS: 20-gauge left forearm, patent",
        "MONITORING PLAN:",
        "Continuous pulse oximetry",
        "Capnography",
        "Blood pressure q3 minutes",
        "Continuous ECG",
        "Dedicated monitoring nurse",
        "MEDICATIONS ADMINISTERED:",
        "TIME | MEDICATION | DOSE | ROUTE | INDICATION 0815 | Glycopyrrolate | 0.2mg | IV | Reduce secretions 0825 | Midazolam | 2mg | IV | Anxiolysis 0827 | Fentanyl | 75mcg | IV | Analgesia/sedation 0830 | Propofol infusion | Start | IV | Deep sedation | (50-125 mcg/kg/min) | | | 0912 | Propofol | Stop | IV | End of procedure",
        "TOTAL PROPOFOL: 380mg",
        "TOPICAL ANESTHESIA:",
        "Benzocaine 20% spray to oropharynx (4 applications)",
        "Lidocaine 2% instilled via bronchoscope: 20mL total",
        "EQUIPMENT: BRONCHOSCOPE: Olympus BF-UC180F (Linear EBUS scope) ULTRASOUND: Olympus EU-ME2 Premier Plus TBNA NEEDLES: 22-gauge Olympus NA-201SX-4022 RAPID ONSITE EVALUATION: Available (Dr. Baker present)",
        "PROCEDURE DETAILS:",
        "TIMEOUT: Performed at 0830",
        "Patient identity confirmed: Dorothy Mae Russell, MRN 5729384, DOB 06/14/1944",
        "Procedure confirmed: EBUS-TBNA for LLL mass and mediastinal adenopathy",
        "Site confirmed: Mediastinal lymph nodes",
        "Allergies confirmed: Sulfa drugs",
        "Consent confirmed: Yes, in chart",
        "Team introductions completed",
        "Equipment checked",
        "PROCEDURE START: 0832 PROCEDURE END: 0912 TOTAL TIME: 40 minutes",
        "SEDATION SUMMARY: Patient achieved moderate-to-deep sedation level. Remained hemodynamically stable throughout procedure. SpO2 maintained 91-95% on 4L O2 via nasal cannula. No episodes of hypotension or arrhythmia. Responded appropriately to verbal stimuli. Total sedation time: 47 minutes. Recovered well.",
        "PROCEDURE NARRATIVE:",
        "After adequate sedation achieved and timeout completed, EBUS bronchoscope introduced via oropharynx under direct visualization.",
        "UPPER AIRWAY INSPECTION:",
        "Oropharynx: Normal",
        "Epiglottis: Normal",
        "Vocal cords: Symmetric, mobile, no masses",
        "Subglottis: Patent",
        "TRACHEOBRONCHIAL TREE:",
        "Trachea: Normal caliber, no masses, mild mucosal edema",
        "Carina: Sharp, mobile",
        "Right mainstem: Patent",
        "Left mainstem: Patent",
        "Segmental airways: All visualized segments patent",
        "No endobronchial masses visualized",
        "SYSTEMATIC MEDIASTINAL ULTRASOUND SURVEY:",
        "╔══════════════════════════════════════════════════════════════╗ ║ STATION │ SIZE │ MORPHOLOGY │ SAMPLED │ ROSE ║ ╠══════════════════════════════════════════════════════════════╣ ║ 2R │ 9x6mm │ Normal hilum │ No │",
        "║ ║ 11L │ 19x13mm │ Hypoechoic │ YES │ MALIGNANT║ ╚══════════════════════════════════════════════════════════════╝",
        "TRANSBRONCHIAL NEEDLE ASPIRATION - DETAILED:",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 7 - SUBCARINAL NODE ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound Characteristics:",
        "Location: Between RMB and LMB, posterior position",
        "Dimensions: 41mm (long) x 27mm (short) x 24mm (depth)",
        "Shape: Round",
        "Borders: Well-defined",
        "Echotexture: Diffusely hypoechoic",
        "Hilum: Completely absent",
        "Necrosis: None evident",
        "Vascularity: Peripheral vessels on color Doppler",
        "Elastography: Score 5/5 - very firm (blue pattern)",
        "INTERPRETATION: HIGHLY SUSPICIOUS FOR MALIGNANCY",
        "Aspiration Technique: 22-gauge needle advanced under real-time ultrasound guidance. Needle tip visualized entering node. Suction applied with to-and-fro motion (20-25 agitations per pass).",
        "Pass 1 (0842):",
        "Excellent sample obtained",
        "Visible tissue core in needle hub",
        "ROSE: ADEQUATE specimen, abundant cellularity",
        "ROSE: MALIGNANT CELLS IDENTIFIED",
        "ROSE: Morphology consistent with ADENOCARCINOMA",
        "Pass 2 (0845):",
        "Confirmatory sampling",
        "ROSE: Confirmed adenocarcinoma",
        "Pass 3 (0848):",
        "Additional tissue for molecular studies",
        "Sent for: EGFR, ALK, ROS1, BRAF, PD-L1",
        "Pass 4 (0851):",
        "Microbiology specimen",
        "Sent for: AFB smear/culture, Fungal culture, Bacterial culture",
        "Complications: None. Minimal bleeding, self-limited.",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4L - LEFT LOWER PARATRACHEAL ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 33x21mm, hypoechoic, no hilum",
        "Pass 1-3 (0855-0901): ROSE: POSITIVE FOR MALIGNANCY, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 4R - RIGHT LOWER PARATRACHEAL",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 28x17mm, loss of hilum",
        "Pass 1-3 (0903-0907): ROSE: MALIGNANT, consistent with adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10L - LEFT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 24x16mm, abnormal appearance",
        "Pass 1-2 (0908-0910): ROSE: POSITIVE, adenocarcinoma",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 11L - LEFT INTERLOBAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 19x13mm, hypoechoic",
        "Pass 1-2 (0911-0912): ROSE: MALIGNANT CELLS PRESENT",
        "━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ STATION 10R - RIGHT HILAR ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━",
        "Ultrasound: 15x10mm, maintained normal architecture",
        "Pass 1-2 (0909-0910): ROSE: BENIGN reactive lymphocytes, NO MALIGNANCY",
        "FINAL AIRWAY INSPECTION: Bronchoscope withdrawn slowly with careful inspection. No evidence of bleeding. All airways patent.",
        "RAPID ON-SITE EVALUATION SUMMARY: Cytopathologist: Linda Baker, MD",
        "POSITIVE STATIONS (MALIGNANT): ✓ Station 7 - Adenocarcinoma ✓ Station 4L - Adenocarcinoma ✓ Station 4R - Adenocarcinoma",
        "✓ Station 10L - Adenocarcinoma ✓ Station 11L - Adenocarcinoma",
        "NEGATIVE STATION (BENIGN): ✓ Station 10R - Reactive lymphoid tissue only",
        "CYTOLOGIC INTERPRETATION: Malignant cells consistent with metastatic adenocarcinoma present in multiple mediastinal and hilar lymph node stations bilaterally. Tumor cells demonstrate glandular differentiation. No small cell features. Awaiting final pathology and molecular markers.",
        "SPECIMENS SUBMITTED TO PATHOLOGY:",
        "CYTOLOGY SPECIMENS: □ Station 7 - Subcarinal (4 passes) □ Station 4L - L lower paratracheal (3 passes) □ Station 4R - R lower paratracheal (3 passes) □ Station 10L - L hilar (2 passes)",
        "□ Station 10R - R hilar (2 passes) □ Station 11L - L interlobar (2 passes)",
        "Total: 16 needle passes across 6 lymph node stations",
        "CELL BLOCKS: □ Station 7 (2 blocks prepared)",
        "MOLECULAR TESTING (Station 7): □ EGFR mutation analysis (exons 18-21) □ ALK rearrangement (FISH and IHC) □ ROS1 rearrangement (FISH) □ BRAF V600E mutation □ PD-L1 immunohistochemistry (22C3 antibody) □ Next-generation sequencing (NGS) comprehensive panel",
        "MICROBIOLOGY (Station 7): □ Acid-fast bacilli (AFB) smear and culture □ Fungal culture □ Bacterial culture",
        "FLUOROSCOPY: Not utilized for this procedure",
        "ESTIMATED BLOOD LOSS: <5mL",
        "COMPLICATIONS: None",
        "ADVERSE EVENTS: None",
        "PATIENT TOLERANCE:",
        "The patient tolerated the procedure well. Hemodynamically stable throughout with no episodes of:",
        "Hypoxemia (SpO2 maintained 91-95%)",
        "Hypotension",
        "Hypertension",
        "Tachycardia or bradycardia",
        "Arrhythmias",
        "Bronchospasm",
        "Significant bleeding",
        "Laryngospasm",
        "Recovered from sedation appropriately within 35 minutes post-procedure. Alert and oriented x3. Following commands. Gag reflex intact. No nausea or vomiting.",
        "POST-PROCEDURE ORDERS:",
        "MONITORING: □ Recovery area observation x 2 hours □ Vital signs: q15min x 4, then q30min x 2 □ Continuous pulse oximetry x 2 hours □ Call MD for: chest pain, dyspnea, hemoptysis, fever >100.4°F, SpO2 <90%",
        "ACTIVITY: □ Bedrest x 1 hour, then ambulate with assistance",
        "DIET: □ NPO x 1 hour (assess gag reflex) □ Then advance to regular diet as tolerated",
        "MEDICATIONS: □ Resume home medications □ Pain: Acetaminophen 650mg PO PRN (throat discomfort)",
        "DISCHARGE CRITERIA: □ Stable vital signs □ No respiratory distress □ Adequate O2 saturation on room air or baseline □ Tolerating PO □ Responsible adult to drive home □ Understands discharge instructions",
        "DIAGNOSTIC IMPRESSION:",
        "1.        SUCCESSFUL EBUS-TBNA WITH ADEQUATE TISSUE ACQUISITION Multiple mediastinal and hilar lymph node stations sampled with excellent cytologic yield.",
        "2.        ADENOCARCINOMA OF THE LUNG (based on ROSE cytology) Primary left lower lobe adenocarcinoma with extensive lymph node metastases",
        "3.        EXTENSIVE N3 NODAL DISEASE Bilateral mediastinal and hilar lymph node involvement:",
        "o        N3 disease: Stations 4L, 10L, 11L (contralateral nodes positive)",
        "o        N2 disease: Stations 7, 4R (ipsilateral mediastinal)",
        "4.        STAGE IIIC DISEASE (minimum staging: cT3N3M0) Based on: 4.2cm LLL mass (T2 minimum, may be T3/T4 pending assessment of location/invasion) + N3 nodal disease",
        "5.        PROGNOSIS: Advanced stage disease. Not a surgical candidate. Systemic therapy indicated.",
        "6.        MOLECULAR TESTING PENDING: Critical for treatment selection - EGFR, ALK, ROS1, PD-L1, comprehensive NGS panel",
        "TREATMENT RECOMMENDATIONS:",
        "IMMEDIATE (Within 1 week): □ URGENT Medical Oncology Consultation Scheduled for 04/10/2025 with Dr. Sarah Mitchell",
        "□ Multidisciplinary Tumor Board Presentation Thursday conference 04/11/2025 Teams: Medical oncology, radiation oncology, thoracic surgery, pulmonology, radiology, pathology",
        "□ Patient/Family Conference Schedule dedicated time to discuss:",
        "Diagnosis of adenocarcinoma",
        "Stage IIIC disease",
        "Treatment options",
        "Prognosis",
        "Goals of care",
        "STAGING COMPLETION: □ Brain MRI with contrast (ORDERED - to evaluate for metastases) High priority given advanced nodal disease",
        "□ Abdominal/Pelvic CT (if not recent) Evaluate for distant metastases",
        "□ Bone scan or PET-CT total body May already have sufficient information from recent PET",
        "AWAITING RESULTS (3-7 business days): □ Final cytopathology report □ Molecular testing results (CRITICAL for treatment selection):",
        "EGFR mutations → Consider EGFR TKI if positive",
        "ALK rearrangement → Consider ALK inhibitor if positive",
        "ROS1 rearrangement → Consider ROS1 inhibitor if positive",
        "PD-L1 expression → Impacts immunotherapy decisions",
        "Comprehensive NGS → May identify other actionable mutations",
        "TREATMENT OPTIONS (pending molecular results): □ Systemic Chemotherapy Standard platinum-doublet regimen",
        "□ Targeted Therapy If actionable mutation identified (EGFR, ALK, ROS1, etc.)",
        "□ Immunotherapy Consider based on PD-L1 expression, may combine with chemotherapy",
        "□ Radiation Therapy Role to be determined - may be palliative or consolidative",
        "□ Clinical Trial Evaluate eligibility for appropriate trials",
        "SUPPORTIVE CARE: □ Palliative Care Consultation Early integration recommended for symptom management and goals of care discussions",
        "□ Social Work Financial counseling, support services",
        "□ Nutrition Address weight loss, optimize nutritional status",
        "□ Patient Navigator Coordinate care, appointments, resources",
        "FOLLOW-UP APPOINTMENTS: □ Interventional Pulmonology Clinic: 1 week (04/15/2025) Review final pathology and molecular results",
        "□ Medical Oncology: 04/10/2025 (already scheduled)",
        "□ Tumor Board Results Discussion: Following 04/11 conference",
        "PATIENT EDUCATION PROVIDED: □ Explained diagnosis of lung adenocarcinoma □ Discussed staging (Stage IIIC - advanced but not metastatic) □ Reviewed that surgery is not an option due to extent of lymph node involvement □ Explained importance of molecular testing for treatment selection □ Discussed general treatment approach (chemotherapy, targeted therapy, immunotherapy) □ Set realistic expectations about prognosis □ Provided written materials on lung cancer □ Gave contact information for lung cancer support groups □ Reviewed warning signs: fever, severe chest pain, coughing up blood, severe shortness of breath □ Encouraged questions - patient and family very engaged and understanding",
        "PSYCHOSOCIAL: Patient and family understandably distressed by diagnosis. Daughter present for procedure and results discussion. Patient has strong family support system. Discussed importance of addressing emotional and practical needs alongside medical treatment.",
        "ATTESTATION:",
        "I personally performed this procedure and was present for the entire duration including all critical portions. The patient was appropriately monitored throughout with dedicated nursing staff. Informed consent was obtained. The procedure was performed in accordance with accepted standards of care. All diagnostic findings and treatment recommendations documented above represent my professional medical assessment and judgment.",
        "BILLING INFORMATION:",
        "CPT CODES: □ 31652 - Endobronchial ultrasound (EBUS) during bronchoscopic diagnostic or therapeutic intervention(s), including fluoroscopic guidance when performed (first target) □ 31653 x5 - Each additional target (Stations 4L, 4R, 10L, 10R, 11L)",
        "ICD-10 CODES: □ C34.32 - Malignant neoplasm of lower lobe, left bronchus or lung □ C77.1 - Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes □ Z85.116 - Personal history of other tobacco dependence (former smoker)",
        "ELECTRONIC SIGNATURE:",
        "Richard Montgomery, MD, FCCP, FCCM Board Certified: Internal Medicine, Pulmonary Disease, Critical Care Medicine, Interventional Pulmonology Medical License: CA-A12345 DEA: BM1234563 NPI: 1234567890",
        "Digitally Signed: 04/08/2025 10:45 AM",
        "REPORT DISTRIBUTION: □ Electronic Medical Record (Primary) □ Referring Physician: Dr. James Peterson, Internal Medicine",
        "□ Medical Oncology: Dr. Sarah Mitchell □ Cytopathology: Dr. Linda Baker □ Patient Portal (patient-friendly summary letter to follow)",
        "══════════════════════════════════════════ END OF REPORT ══════════════════════════════════════════"
      ],
      "nav_platform": null,
      "nav_registration_method": null,
      "nav_registration_error_mm": null,
      "nav_rebus_used": null,
      "nav_rebus_view": null,
      "nav_imaging_verification": "Fluoroscopy",
      "nav_tool_in_lesion": null,
      "nav_sampling_tools": [
        "needle"
      ],
      "nav_cryobiopsy_for_nodule": null,
      "sedation_reversal_given": null,
      "sedation_reversal_agent": null,
      "ebus_photodocumentation_complete": null,
      "procedure_setting": null,
      "anticoag_status": null,
      "anticoag_held_preprocedure": null,
      "radiographic_findings": null,
      "lesion_size_mm": 42.0,
      "lesion_location": null,
      "pet_suv_max": null,
      "pet_avid": null,
      "bronchus_sign_present": null,
      "cao_location": null,
      "prior_therapy": null,
      "airway_device_size": null,
      "ventilation_mode": null,
      "anesthesia_agents": null,
      "ebus_scope_brand": null,
      "ebus_stations_sampled": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "linear_ebus_stations": [
        "10L",
        "10R",
        "11L",
        "11R",
        "4L",
        "4R",
        "7"
      ],
      "ebus_needle_gauge": null,
      "ebus_needle_type": null,
      "ebus_systematic_staging": null,
      "ebus_rose_available": null,
      "ebus_rose_result": null,
      "ebus_elastography_used": null,
      "ebus_elastography_pattern": null,
      "ebus_intranodal_forceps_used": null,
      "ebus_stations_detail": null,
      "cao_primary_modality": null,
      "cao_tumor_location": null,
      "cao_obstruction_pre_pct": null,
      "cao_obstruction_post_pct": null,
      "stent_type": null,
      "stent_deployment_method": null,
      "stent_diameter_mm": null,
      "stent_length_mm": null,
      "stent_location": null,
      "blvr_cv_assessment_method": null,
      "blvr_chartis_result": null,
      "ablation_device_name": null,
      "ablation_power_watts": null,
      "ablation_duration_seconds": null,
      "ablation_max_temp_c": null,
      "ablation_margin_assessed": null,
      "pleural_side": null,
      "pleural_intercostal_space": null,
      "pleural_opening_pressure_measured": null,
      "pleural_opening_pressure_cmh2o": null,
      "pleural_fluid_appearance": null,
      "pleural_volume_drained_ml": null,
      "pleural_thoracoscopy_findings": null,
      "bronch_indication": null,
      "bronch_location_lobe": null,
      "bronch_location_segment": null,
      "bronch_guidance": null,
      "bronch_num_tbbx": null,
      "bronch_tbbx_tool": null,
      "bronch_specimen_tests": null,
      "bronch_immediate_complications": null,
      "ebl_ml": null,
      "hypoxia_respiratory_failure": null,
      "fluoro_time_min": null,
      "radiation_dap_gycm2": null,
      "ablation_complication_immediate": null,
      "providers": {
        "attending_name": "ATTENDING: Montgomery",
        "fellow_name": null,
        "assistant_name": null,
        "assistant_role": null,
        "trainee_present": null
      },
      "metadata": {
        "data_entry_status": "Complete",
        "version": "0.4.0",
        "generated_at": "2025-12-01T15:40:50.155518"
      }
    },
    "source_file": "synthetic_notes_with_registry.jsonl",
    "cpt_verification_errors": [],
    "cpt_validation_metadata": {
      "golden_knowledge_version": "2.7",
      "valid_codes": [
        "31653"
      ],
      "invalid_codes": []
    },
    "data_quality_flags": [
      "CONCATENATED_NOTE: Note contains header for 'Mills, Robert E' (03/08/2025) but body for 'Russell, Dorothy Mae' (04/08/2025). Extracted data corrected to match the detailed body (Russell)."
    ],
    "patch_metadata": {
      "patched": true,
      "patch_version": "1.0.0",
      "patch_date": "2025-12-02T02:00:48.040705",
      "changes": [
        "Extracted lesion_size_mm: 42.0",
        "Extracted EBUS stations: ['10L', '10R', '11L', '11R', '4L', '4R', '7']"
      ],
      "warnings": []
    },
    "coding_review": {
      "reviewer": "IP-Coder-Patch-GPT",
      "review_date": "2025-12-06",
      "coding_system_version": "ip_coding_billing.v2_7",
      "source_note_citation": "EBUS-TBNA report for Russell, Dorothy Mae (concatenated note body).",
      "knowledge_citations": [
        "IP coding & billing knowledge base v2.7",
        "2025 MPFS facility RVUs"
      ],
      "per_code": [
        {
          "code": "31653",
          "description": "Bronchoscopy with EBUS sampling, 3 or more nodal stations.",
          "category": "bronchoscopy_ebus_linear",
          "units": 1,
          "facility_total_rvus_2025": 7.7,
          "facility_mpfs_payment_2025": 249.0,
          "bundling_or_modifier_notes": "Primary code. Supported by sampling of 6 stations (7, 4L, 4R, 10L, 10R, 11L) documented in the 'Russell' portion of the note."
        }
      ],
      "totals_2025_facility": {
        "total_facility_rvus": 7.7,
        "total_facility_mpfs_payment": 249.0,
        "computation_notes": "Single code 31653."
      },
      "rationale": [
        "Data Quality: The note contains a header for 'Mills' but the detailed procedure describes 'Russell'. The coding review is based on the detailed 'Russell' note which documents EBUS-TBNA of 6 stations.",
        "Code selection: Sampling of 3+ stations maps to 31653. No peripheral lesion sampling or other interventions documented in the detailed section."
      ]
    },
    "synthetic_metadata": {
      "source_file": "golden_extractions/consolidated_verified_notes_v2_8_part_007.json",
      "original_index": 4,
      "style_type": 9,
      "generated_name": "Cynthia B. Bell",
      "generation_date": "2025-12-09T09:18:39.659600"
    }
  }
]